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Kilovoltage Range X-ray Characterisation and
Diagnostic Applications of the MOSkin Dosimeter
Nathan Kenneth Thorpe




The use of diagnostic imaging services has been increasing significantly over recent
decades as the availability and the sophistication of diagnostic imaging equipment has
expanded. This has resulted in improved patient outcome through earlier and more
accurate diagnoses at cost of increasing radiation exposure to the general populace.
This may result in an increased incidence of radiation-induced conditions and cancer.
Monitoring the radiation exposures during these procedures is crucial to preventing ra-
diation induced conditions and minimising radiation exposure both to patients and to
operators of radiation imaging technologies where possible. This thesis investigated the
applications of the MOSkin dosimeter, in clinical diagnostic procedures. The MOSkin
provides advantages over traditional dosimetry solutions by providing minimal beam
perturbation, the ability to measure doses in real-time, exhibiting radio-transparency
in images acquired by diagnostic beam qualities and by allowing users to measure dose
delivered at water-equivalent depths of 0.07 mm and 3 mm, depths representative of
radiation induced damage to the patient’s skin and eyes. The aims of this thesis
were to comprehensively characterise the dosimeter for use in kilovoltage range x-ray
beam qualities, establish clinical applications, specifically in angiographic catheterisa-
tion laboratories, to develop dose minimisation strategies in clinic, to assess vendor
implemented upgrades in clinic and to identify the specifications needed for develop-
ing future diagnostic dosimetry solutions. By addressing these aims, this thesis has
produced a compelling argument for broader clinical adoption of diagnostic dosimetry
solutions, has confirmed the efficacy of the MOSkin dosimeter in measuring diagnostic
patient doses, has enabled the development of more sophisticated dose minimisation
strategies in clinics, has improved upon existing standards for comparing c-arm system
hardware performance by implementing simultaneous measurement of several metrics
for both image quality and dose delivery performance and has formed a prospective
study into development of an operator specific dosimetry solution.
KEYWORDS: MOSkin, MOSFET, Angiography, Dosimetry, Image Quality
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Chapter 1
Radiation Induced Risk in
Radiology
Diagnostic radiology is an invaluable tool with widespread utility in the diagnosis and
treatment of disease. Radiographic procedures harness the properties of radiation to
render detailed structural and functional mappings of a patient’s physiology that oth-
erwise could not be seen or completely understood. The utilisation of radiographic
procedures continues to grow as medical knowledge, imaging technologies and clinical
techniques are developed and improved on. This has improved patient outcomes at
the cost of increasing clinical radiation exposures to patients and, in some cases, to
clinicians. While radiation exposure should be reduced where possible, if a procedure
is necessary for the diagnosis or treatment of a condition then the risk-benefit ratio
of the procedure would favour performing the procedure. Instead of forgoing these
procedures, efforts should be placed towards monitoring exposures, developing dose
minimisation strategies and developing technologies and techniques that lower radia-
tion exposures where possible. In 1977, the International Commission on Radiation
Protection (ICRP) Publication 26 proposed general recommendations that included
the adoption of an effective dose quantity[1]. The quantity was intended as a simplified
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radiation protection quantity that would represent the biological impact of all radi-
ation sources on all organs and biological tissues irradiated during an exposure. To
calculate the effective dose, the dose delivered to each organ volume is first weighted
based on the type of radiation that is incident and the type of tissue irradiated. These
weighting factors were established in ICRP Publication 60 based on Monte Carlo sim-
ulations before later being updated in ICRP Publication 103 using newer simulation
frameworks and clinically reported evidence[2,3]. The weighted dose values are then
summated into an effective dose value, as shown in Equation 1.1 The effective dose
is useful for the justification, optimisation and limitation of radiation exposures to the
public.
E = ΣTwR ΣTwRDT,R , Sv (1.1)
Effective dose has become a convenient measure of the radiation exposures and of
radiation-induced risk attributed to patients undertaking radiology procedures. There
are several reviews in the literature comparing effective doses reported for various ra-
diology procedures using this metric. These reviews were written with the intent to
inform clinical behaviours and to open discussion on the risks presented by everyday
clinical procedures. This section will discuss some of these reviews in detail, specifi-
cally the European Dose DataMed (DDM) initiatives that identified radiation exposure
risks to the public, the 2008 Mettler review that compared a broad range of radiol-
ogy procedures and the Vilar-Palop review which presented a modern update to the
Mettler review with consideration of the outcome of the DDM initiatives, paediatric
exposures and of the update in ICRP weighting factors[4-7]. In 2003, the European
Dose DataMed initiative was launched to assess public exposure from diagnostic and
interventional imaging procedures[4]. The DDM collected information on the frequency
of diagnostic and interventional procedures and the effective doses experienced during
these procedures as reported across ten European countries. As part of the survey, the
3
DDM identified the top twenty procedures that were the highest contributors to the
collective public exposure. The DDM initiative laid the foundation for the broader
DDM2 initiative that expanded the scope of the study to 36 European countries, con-
tinued monitoring public exposure from the top twenty contributors list and explored
the implementation of diagnostic reference levels in different procedures[5]. The DDM
top twenty identifies four key categories of imaging procedures: radiographs, com-
puterised tomography (CT) scans, fluoroscopic imaging and interventional cardiology
procedures. This was consistent with a report from the United Nations Scientific Com-
mittee on the Effects of Atomic Radiation (UNSCEAR) published in 2008 that stated
‘just under half of the collective effective dose due to diagnostic radiology arises from
three key procedures: CT, angiographic examination and interventional radiology’[8].
In 2008, another extensive review of effective doses in common radiology proce-
dures was published by Mettler et.al.[6]. The review summarised findings published
in 157 peer reviewed articles published between 1980 and 2007, representing clinics
based across the United States, Canada, Japan, Australia and Western Europe. Met-
tler et.al. presented the effective doses for 31 radiographic procedures with literature
reported values ranging from 0.0002 mSv to 180 mSv. In publishing a review of these
reported effective doses, Mettler et.al. intended to provide patients and clinicians with
an indication of radiation-induced risk and detriment that could be used both in the
justification and optimisation of procedures. Mettler et.al. noted that the literature
reported the highest effective doses during computerised tomographic scanning and in-
terventional procedures. He also noted high variation in effective doses reported during
fluoroscopic and interventional procedures. In 2016, Vilar-Palop et.al. published a re-
view of effective doses reported in the literature and noted changes in these results
since the 2007 Mettler et.al. publication[7]. The Vilar-Palop et.al. review focuses
on the top 20 procedures identified by the DDM initiative and summarises the find-
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ings of 33 peer-reviewed articles representing clinics in Asia, Australia, Brazil, Europe
and the United States. The review reported effective doses calculated using both the
ICRP Publication 60 and ICRP Publication 103. Both standards were included where
possible as many publications were reporting exposures either using the deprecated
ICRP Publication 60 guidelines exclusively or in supplement to the ICRP Publication
103 guidelines. The review also used the average effective dose values reported by the
Mettler et.al. review and the DDM2 initiative in comparison to the study’s reported
figures.
A commonality between all four of these reviews was that interventional procedures
were one of the highest dose procedures despite their comparatively lower procedural
frequency. The DDM initiatives reported two interventional cardiology procedures,
cardiac angiography and percutaneous transluminal coronary angioplasty (PTCA), in
their top 20 highest dose procedures. In both the Mettler et.al. and Vilar-Palop et.al.
literature reviews, interventional cardiology procedures reported exposures ranging
across a broad effective dose range with some procedures ranking consistently amongst
the highest dose procedures reviewed. Another review of the literature written by Pan-
tos et.al. suggested that this variability in interventional cardiology procedure doses
correlated closely with the complexity of the procedures, the type of fluoroscopic equip-
ment available at the catheterisation laboratory, the differences in operator experience
and the level of radiation protection training employed at individual clinics[9]. The con-
sensus within the literature is that exposures in interventional cardiology procedures
have high potential for optimisation and that there is a real need for comprehensive
dosimetry solutions informing the implementation of dose minimisation strategies.
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1.1 Interventional Cardiology Procedures
Interventional cardiology is a subdiscipline of interventional radiology that focuses
on the diagnosis and treatment of cardiovascular disease. Procedures are performed
through the execution of minimally invasive percutaneous surgical techniques. Proce-
dures can involve coronary catheterisation, angiographic imaging, angioplasty, delivery
of thrombolytic agents, stent placement, valve replacement/repair and radiofrequency
ablation. Procedures are performed under fluoroscopic image guidance provided by
an angiographic c-arm system. These systems and techniques enable clinicians to ad-
minister targeted treatments to cure disorders where open surgery would have once
been necessary. Cardiovascular disease is the leading cause of death in Australia and
was responsible for 43,963 deaths in 2016[10]. In the 2014/2015 financial year, approx-
imately 4.2 million Australians reportedly suffered from cardiovascular disease, which
includes 2.6 million reports of hypertension and 1.2 million reports of heart disease[11].
This represents a 53% increase in reports of hypertension and a 36% increase reports
of heart disease since the year 2001. In the 2015/2016 financial year, the Australian
Institute of Health and Welfare reported that 577,661 procedures were performed on
patient cardiovascular systems, which was an increase in procedures of 34.6% since the
2000/2001 financial[12,13]. This total for cardiovascular procedures in the 2015/2016
financial included:
 1,918 cardiac catheterisation procedures, which is an increase of 77.4% since the
2000/2001 financial year.
 134,195 coronary angiography procedures, which is an increase of 63.8% since
the 2000/2001 financial year.
 44,334 percutaneous transluminal coronary angioplasty procedures, which is an
increase of 88.8% since the 2000/2001 financial year.
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Figure 1.1: Percentage Share and Total of Revascularisation Procedures Performed
in Australia (2000-2014)[14]
Figure 1.2: Trends in Revascularisation Procedural Preference in OECD Countries
(2000-2013)[14]
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According to the Organisation for Economic Co-operation and Development (OECD)
health report of 2015, utilisation of angioplasty in revascularisation procedures in Aus-
tralia has gradually increased from 56.9% in the year 2000 to 76.0% in 2014, as shown
in Figure 1.1[14]. This trend was observed globally across all 31 of the OECD survey
countries, as shown in Figure 1.2. The growing utilisation of angioplasty techniques
can be attributed to the benefits that these techniques provide over traditional bypass
surgery and is consistent with the decline in utilisation of bypass surgery, tradition-
ally the gold standard for revascularisation procedures. This shift in preference makes
sense, angioplasty offers health outcomes comparable to bypass surgery for most forms
of coronary artery disease through use of minimally invasive techniques and can be
performed without inducing anaesthesia. The development of new angiographic tech-
niques and equipment, such as drug eluting stents, are constantly improving patient
outcome, improving the versatility of the procedure and reducing the advantages that
traditional bypass surgeries can offer. Angioplasty patients also experience less pain,
reduced hospitalisation times and reduced risk of in-hospital mortality when compared
to bypass patients[15-17]. Bypass surgery is still recommended for patients over the
age of 65, patients with diabetes, patients with multivessel coronary artery disease,
patients with impaired ventricular function and for patients who have experienced
restenosis. While angioplasty does offer many advantages over bypass surgery, the
procedure does carry a higher risk of restenosis than bypass surgery and requires flu-
oroscopic imaging, meaning it contributes to the total public medical exposure.
Advances in angiographic techniques and equipment have also led to the develop-
ment of percutaneous treatments for paediatric and adolescent heart conditions that
were once either untreatable or required open heart surgery[7,18]. Paediatric conditions
such as patent ductus arteriosus and patent foramen ovale are now commonly treated
using interventional techniques including atrial septostomy, aortic dilatation, aortic
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valvuloplasty, pulmonary valvuloplasty and pulmonary artery angioplasty. Due to
the complexity of these interventional paediatric procedures, patients may experience
extended imaging times, require multiple catheterisations and require regular angio-
graphic follow-ups after treatment. As such. these procedures, while lifesaving, can
result in significant accumulated radiation exposures to children which can result in
fluoroscopic injuries and increases the child’s lifetime risk of developing cancer[7,18-22].
This is in part due to the heightened radiation sensitivity and longer remaining life
spans of children as compared to adults. The increasing use of interventional cardiol-
ogy procedures, the broadening range of applications for interventional techniques, the
increasing exposure to paediatric patients and the growing public diagnostic collective
exposure substantiate the need for thorough investigation into the radiation related
risks involved with these procedures and the potential for dose minimisation in every
day practice.
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1.2 The Risks of Radiation-induced Injury during
Interventional Procedures
1.2.1 Classifications of Radiation-Induced Injury
To understand the necessity of monitoring exposure, it is important to understand
the risks associated with radiation overexposure. Radiation damage to biological ma-
terial occurs when radiation is incident upon a cell and causes damage to the cell
through direct or indirect action[23]. Direct action refers to when radiation causes ion-
isation within the biological material of interest, potentially by ionising key structural
molecules within organelle structures, while indirect action refers to when radiation
causes ionisation through highly reactive free radicals produced by direct action[23 - 25].
These free radicals most commonly include hydroxyl groups, nitrogen species and
alkoxyl type free radicals. The damage caused by radiation exposure can cause cell
death and genetic abnormalities, or mutations, in cells that survive the exposure.
This can cause the tissue to develop radiation-induced conditions. These conditions
can be categorised into two classifications: stochastic conditions and deterministic
conditions[1,3].
Stochastic conditions occur due to genetic mutations and abnormalities[25]. Genetic
mutation happens spontaneously in nature but can occur at greater frequency due to
radiation exposure. While genetic mutations can be beneficial, they more commonly
cause genetic diseases and carcinogenesis and can result in hereditary effects that can
be observed in the exposed individual’s subsequent offspring. Stochastic conditions
occur with probabilistic incidence and therefore the probability of inducing a stochas-
tic condition will most likely increase as radiation exposure is accumulated over time.
The severity of stochastic conditions is independent of dose[3]. The ICRP recommends
assessing stochastic risk using the effective dose metric. Using the prevailing model,
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the linear no-threshold model, the ICRP estimated in ICRP Publication 103 that the
risk of developing a stochastic condition from an exposure is approximately 5.7% /Sv.
This figure was comprised of an increased risk of carcinogenesis of 5.5% /Sv and an
increased risk of heritable effects of 0.2% /Sv. The US National Research Council on
Radiation Protection and Measurements (NCRP) supported the linear no-threshold
model for doses lower than 100 mSv at the conclusion of their seventh Biological Ef-
fects of Ionizing Radiation report (BEIR VII) stating that there was no observable
threshold below which ionising radiation was proven to be harmless or beneficial[26].
UNSCEAR, the NCRP and the ICRP have all released publications concluding that
the linear no-threshold model is an important basis for radiation protection measures
for low dose exposures but caution that the model may not accurately represent bi-
ological risk for low dose exposures[3,27,28]. Other studies have disputed the linear
no-threshold model claiming that there is insufficient epidemiological evidence. In-
stead, these studies suggest that thresholds for stochastic conditions may exist, that
dose-response behaviour may exhibit non-linearity and that individual risk thresholds
may vary greatly from population-averaged thresholds. Some studies even suggest low
doses of radiation may be beneficial, as per the radiation hormesis model, and conclude
that extrapolation of the linear no-threshold model is harmful both to scientific and
public understandings and perspectives of radiation induced-risk[29 - 34].
Deterministic conditions occur when radiation exposure to a tissue exceeds a thresh-
old dose value and causes sufficient levels of cell death within a tissue which results
in impaired functionality of the tissue[3]. Deterministic risk can be estimated by as-
sessing the radiation dose delivered to specific tissues during a procedure. Once the
threshold dose is exceeded, the severity of the condition will increase with further ex-
posure to the tissue. Some tissues, such as the skin, can repair over time which means
that, depending on the tissue, subsequent exposures may not necessarily accumulate to
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cause deterministic conditions. The ICRP recognises that radiation sensitivity varies
between individuals and as such in ICRP Publication 103, the ICRP set deterministic
thresholds using conservative dose values that represent the absorbed dose required to
induce a condition within 1% of the general population. Commonly observed deter-
ministic conditions include cataract formation, sterility, dermatitis, hair loss, epilation,
erythema, telangiectasia, ulceration of tissues and, in extreme cases, acute radiation
syndrome, cellular necrosis and death[35].
1.2.2 Radiation-induced injuries in the Catheterisation Lab
Earlier it was established that interventional radiology procedures, specifically coro-
nary interventions, result in significant contributions toward total accumulated public
exposure despite comparatively lower procedural frequency. The reviews observed that
the radiation exposures during these types of procedures vary considerably. Patient
exposure may also be extended due to unforeseen circumstances, repeated procedures
or complications during a specific procedure. As such, patient dose and the incidence
of radiation-induced conditions can be difficult to anticipate or even to assess. To
conservatively estimate the incidence of radiation-induced conditions resulting from
diagnostic doses, the doses reported by the literature for the two highest exposure
coronary interventional procedures identified in the DDM top 20 have been collated
below:
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 The Dose DataMed 2 initiative reported that cardiac angiography procedures
resulted in an average effective dose of 7.71 mSv with reported values ranging
from 3.3 - 11.3 mSv while angioplasty procedures produced an average effective
dose of 15.2 mSv with reported values ranging from 4.0 - 29.0 mSv[5].
 The Mettler et.al. review reported that cardiac angiography procedures resulted
in an average effective dose of 7.0 mSv with reported values ranging from 2.0
- 15.8 mSv while angioplasty procedures produced an average effective dose of
15.0 mSv with reported values ranging from 6.9 - 57.0 mSv[6].
 Vilar-Palop et.al. reported that cardiac angiography procedures produced an
average effective dose of 9.3 mSv with reported values ranging from 3.3 - 22.3
mSv while angioplasty procedures produced an average effective dose of 19.5
mSv with reported values ranging from 7.4 - 48.6 mSv[7].
If the stochastic risk were extrapolated from the ICRP risk estimate presented earlier,
a 5.7% risk of stochastic condition incidence per Sv, then these average effective doses
could translate to an average of 944 stochastic conditions induced per million angio-
plasty procedures performed. Alternatively, using the collective doses reported during
the Dose DataMed 2 initiative would predict 2,562 stochastic conditions induced per
year from the exposures experienced during interventional procedures[5]. There are
some published epidemiology studies researching the stochastic risks involved in diag-
nostic procedures. Mathews et.al found that in Australia, CT patients exposed to an
average procedural effective dose of 4.5 mSv exhibited a 24% higher incidence of can-
cer[36]. Mathews et.al, observed risk increased was proportional to exposure and was
greater for younger patients. While their study involved a different imaging modality
and potentially assessed a different patient demographic, the doses in interventional
cardiology are similar or higher than those seen in their study and as such it is not
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unreasonable to assume similar stochastic risks may be induced from angiographic
exposures[37].
Patients are also at risk of developing deterministic conditions from angiographic
procedures. During angiographic procedures the maximum dose is delivered at skin
depth and as such the patient’s skin is especially vulnerable to deterministic injuries.
Koenig et.al. produced an extensive two-part review of radiation-induced injuries
resulting from fluoroscopic exposures[38,39]. The review included 47 angiography pa-
tients who had suffered from injuries that ranged from radiodermatitis, erythema,
ulceration and even necrosis of the skin tissue. Injured patients included a 48-year-old
woman with severe coronary artery disease who underwent two percutaneous translu-
minal coronary angioplasties with stent placement performed within the same month
who suffered a well-marginated focal erythema with desquamation within 2 months
of the last procedure and a 17-year-old girl with a history of cardiac arrhythmia who
underwent two cardiac ablation procedures within a 13-month period and developed
an atrophic indurated plaque, skin telangiectasia, was placed at an increased risk of
breast cancer and suffered limited mobility in her right arm. Koenig et.al. suggest
that these deterministic conditions occurred when long exposure times were necessary,
when large field sizes were predominantly used, where limited or overlapping beam pro-
jections were used, when extraneous body parts were imaged, when thicker patients
were imaged, when high exposure imaging settings were utilised and when clinicians
were not trained to practise dose minimisation strategies and were unaware of radio-
biological effects. Koenig et.al. also noted that real-time direct dosimetry solutions to
monitor skin dose were not implemented during any of the case studies investigated
and suggested that the implementation of these dose monitoring systems would inform
clinician behaviour in a more meaningful way than c-arm reported quantities such as
fluoroscopic time. While the Koenig et.al. review was published in 2001, similar
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concerns of fluoroscopic injury have since been published since then by Balter et.al.
and Boncher et.al. that were motivated by similar concerns[39, 40]. In some cases, it
is necessary to perform interventional procedures to pregnant women to administer
life-saving treatments. Care must be taken when imaging during these procedures as
foetuses are particularly susceptible to both stochastic and deterministic conditions
and exposure could lead to malformation or death of the foetus[22].
Clinicians experience a significantly lower radiation exposure than patients during
procedures, however, recent studies suggest that clinicians may be at risk of radiation-
induced conditions due to accumulation of exposure between procedures over the span
of the clinician’s career. Clinician based studies have reported that interventional
operators are potentially at risk of developing stochastic conditions such as predomi-
nantly left-brain tumours and deterministic conditions such as dermatitis and hair loss
to the hands and legs[41 - 43]. Recent studies have also presented compelling evidence
suggesting that clinicians are developing radiation-induced rear-lens cataracts[44 - 48].
The initial evidence suggested that the observed radiation-induced cataract formation
was deterministic in nature, however, there are studies that consider the possibility
that the condition is stochastic in origin[29]. Details about clinician conditions are still
emerging and are further shaping our understanding of the impact of low dose expo-
sures. Radiation protection agencies including EURADOS, ICRP, the International
Atomic Energy Agency (IAEA) and the Australian Radiation Protection and Nuclear
Safety Agency (ARPANSA) have responded as new evidence becomes available by
releasing statements updating recommended dose limits[49 - 51].
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1.2.3 Sources of Radiation Exposure in Angiography
Interventional cardiology procedures are performed with a device known as the an-
giographic c-arm system. The c-arm system consists of a c-shaped gantry with a
fluoroscopic x-ray tube attached to one end of the gantry and a radiation imaging
detector mounted to the other. The c-arm system produces a filtered spectrum of
kilovoltage range diagnostic x-rays. The c-arm x-ray beam characteristics are set au-
tomatically using vendor-specific algorithms installed to the system on commission.
The c-arm system selects beam qualities based on information specific to each imag-
ing projection and target using metrics such as the photon flux incident on the imaging
panel and the signal-to-noise ratio of the acquired images. Most systems operate un-
der a pulsed imaging modality with each image acquired within milliseconds. Some
systems, known as G-Stand or biplanar systems, include a secondary imaging appa-
ratus. During imaging, the primary beam is incident on the patient volume. Scatter
radiation is produced when radiation scatters from the patient volume, patient couch,
imaging plate, roof and walls of the catheterisation laboratory. Clinicians are partially
protected from primary beam by radio-protective boundaries and lead shielding. The
distribution of scatter radiation is dependent on the type of c-arm system used, the
catherisation laboratory geometry and the material of the roof and walls and as such
the scatter distribution is specific to each individual catheterisation laboratory.
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1.3 Radiation Safety and Exposure Limitations
1.3.1 Measurement and Assessment of Patient Dose
For patients, radiation exposure during angiographic procedures is routinely estimated
using the estimated air Kerma delivered to the international reference point and the
Kerma Area Product (KAP)[52 - 59]. Fluoroscopic imaging time is also recorded but
is not a reliable indicator of patient dose.
The air Kerma is defined as the kinetic energy released per unit mass in air by
uncharged ionising radiation. The air Kerma is typically monitored using a KAP
meter adjacent to the x-ray tube. In Australia, all newly commissioned c-arm systems
are legally required to include an installed KAP meter [58]. The air Kerma measured
by this KAP meter is used to estimate the air Kerma at international reference point
which is defined at 15 cm from the rotational isocentre of the c-arm gantry toward
the x-ray tube. This point estimates the distance between the x-ray tube and the
underside of the patient and is used to estimate the patient skin dose. The derivation
of air Kerma is performed utilising the KAP.
DAP = KAP = Kerma ∗ Area (1.2)
The KAP is defined as the air Kerma multiplied by the cross-sectional area of the
x-ray beam at measurement point. This is expressed in Equation 1.2[24]. When
calculating the KAP quantity, it is assumed that changes in photon fluence are driven
solely by the inverse square law. The inverse square law states that emissions originat-
ing from a point source will reduce in fluence, or intensity per unit area, proportionally
to the distance from the source squared. This phenomenon occurs due to geometric
dilution, that is, while net intensity is constant, the area that the emissions are spread
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Figure 1.3: Illustration of the Kerma Area Product
across increases proportionally to the distance from the source squared. By taking the
product of the photon intensity at measurement point and the cross-sectional area at
measurement point the dependencies on distance from the point source squared are
cancelled out. This means the KAP quantity is effectively independent of distance
from the point source, as demonstrated in Figure 1.3. As such, the KAP measured
by the KAP meter is equal to the KAP at international measurement point which can
be used to estimate the air Kerma at international measurement point.
Older c-arm systems have historically presented a dose area product (DAP) quan-
tity. In 2008, the term DAP meter was revised and replaced with the more accurate
term KAP meter[59]. This has resulted in some publications using the terms Kerma
and Dose interchangeably. The NCRP recommends that angiography patients should
be referred for follow-up should peak skin dose exceed 3 Gy, cumulative air Kerma at
reference point exceed 5 Gy or fluoroscopy imaging time exceed 60 minutes[57]. The
NCRP also recommends against clinics relying on fluoroscopy time alone for referral.
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ARPANSA have published an initial national dose reference level (NDRL) for an-
giographic procedures [60]. These reference levels are established by surveying clinical
data and are used for optimisation purposes or for benchmarking of clinical perfor-
mance. The NDRL is set at the 75th percentile of the survey data. At time of writing,
the only published interventional NDRL was for coronary angiograms performed on
adult ”Patients with ‘normal’ coronaries; no or physiologically insignificant diameter
stenosis ( < 50% narrowing)”. The current published NDRLs for this procedure are
KAP = 30 Gy · cm2 and air Kerma = 0.5 Gy.
1.3.2 Limitations on Occupational Exposures
ARPANSA is the Australian government’s primary authority on radiation protection
and nuclear safety. ARPANSA requires that all radiation workers likely to receive
an annual occupational exposure of greater than 1 mSv should be equipped with an
appropriate personal radiation monitoring device[58]. This device should be worn on
the torso between waist and chest height under any personal protective equipment
and should be worn for no longer than three months before readout of the dosime-
ter is performed. ARPANSA also recommends use of a secondary dosimeter to be
worn outside of any personal protective equipment at collar level and approves of the
use of extremity dose monitors where appropriate. ARPANSA specified occupational
equivalent dose limits are consistent with recommendations published in ICRP Publi-
cation 103 except for the eye lens equivalent dose limits which were updated in ICRP
Publication 118[3,32,51,59]. These recommendations are as follows:
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 The annual effective dose resulting from occupational exposures should not ex-
ceed 20 mSv per year as averaged over a 5-year period and should not exceed 50
mSv during any single year.
 In the case of pregnant workers, effective dose should not exceed 1 mSv for the
duration of pregnancy.
 The equivalent dose to the eye lens resulting from occupational exposures should
not exceed 20 mSv per year as averaged over a 5-year period and should not
exceed 50 mSv during any single year.
 The equivalent dose to the hands, feet and skin as averaged over one square
centimetre of skin should not exceed an effective dose of 500 mSv per year.
Figure 1.4: a) Cardiologist’s Personal Protective Equipment and b) Common Oper-
ator Exposure Monitoring Points[58]
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Occupational dose is routinely monitored using personal radiation monitoring de-
vices which often incorporate either film or luminescent dosimeters as their radiation
sensitive element. These dosimeters will be discussed further in Section 1.5. ICRP
Publication 139 recommends use of supplementary dosimeters to monitor doses de-
livered above the clinicians’ collar level and delivered to the clinicians’ extremities
including to the fingers, thigh and gonad regions[61]. Radiation personal protective
equipment and operator dose measurement points recommended by ICRP Publication
139 are depicted in Figure 1.4.
1.4 Alternative measures of radiation exposure
Clinicians may choose to supplement mandatory exposure reporting with a range of
available dosimetry solutions. This section will detail solutions most commonly pre-
sented in the literature for coronary angiographic procedures listing the advantages
that each can provide to clinicians.
1.4.1 Radiochromic Film Dosimeters
Radiochromic film dosimeters are large area film dosimeters used to measure radiation
dose distribution over a specified area. Radiochromic film has applications in ma-
chine quality assurance, patient dosimetry and clinician dosimetry. Radiochromic film
features an active layer commonly embedded between protective polymer/polyester
sheets. The active layer typically consists of a marker dye that will change colour
when exposed to radiation. Additives can be mixed into this active layer by manu-
facturers to adjust the film characteristics and produce specialised films for specific
applications. Radiochromic film dosimeters are often considered an industry gold
standard due their long history of use in radiation laboratories.
Radiochromic film dosimeters provide a visualisation of the dose delivered to a pa-
1.4. Alternative measures of radiation exposure 21
tient volume in high level spatial resolution. As such, film dosimeters can retroactively
identify areas of local overexposure and can be used to quantify the peak skin dose
experienced during procedures. The most common radiochromic film used during an-
giographic procedures is the Gafchromic XR-RV3 film which is designed for use with
interventional beam qualities. Farah et.al. estimate that the XR-RV3 type film can
be used to determine skin dose delivery to within typically 20% uncertainty, however,
the accuracy of the film is heavily dependent on the quality of the film, the scanning
methodology and the care taken during readout[62]. Farah et.al. estimated that proper
care can reduce uncertainty to within 5% while minimal care can cause uncertainty to
increase to up to 40%. Due to the cost of buying new film, the use of film in catheteri-
sation laboratories tends to be reserved for high dose procedures, such as chronic total
occlusion cases, where there is risk of exceeding the 2 Gy deterministic threshold[63].
1.4.2 Indirect Dosimetry Solutions
Indirect dosimetry methods involve estimation of patient effective dose and peak skin
dose using exposure parameters such as air Kerma at reference point, Kerma area
product, imaging time, x-ray tube voltage, beam current, pulse width c-arm posi-
tion, c-arm angulation. These studies are often supplemented with data from direct
dosimetry solutions. A study by Compagnone et.al. attempted to estimate patient
effective doses through Monte Carlo simulations that used exposure parameters pro-
vided by the c-arm system[64]. Compagnone et.al. were able to calculate estimations
of the patient effective dose and equivalent doses delivered to specific patient organs.
Compagnone et.al. observed close correlation of the estimated effective dose with
the machine reported dose area product using two separate simulation methodologies.
Compagne et.al. also found that using simple conversion coefficients with machine
reported DAP values could be used to effectively estimate equivalent dose to 10 crit-
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ical organs. Compagne et.al. suggest that these equivalent dose values may be more
appropriate quantities for estimating patient exposures and stochastic risk than the es-
timated effective patient dose. In a 2008 study, Dominiek et.al. attempted to correlate
DAP to the maximum skin dose delivered to patients as monitored using large area
film dosimeters to prevent deterministic injury[65]. The research concluded similarly
to previous studies performed by Vano et.al., Van de Putte et.al. and Morell et.al.
in that dose area product alone cannot be used to predict maximum skin dose in a
meaningful way[66 - 69]. Despite this result, Dominiek et.al. suggested DAP could be
used as a rough indicator of risk and could be used to define trigger levels to caution
clinicians on patient exposure. Dominiek et.al. also stressed that correlations between
maximum skin dose and system beam monitoring quantities should be established
individually for each catheterisation laboratory they are deployed at.
1.4.3 Dose contouring software packages
Vendors have recently begun installing commercial dose distribution visualisation soft-
ware packages[70 - 72]. These software packages paint the air Kerma values as reported
by the c-arm system to a standardised patient volume. Visualisation better enables
clinicians to utilise a variety of beam projections during imaging which reduces the
risk of local overexposure. In the validation of the GE Dose Map system, Bordier
et.al. observed that the dose distributions produced by the dose tracking system
compared favourably to dose distributions assessed using radiochromic film and could
predict peak skin dose to within 25% of the dose measured by XR-RV3 film[71]. A
key advantage of visualisation software packages is that they provide an estimation of
dose distribution that is functionally similar to the results available using film-based
dosimeters, but they require less effort to set up and are reusable without incurring
costs additional to the initial software purchase price. Furthermore, in the future,
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visualisation software could potentially be paired with virtual and augmented reality
technology which is already used in some clinics to guide catheterisation procedures.
1.4.4 Solid-State Dosimetry: Band Theory Basics
The remaining common dosimeters in angiography are solid-state dosimetry solutions.
Solid-state devices take advantage of the conductive properties of metals, insulators
and semiconductor materials[23]. This section will explain the electronic properties
of solid-state dosimeters using band theory so that the mechanisms used by solid-
state dosimeters to measure incident radiation can be explained more specifically in
subsequent sections.
Band theory introduces two bands that are used to characterise electrons in a
material, the valence band and the conduction band. The valence band consists of the
electrons that exist within the outermost stable orbital electron shell of the materials
atomic lattice while the conduction band consists of electrons that can move freely
throughout the lattice and as such contribute as charge carriers, enabling the material
to conduct charge. In metals there is an excess of electrons present in the material.
The excess electrons partially fill the conduction band and electrons can transition
between free and bound states without stimulus. In insulative non-metal materials
the conduction band is depleted and the valence band is full. These valence band
electrons are bound tightly to the lattice and do not contribute to conduction. The
energy input needed to break the bond between the electron and lattice, that is, to
transition electrons from the valence band to conduction band, is known as the band
gap. In insulators this band gap is typically prohibitively large and as such insulators
will inhibit conduction of charge carriers. The electrical properties of a material will
exist on a spectrum of perfect conductor (no band gap) through to a theoretical perfect
insulator (infinite band gap).
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Semiconductors are characterised by their approximately half-filled outer orbital
electron shells. This electron configuration enables semiconductors to exhibit both
conductive and insulative properties. Due to the lower energy difference between the
highest occupied molecular orbital and lowest unoccupied molecular orbital, semicon-
ductor lattice bonds are typically weaker than the lattice bonds found in insulators.
As such, the band gap in semiconductors is smaller than in insulators. The smaller
bandgap means that electrons can transition between valence and conduction bands
with relatively low energy input enabling conduction within the material. The electri-
cal properties of semiconductors can be changed during fabrication in a process known
as doping. The doping process involves introducing impurities to the semiconductor
lattice during fabrication and can result in n-type or p-type semiconductors.
 N-type (negatively charged) semiconductors are produced by doping the semi-
conductor with group V electron donor atoms such as phosphorous or arsenic.
The dopant atoms have an additional electron available. The electron will be
unable to bond locally due to the geometry of the semiconductor lattice and
therefore n-type semiconductors more negatively charged electrons than an in-
trinsic semiconductor. The excess electrons require less energy to transition to
the conduction band than bound electrons. In band theory, these electrons oc-
cupy donor energy levels in the higher energy section of the band gap below the
conduction band. Conduction in n-type semiconductors results from movement
of electrons in the conduction band.
 P-type (positively charged) semiconductors are produced by doping the semi-
conductor with group III electron acceptor atoms such as boron or gallium. The
dopant atoms have less electrons than the semiconductor atoms they replace and
therefore cannot complete bonds with all neighbouring semiconductor atoms.
The empty electron positions, holes, result in a lower net electron count and
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therefore n-type semiconductors are more positively charged than an equivalent
intrinsic semiconductor. The holes attract electrons toward the valence band. In
band theory, these electrons occupy acceptor levels in the lower energy section
of the band gap above the valence band. Conduction in p-type semiconductors
results from movement of positively charged holes in the valence band.
Solid-state dosimeters take advantage of the electronic properties of metals, semicon-
ductors and insulators to measure incident radiation. This is achieved by trapping
charge carriers induced by ionising radiation within specific discreet energy levels that
exist within the band gap. Readout of a solid-state dosimeter will measure the number
of trapped charges within the dosimeter either through liberating the trapped charges
or by measuring changes in the electrical properties of the dosimeter. For a dosimeter
to be effective, the relationship between the number of trapped charges and the quanta
of incident radiation must be consistent and well understood.
1.4.5 Luminescent Dosimeters
Luminescent dosimeter is a term used to describe several solid-state dosimeters that
emit light proportional to the radiation the dosimeter has been exposed to dur-
ing irradiation of the dosimeter[23]. The main types of luminescent dosimeter in-
clude thermoluminescent dosimeters (TLD), optically stimulated luminescent dosime-
ters (OSLD) and radiophotoluminescent glass dosimeters (RPLD or RPLGD)[73 - 78].
These dosimeters are commonly packaged as chips or pellets that can be used for
measuring radiation exposure to a discreet point. Luminescent dosimeters can also
be used to measure dose distributions across an area either by arranging the dosime-
ters into an array or by suspending a powder format of the dosimeter throughout a
material. TLDs are luminescent dosimeters that emit light proportional to accumu-
lated radiation exposure when heated. The most common TLDs consist of lithium
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fluoride doped with either magnesium or titanium. These dopants produce charge
traps at discreet energy levels distributed throughout the band gap. When exposed
to ionising radiation, electrons are scattered within the TLD. Some of these charges
will be captured within the dopant-induced charge traps. Readout of TLDs is per-
formed by thermally ‘annealing’ the dosimeters. During the annealing process, the
TLD is coupled to a photomultiplier tube and placed within an oven/kiln/furnace.
The ambient temperature within the apparatus is raised slowly. As an example, a
typical TLD-100 readout will involve heating the TLD from 50 °C to 350 °C at a rate
of ∼0.2 °C/s. As ambient temperature increases, the energy distributed throughout
the TLD increases. When the energy within the TLD exceeds the band gap energy
of a charge trap the charge will be liberated and a photon will be emitted. These
photons are collected by the photomultiplier tube. The readout results in a photon
collection profile, the ‘glow curve’, that represents the data in terms of photon count
with respect to either time or temperature. The glow curve will feature peaks in
photon collection at specific times. These peaks correspond to the band gap energy
of specific charge traps. The photons collected in specific peaks are integrated and
these integrated values are proportional to the accumulated radiation dose delivered
to the TLD. This readout process is destructive meaning dose cannot be verified but
the TLD can be reused post-annealing. OSLDs are luminescent dosimeters that emit
light proportional to accumulated radiation exposure when exposed to an ultraviolet
range to visible light ranged light source. These dosimeters are typically composed of
carbon doped aluminium oxide. OSLDs are functionally analogous to TLDs in that
the carbon dopant creates charge traps within the lattice that trap charges scattered
by ionising radiation. The primary differentiation is in the readout method utilised.
Readout of an OSLD is performed by optically stimulating the OSLD with a pulsed
laser light and collecting emitted photons via a coupled photomultiplier tube. As an
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example of stimulation sources, the aluminium oxide OSLD is stimulated using an
argon laser light (λ ≈ 515 nm). The incident laser light pulse will liberate a portion
of the trapped charges causing photons to be emitted by the OSLD which are then
collected by the photomultiplier tube. As only a small portion of the trapped charges
are liberated in the readout process, OSLD readout can be repeated allowing users to
reproducibly verify readouts and to maintain physical records of exposures. OSLDs
are replacing TLDs in many applications due to their high sensitivity (1 µGy mini-
mum reported dose), large dose measurement range (readout achievable in range of 10
µGy to 10 Gy), reduced fading effects as compared to traditional TLDs and their abil-
ity to provide a non-destructive verifiable dosimetry history[73 - 76]. RPLGDs are the
latest developed type of luminescent dosimetry technology[76 - 78]. Unlike TLDs and
OSLDs, the glass compound is an inorganic amorphous solid. RPLGDs are composed
of a silver-phosphate activated doped glass compound. On irradiation, ionised charges
interact with the silver phosphate to create Ag0 and Ag2+ ions isolated within the
glass. These ions act as electron and hole traps respectively and are referred to either
as colour or defect centers. Readout is performed by pulsing an ultraviolet light source
(λ ≈ 337 nm) onto the RPLGD. This stimulates the colour centers and transitions the
trapped charges into an excited state. The trapped charges will subsequently undergo
deexcitation and will emit photons in the high energy visible range (λ ≈ 600 – 700
nm). As trapped photons are not liberated, RPLGDs provide a permanent history of
accumulated dose and can be reused after readout up to the maximum exposure value.
The lifetime of a RPLGD is dependent on the amount of silver phosphate dopant used
during fabrication. As of time of writing, the three most commonly used RPLGD
lifetimes are the low-dose range RPLGD (maximum dose = 10 µGy), the high-dose
range RPLGD (maximum dose = 10 Gy) and the radiotherapy dose range RPLGD
(maximum dose = 500 Gy). The lifetime of these dosimeters is moderated by adjusting
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silver phosphate content. Increasing silver phosphate content will increase maximum
readout value, however, it will also affect the penetrability of the dosimeter to ionising
radiation and as such sensitivity is also dependent on the doping concentration. This
energy dependence necessitates design of specific shielding solutions for the RPLGD
to be used in low energy exposure applications. RPLGDs offer many advantages over
conventional luminescent dosimeters such as their repeatable non-destructive readout
process, improved intensity retention on repeated readouts (as compared to OSLDs)
and broader potential measurement ranges. These advantages ensure that with further
development RPLGDs will be an important part of the personal dosimetry technology
landscape in the future.
1.4.6 Electronic Dosimeters
Active personal dosimeters, also known as electronic dosimeters, are solid-state qual-
itative radiation monitors that inform clinicians when the exposure rate delivered to
the clinician increases significantly[79]. These dosimeters can be set to trigger auditory
and visual alarms when clinician exposure or exposure rate exceeds a threshold value.
The active volumes for these dosimeters are typically based on Geiger-Müller tube,
scintillation crystal or silicon diode technologies. A study performed by Clairand
et.al. observed the energy dependence, angular dependence and dose rate depen-
dence of several popular commercial electronic dosimeters and concluded that while
the dosimeters performed with satisfactory response for continuous low dose radiation
fields, not all dosimeters could respond reliably when exposed to high dose radiation
fields and pulsed radiation fields[80]. As such, Clairand et.al. stated that while elec-
tronic dosimeters are a useful tool for reducing operator dose, the dosimeters could
not be recommended in place of the traditional passive dosimeters used for personal
radiation monitoring.
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1.4.7 MOSFET Dosimeters
MOSFET dosimeters are another specific field of solid-state dosimeter with a long
history in radiation dosimetry applications. The first published use of MOFSFETs as
radiation dosimeters was the advent of the RADFET as designed by Andrew Holmes-
Siedel et.al. in 1974. The RADFET was a MOSFET-type dosimeter designed specif-
ically for monitoring radiation exposures experienced by orbital satellites[81]. The
potential of the RADFET established interest in the technology in other industries
including clinical exposure monitoring. While some clinics have had success in apply-
ing generic MOSFETs in clinical environments, there are more sophisticated solutions
designed for clinical applications[82]. In diagnostic radiological applications, the three
most commonly published MOSFET dosimetry solutions available are the RADFET,
the Thomas-Nelson MOSFET and the MOSkin dosimeter[81,83 - 95]. As the oldest
MOSFET dosimetry system, the RADFET has undertaken many iterations in design.
Typically, the RADFET features a 1 mm epoxy encapsulation that acts as a build-up
layer. Key developments in RADFET technology for clinical applications have in-
cluded real-time readout capabilities and a stacked RADFET configuration that dras-
tically enhances the devices sensitivity. The RADFET was the first MOSFET-type
dosimeter to prove the viability and advantages of MOSFET-type dosimeters includ-
ing small form factors, low production costs, instant non-destructive readout and easy
integration with computerised systems. The Thomas-Nelson MOSFET, or also more
commonly known as the Best Medical Canada mobileMOSFET, is currently the most
extensively used MOSFET dosimetry solution available for diagnostic dosimetry. The
mobile MOSFET is a dual bias MOSFET system encapsulated within a black epoxy
bulb[87, 88]. The mobile MOSFET is sometimes used with a variety of brass cap-
ping materials to improve reproducibility and angular response of the device. The
mobileMOSFET system has been used extensively to measure doses delivered during
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diagnostic procedures after successful validation of the dosimeter for CT applications
in 2007[89]. The system has also been applied in paediatric interventional procedures
where it has been used to measure patient skin doses, to estimate stochastic risk to
patients and to measure organ doses delivered to an anthropomorphic phantom vol-
ume[90 - 93]. The final dosimeter listed, the MOSkin dosimeter, was developed by
the Centre for Medical Radiation Physics for radiotherapy applications [94,95]. The
MOSkin design features a novel packaging solution that enables measurement at a
reproducible surface depth meaning no corrections are necessary to measure the dose
delivered to the measurement point and any measurement depth can be recreated by
producing an appropriate build up layer. The MOSkin is capable of real-time dose
monitoring and thermal compensation is built into the reader systems. While designed
for radiotherapy procedures, preliminary studies have applied the MOSkin dosimeter
in diagnostic applications such as CT and interventional procedures[95]. The MOSkin
dosimeter and the general behaviours of MOSFET-based dosimetry systems will be
discussed in greater depth in Chapter 2.
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1.5 Why aren’t direct dosimetry solutions broadly
deployed during interventional procedures? The
Potential of the MOSkin dosimetery solution
Direct dosimetry solutions are not commonly utilised in coronary angiography due to
limitations of commercially available dosimeters. Several of the dosimetry solutions
discussed so far lack real-time functionality and as such these dosimeters are limited to
retrospectively evaluating risk. Most commercial dosimetry solutions that do feature
real-time readout capabilities are unfortunately radio-opaque to the c-arm beam as
shown in Figure 1.5 Radio-opaque dosimeters are acquired during imaging which
can obscure the cardiologist’s view of the patient’s cardiovascular system which could
potentially result in protracted examination times, increased risk of clinical errors
and misdiagnosis of patient conditions[96]. Furthermore, radio-opaque dosimeters can
affect the c-arm system’s selection of beam characteristics, such as the beam current,
tube voltage, filtration and pulse width, which can increase the radiation exposure
experienced during the procedure.
Despite the obvious challenges involved in implementing direct dosimetry solutions,
the development of appropriate real-time direct dosimetry solutions for use in the in-
terventional catheterisation laboratory is essential to understand and reduce radiation
exposures during interventional procedures. The current existing solutions are not ap-
propriate and lack real-time preventative capabilities. Simulation/projection methods
are also inadequate as they do not physically measure the real doses experienced by
patients and operators and therefore cannot truly represent clinical doses with absolute
certainty. If an appropriate direct dosimetry solution were developed, it could poten-
tially inform clinicians in real-time and not only assess risk, but potentially prevent
injuries, assist in dose minimisation strategies and supplement existing solutions.
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Figure 1.5: Radiopacity of Traditional Real-Time Dosimetry Systems[96]
The aims of this research thesis are as follows:
1. To prove the functionality and utility of the MOSkin dosimeter when deployed
in the interventional catheterisation laboratory.
2. To demonstrate the behaviours of the MOSkin dosimeter in response to clinical
beam qualities and international standard beam qualities through use of estab-
lished and novel methodologies, developing a foundation toward comprehensive
diagnostic characterisation of the dosimeter.
3. To develop clinically useful dose minimisation strategies.
4. To establish a methodology to simultaneously evaluate both the image quality
and entrance dose delivered to a standard phantom for the comparison of c-arm
systems and clinical imaging protocols.
5. To identify the needs for an appropriate real-time operator dose monitor.
6. To provide foundational research for a future dosimetry solution specifically tai-




Application in the Coronary
Catheterisation Laboratory
This chapter supplements the literature review regarding solid-state devices and intro-
duces the MOSkin dosimeter, a novel radiation dosimetry solution developed by the
Center for Medical Radiation Physics at the University of Wollongong. The MOSkin
will be the primary dosimetry solution used throughout this research thesis and this
chapter characterises the MOSkin dosimeter for clinical applications in the coronary
catheterisation laboratory. The characterisation assessed the lifetime sensitivity of the
MOSkin dosimeter, calibrated the MOSkin to clinical and standard radiation protec-
tion beam qualities, compared the MOSkin response to established dosimeters and by
thorough simulated the MOSkin response to kilovoltage range x-ray beam qualities.
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2.1 Introduction to MOSFET dosimetry solutions
2.1.1 Solid-State Dosimetry: Development of electronic
dosimeters
Solid-state device is a term referring to an electronic component composed of semi-
conductor and metallic structures used to manipulate the flow of electric current [23].
The fundamental functional structure of a solid-state device is the p-n junction, a
semiconductor crystal that consists of p-type semiconductor and n-type semiconduc-
tor layers arranged in an alternating arrangement. Devices consisting of a single p-n
junction are classified as diodes. Because of the doping of the diode layers, the p-type
silicon will contain a higher concentration of holes while the n-type silicon will contain
a higher concentration of electrons. This causes an electric field to form across the
diode and charge carriers will accumulate at the junction. The diffusion of charge at
the junction will result in the formation of ions. The Coulomb force from these ions
will repel opposing charges which in turn inhibits further electron diffusion across the
junction in the absence of an applied bias. As this region contains no charge carriers it
is referred to as the depletion region. For charge to traverse the depletion region, the
energy of the charge must surpass the potential difference between the p-type and n-
type semiconductor layers. This potential difference, and therefore the conductivity of
the device, can be manipulated by applying a bias. When a forward bias is applied to
the diode (positive voltage to p-type side), the depletion region across the p-n junction
is reduced. If the potential difference applied surpasses a threshold voltage, the diode
will conduct current proportional to the bias applied. When a reverse bias is applied
(negative voltage applied to the p-type side), the potential difference across the p-n
junction will increase which will further inhibit conduction. Reverse biased diodes do
exhibit a small current conduction across the p-n junction, however, this conduction
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is a result of minority charge carrier conduction and is referred to as leakage current
or reverse saturation current. The diode is the fundamental solid-state dosimeter, but
more complicated devices can be developed from this foundation. One of the most
important class of solid-state devices, and more pertinent to this research thesis, is
the transistor. A transistor can be produced by fabricating three alternating layers
of doped semiconductor, that is, in either a p-n-p or n-p-n configuration. Transistors
can be utilised to amplify signals or to redirect current based on the bias applied to
the device. Transistors, specifically MOSFETs, have revolutionised electronics as they
are inexpensive, mass-producible, extremely customisable and have enabled electronic
devices to be miniaturised to the nanometre scale.
2.1.2 MOSFET-type Radiation Dosimeters
The Metal Oxide Silicon Field Effect Transistor (MOSFET) is a specific design of field-
effect transistor. The MOSFET typically feature the following five structures/terminals






There are two basic variants of MOSFET based on the alternating doped silicon
configuration used in the (source-substrate-drain), the p-channel MOSFET (p-n-p) or
the n-channel MOSFET (n-p-n). An example of a p-channel MOSFET is presented
in Figure 2.1. The MOSFET is differentiated from other transistor designs by the
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inclusion of a thin silicon dioxide layer separating the gate and substrate materials fab-
ricated through inducing controlled oxidation upon the surface of the silicon substrate.
During operation, electrons enter MOSFET via the source terminal. These electrons
travel through the substrate. These charges cannot reach the gate terminal due to
the insulative oxide layer between the gate and substrate and instead exit the sub-
strate via a channel connecting to the drain terminal. The conductivity of the channel
linking the source and drain terminals is determined by the potential difference be-
tween the gate and substrate terminals which can be adjusted by applying bias to the
gate. A current will be induced across the MOSFET when the gate voltage exceeds a
threshold voltage, VTh. Radiation exposure affects the functionality of MOSFET type
devices[94]. When ionising radiation is incident upon a MOSFET, electron-hole pairs
are generated throughout the device. The total charge induced is highly proportional
to the absorbed dose delivered by the incident radiation to the gate oxide material.
Electrons liberated within the oxide layer are removed by biasing the gate terminal.
The removal of electrons via the gate causes hole migration and accumulation near the
interface between the oxide layer and the substrate, approximately 0.2 to 20 nm from
the interface. This region contains high concentrations charge traps as described in
Section 1.5.4. These charge traps capture holes and forms a semi-permanent charge
sheet near the interface region. The charge sheet produces an electric field which
impairs the conductivity of the substrate material and as such necessitates a higher
gate voltage to stimulate current flow across the device. By measuring the shift in the
threshold voltage needed to stimulate current flow within the MOSFET, the energy
deposited within the oxide layer, or the dose, can be determined. This means that the
MOSFET can be used as a radiation dosimeter. An example of how these electrical
characteristics shift after irradiation for a MOSFET dosimeter is presented in Figure
2.2. Radiation sensitivity of a MOSFET-type is determined by a few factors. The
2.1. Introduction to MOSFET dosimetry solutions 37
gate oxide thickness is proportional to the number of ionisation events occurring due
to incident radiation and as such a thicker gate oxide will increase sensitivity of the
MOSFET. The collection efficiency of ionised charges in the MOSFET can also be
moderated by inducing an electric field across the gate oxide. This is achieved by
biasing the gate node.
MOSFET-type devices feature several favourable qualities for application as radi-
ation dosimeters. MOSFETs are feature a compact sensitive volume that is scalable
down to the sub-millimetre scale. As such, the MOSFET can be used as both a precise
point dose monitoring solution of can be used in high spatial resolution array detector
solutions. MOSFETs are also quite cheap produce, are scalable to purpose and their
designs are customisable for intended use. MOSFET dosimeters are typically highly
sensitive to radiation and provide stable, reproducible outputs. Exposures experienced
by MOSFET-type dosimeters accumulate, meaning the device provides a permanent
record of exposure. The readout procedure for MOSFET dosimeters varies with design
but readout solutions typically feature low power consumption, near-instantaneous
dose reporting and readout can be repeated with no cooldown period required for dose
verification or for providing real-time feedback to the operator. MOSFET devices are
safe to apply to the skin, are waterproof, are easy to apply to the patient volume and
real-time feedback can be used to prevent radiation injuries to sensitive at-risk tissues.
Previous applications have seen these dosimeters applied both as skin dosimeters and
in vivo dosimeters during radiotherapy procedures. There are some drawbacks to
MOSFET dosimeter technologies that should be noted. MOSFET threshold voltages
are sensitive to temperature dependence. An increase in temperature will cause an
increase in the conductivity across the substrate material which results in a shift in the
ID-VG characteristics that can easily be mistaken for an increase in accumulated dose.
This temperature effect means that for accurate dosimetric measurements MOSFETs
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Figure 2.1: Cross-section of a generic p-channel type MOSFET Dosimeter
Figure 2.2: ID-VG Characteristics of a MOSFET Dosimeter before/after irradiation
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need to reach temperature equilibrium with the ambient environment or readout needs
to be corrected to compensate for temperature changes. Conventional MOSFETs also
have a finite lifetime limited either by the maximum threshold voltage measurable
by the readout equipment or by saturation of charge traps within the oxide layer.
MOSFETs may also exhibit energy dependant responses, sensitivity can degrade as
charges accumulate toward saturation point and may experience fading effects due to
trap recombination events occurring after irradiation. Many of these disadvantages
can be mitigated through the design of the electronics, the readout methodology and
the packaging solution used.
2.1.3 The MOSkin Dosimeter
The MOSkin dosimeter, shown in Figure 2.3 with the Clinical Semiconductor Dosime-
try System, is a p-channel MOSFET-type dosimeter capable of:
 providing real-time dosimetric output
 performing in-built temperature compensation
 measuring dose at a tissue equivalent depth of 0.07 mm[94]
The MOSkin encapsulation has been designed to measure radiation doses delivered
to the 0.07 mm measurement depth, enabling the measurement of representative skin
and surface dose values. The ICRP recommend monitoring dose at this depth to
monitor radiation exposure to the skin, hands, feet and eye lens. This depth was first
recommended in ICRU Report 39 where three important measurement depths were
identified, the 0.07 mm, 3 mm and 10 mm tissue depths[3,97]. Dose delivered to these
depths denoted as the dose quantities Hp(0.07), Hp(3) and Hp(10) respectively. The
0.07 mm measurement depth is representative of damage delivered to the first layer of
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radiation sensitive skin, the basal layer, meaning the MOSkin dosimeter, by design, is
ideal for skin dosimetry applications[3].
The MOSkin dosimeter has been used to measure skin and in vivo surface doses
delivered during radiotherapeutic procedures including external beam radiotherapy
and brachytherapy[94, 98 - 101]. During these procedures, MOSkin has been used to
measure skin and surface doses, including doses delivered to the rectum wall during
brachytherapy, and has been noted to induce minimal perturbation on introduction to
the field-of-view (FOV) of incident x-ray beams, even less so than TLDs, and as such,
causes minimal dose enhancement effect to surrounding tissue[101]. The MOSkin has
been calibrated for diagnostic range exposures. Initial diagnostic calibration studies
were performed by Lian et.al. who calibrated the MOSkin for CT applications using
a kilovoltage orthovoltage machine and simulated the MOSkin response to monoener-
getic kilovoltage range photons using Monte Carlo code[95, 102]. Further studies were
performed by Safari et.al. who developed calibration methodologies for applying the
MOSkin dosimeter as an eye lens dosimeter in neuro-angiographic applications. These
methodologies utilised the RQR Series of standard radiation protection beam quali-
ties[103-106].
2.1.4 The MOSkin Readout System: Clinical Semiconductor
Dosimetry System
The Clinical Semiconductor Dosimetry System (CSDS) is the traditional readout sys-
tem for the MOSkin dosimeter developed by CMRP. This system is shown in Figure
2.3. This reader is battery powered and can perform readout of up to 10 MOSkin
dosimeters simultaneously. During irradiation, the CSDS applies a 15 V bias across
the gate oxide to encourage charge migration. This increases the sensitivity of the
MOSkin to ionising radiation and ensures linear response to incident radiation. Read-
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Figure 2.3: Photograph of the MOSkin dosimeter with Clinical Semiconductor
Dosimetry System
Figure 2.4: Photograph of the MOSkin dosimeter with the wireless OneTouch Sys-
tem
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out of the MOSkins is performed by pulsing specific current from source to drain,
VS-D, which induces a measurable gate voltage referred to as the threshold voltage, or
VTh. This process can either be initiated manually by pressing a button on the system
with gate voltage displayed via the LCD screen or automatically at a set rate by a
logging system connected via serial port. When using the CSDS it is recommended
to allow the MOSkin dosimeters to reach equilibrium at ambient temperature before
measurement. This was the readout system used for the duration of this research
thesis.
2.1.5 The MOSkin Readout System: OneTouch Dosimetry
System
The latest iteration in MOSkin readout technology is the OneTouch readout system
developed by CMRP [107]. This system is shown in Figure 2.4. The OneTouch system
is powered by battery and can perform readout of up to six MOSkin dosimeters simul-
taneously via micro-USB. The OneTouch system is a wireless readout system that can
connect to a nearby computer through either Bluetooth or ultra-high frequency band-
width connection. During irradiation, the OneTouch reader applies a 9V bias across
the gate oxide as opposed to the traditional CSDS reader which applied a 15V bias.
This reduced bias reduces the sensitivity of the MOSkin but improves the lifetime
for radiotherapeutic applications. Readout is performed similarly to the CSDS and
readout values are logged at a rate specified in the user interface. The user interface
can display readout both as an accumulated dose value and as a percentage of a target
dose value. The OneTouch MOSkin reader records threshold voltage readout up to
microvolt scale precision and provides stable readout values in the sub-millivolt range.
The OneTouch system also features a temperature compensation system. The One-
Touch system calibrates temperature effect by measuring the ratio between the change
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in source-to-gate voltage, ∆ VS-G, and the change in source-to-substrate voltage, ∆
VS-SS, for two temperature points. This novel methodology was developed by CMRP.
The calibration process, expressed formulaically in Equation 2.1, is performed at
ambient room temperature and at an increased temperature induced simply by touch-
ing the head of the MOSkin pigtail. This built-in temperature compensation process
reduces time and setup effort when compared to conventional MOSFET dosimeters
that need to stabilise to the ambient temperature before use and it reduces potential
sources of readout error that can be made during use.
2.2 Methodologies for Diagnostic Characterisation
of the MOSkin Dosimeter
2.2.1 Lifetime Sensitivity of the MOSkin Dosimeter
Previous studies have observed that the sensitivity of the MOSkin dosimeter and other
MOSFET-type dosimeters can decrease slightly over the lifetime of the device[108]. To
assess the lifetime sensitivity of the MOSkin, five dosimeters were irradiated using a
Varian 21EX 6MV linear accelerator based at the Illawarra Cancer Care Centre. The
dosimeters were embedded within a 20 Ö 20 Ö 20 cm3 solid water phantom at a depth
of 1.5 cm where maximum dose to the phantom volume is imparted. The MOSkins
were irradiated to a total dose of 30 Gy as delivered in 1 Gy increments. Readout was
performed 30 seconds after each irradiation. Sensitivity of the MOSkin was calculated
for each irradiation as the response per unit of dose delivered, as formulaically repre-
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2.2.2 MOSkin Characterisation Using Clinical C-arm Beam
Qualities
The linearity of the MOSkin dosimeter response in low dose pulsed beam qualities
was tested using a Toshiba Infinix c-arm system based at Royal North Shore Hospital.
During these measurements, the patient volume was simulated using a 30 Ö 30 Ö
30cm3 Perspex Polymethyl Acrylic (PMMA) phantom. The phantom was positioned
on the patient couch which was then positioned so that the centre of the phantom was
aligned with the c-arm gantry’s rotational isocentre. All measurements were performed
with the c-arm gantry set to the posterior-anterior imaging projection, that is, the
system was set to the default 0° LAO/RAO (Left Anterior Oblique/Right Anterior
Oblique), 0° CRA/CAU (Cranial/Caudal) angulation. During these measurements,
the c-arm system source to image-receptor distance (SID) was set to 100 cm while
the FOV was set to an orthogonal field size (OFS) of 12 cm. This apparatus setup is
diagrammatically represented in Figure 2.5. Three MOSkin dosimeters were fixed to
the underside of the phantom and positioned to a point central to the c-arm system’s
FOV. Irradiation was performed with the c-arm system operated in service mode by
Toshiba engineers. Through service mode the c-arm beam characteristics could be set
manually to fixed values. While the phantom was in field and while using clinically
relevant imaging protocols, the c-arm system automatically selected a peak x-ray tube
voltage of 93 kVp and a pulse width of 8 ms while a frame rate of 15 frames per seconds
(FPS) was specified by the imaging protocol. These values were maintained manually
for each irradiation. The MOSkin dose rate linearity was assessed using x-ray tube
current values of 10, 20, 30, 50, 80, 100, 125, 160 and 200 mA. The irradiations were
performed using approximately 2 minutes of beam time and readout was performed
30 seconds after the irradiation. Beam times were recorded accurately by dividing the
total of imaging frames acquired by frame rate of 15 FPS. The MOSkin responses were
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presented as an averaged response value normalised to time. Error for all averaged
MOSkin response values was estimated by generating a 95% confidence interval for
each measurement point. These confidence intervals were calculated using the standard
deviation of the MOSkin responses and is represented formulaically in Equation 2.2.
Preliminary MOSkin calibration factors for clinical beam lines were established
using the Philips Allura Clarity FD20 and a GE Innova 2100IQ c-arm systems based at
Sutherland Heart Clinic. The calibration was performed by comparing the response of
the MOSkin dosimeter and EBT2 GAFChromic film after irradiation of the dosimeters
using a total of sixteen clinically-used c-arm beam qualities. EBT2 film was chosen as
the gold standard dosimeter for this study due to its energy independence at kilovoltage
range beam qualities[109,110].
Figure 2.5: PMMA Phantom with MOSkin attached to underside positioned at the
c-arm system rotational isocenter
CI95% = 1.96× σx (2.2)
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For the purposes of these experiments, the film was cut into 3 Ö 3 cm2 portions.
Each piece of film was scanned before and after an irradiation. Scanning of the film
was performed at least 24-hours after each irradiation using a Microtek ScanMaker
i800 scanner. This model of scanner can produce images with optical resolutions of
up to 9600 Ö 4800 dots per inch. Scanning is performed using a charge coupled
device scanning element and output images are produced in 48-bit colour. Scanning
was performed at an optical resolution of 300 dots per inch in the reflective scanning
mode after allowing for a 10-minute warmup period. To minimise scanning artefacts
and variability, positioning of the film was consistent for each portion of film and
scanning was repeated 3 times per portion of film. Analysis of the optical density
of the film was performed using the FIJI software package (Laboratory for Optical
and Computational Instrumentation (LOCI) at the University of Wisconsin-Madison,
https://fiji.sc/). The red channel of the film images was isolated for optical density
assessment as this channel provides the highest response for EBT2 film[110]. Optical
density was assessed over a region of interest of area 1 Ö 1 cm2 which was positioned
at a point central to the film area.
Prior to the measurements at Sutherland Heart Clinic, the EBT2 film was cali-
brated using a Gulmay DX3300 orthovoltage unit based at the Illawarra Cancer Care
Centre. The film was placed on the surface of a solid water phantom which was used
to simulated backscatter conditions. Film portions were irradiated to doses ranging
from 0 cGy to 140 cGy. Readout was performed 2 days after the irradiations were
completed.
As per the measurements performed to assess dose rate linearity, the MOSkin clin-
ical calibration was performed using the 30 Ö 30 Ö 30 cm3 PMMA phantom aligned
to rotational isocentre and with the c-arm gantry set to the posterior-anterior imaging
projection. The dosimeters were positioned central to the FOV during measurements.
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Irradiation of the EBT2 films were performed separately to the irradiations performed
using the MOSkin dosimeters. Irradiations were performed using the low dose pro-
tocols used routinely by clinicians at Sutherland Heart Clinic. Measurements were
performed using two SID settings, 100 cm and 110 cm and were performed in both the
high dose pulsed acquisition mode and the lower dose continuous fluoroscopy mode.
The Philips machine was operated using the clinical “CardLow” protocol. This pro-
tocol was developed as a low dose clinical protocol in collaboration with Sutherland
Heart Clinic and used 5 mm of aluminium equivalent (mmAl) beam filtration when
imaging in acquisition mode and 2 mmAl beam filtration when imaging in fluoroscopy
mode. The GE system was operated using the “RDLS” protocol. This protocol was a
variant of an internationally developed low dose standard protocol and used 5 mmAl
beam filtration when imaging in acquisition mode and 2 mmAl beam filtration when
imaging in fluoroscopy mode. Each c-arm system was surveyed using three FOV set-
tings. The Philips system measures field of view using the diagonal field size (DFS).
The Philips system measurements were performed using the 15 cm, 20 cm and 25
cm field sizes. The GE system measures FOV using the OFS. The GE system mea-
surements were performed using the 10 cm, 12 cm and 17 cm OFS field sizes. The
differences in FOV settings between these machines may contribute to differences in
x-ray tube characteristics chosen by the c-arm systems. That said, FOV settings with
comparable projected beam area were chosen to provide comparable irradiation condi-
tions and Table 2.1 provides a direct comparison of each c-arm systems FOV settings,
their associated projected beam area and the ratio of beam areas. The variety of set-
tings chosen embody a large range of c-arm beam qualities and are representative of
the clinical conditions most commonly observed during procedures by the clinicians
at Sutherland Heart Clinic. To compare the MOSkin and film responses, dosimeter
readout was normalised to irradiation time in units of minutes. In acquisition mode,
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time of irradiation was recorded by dividing the total imaging frames acquired during
each irradiation by the frame rate setting in use while in fluoroscopy mode time was
recorded as measured by the c-arm system. The targeted duration of irradiation for the
MOSkin dosimeters was 30 seconds in acquisition mode and 2 minutes in fluoroscopy
mode. The EBT2 film portions were irradiated for approximately 50 seconds in both
acquisition and fluoroscopy mode. The irradiation times selected were necessary to
provide greater statistical certainty. MOSkin calibration factors were calculated as
the ratio of the shift in MOSkin threshold voltage per minute to dose delivered per



















(OFSPh = 15 cm, OFSGE = 10 cm)
112.5 100 1.125
Field Size 2
(DFSPh = 20 cm, OFSGE = 15 cm)
200 225 0.889
Field Size 3
(DFSPh = 25 cm, OFSGE = 17 cm)
312.5 289 1.081
Table 2.1: Comparison of the Beam Area produced at Image Receptor by Diagonal
Field Settings and Orthogonal Field Settings
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2.2.3 Simulated MOSkin Energy Dependence for Diagnostic
X-Ray Spectra
Depending on model and protocol, the x-ray beam characteristics and x-ray tube
filtration may vary between c-arm systems. Through simulation, the MOSkin cali-
bration was expanded to include a broader range of potential c-arm beam qualities.
This was intended to ensure that an appropriate calibration factor would be available
during measurements using any c-arm system and c-arm configuration. Clinically rep-
resentative beam spectra were generated using methodology outlined by Boone and
Seibert[113]. This methodology was used to calculate the energy spectra based on the
x-ray tube potential and beam filtration settings. Using this method, individual spec-
tra were generated for beam potentials ranging from 60 to 120 kVp in 10 kVp intervals
using four filtration settings: 0 mm, 2 mm, 5 mm and 10 mm of aluminium equivalent
material. Each simulation was performed to sufficient photon count to ensure that
error was within 2% of the total photon count. The spectra were normalised to the
integral of the spectrum’s counts. Data detailing the MOSkin relative response to
monoenergetic diagnostic range photons was acquired from a simulation study per-
formed by Lian et.al.[102]. The product of MOSkin response and the photon count
was summated for each individual monoenergetic photon bin using Equation 2.3.
This procedure was performed on all simulated spectra to produce a relative MOSkin
response to each of the simulated x-ray tube potentials which were then scaled using
the results of the clinical system calibration through comparison to film response per-
formed in Section 2.3.2.
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2.2.4 MOSkin Energy and Angular Dependence Using
Standard Diagnostic Beam Qualities
Further characterisation of the MOSkin dosimeters’ energy dependence was performed
by observing the MOSkin response to irradiation using standard radiation protection
beam qualities. The irradiations were performed at the calibration facilities of the
Studiecentrum voor Kernenergie; Centre d’Étude de l’énergie Nucléaire (SCK-CEN).
Using these facilities, the MOSkin response to the Narrow Spectrum Series and RQR
Series of beam qualities was assessed. The Narrow Spectrum Series of beam qualities
was defined by ISO in ISO report 4037-1[111]. Designed to represent the scatter fields
produced by clinical x-ray sources, this series of beam qualities is typically used to
characterise radiation protective equipment and radiation monitoring equipment. The
RQR Series of beam qualities was developed by the IEC to reproduce clinical diagnostic
beam qualities[112]. These beam qualities were produced using an Xstrahl dual x-ray
tube system equipped with a 100 keV and a 300 keV x-ray tube using a variety of
filtration settings. The x-ray tube potentials and x-ray tube filtration settings for each
of the Narrow Spectrum Series beam qualities as specified by ISO are presented in
Table 2.2, while the settings for the RQR Series beam qualities as specified by IEC
are presented in Table 2.3.
Measurements were performed using the 20 Ö 20 cm3 cylindrical PMMA water-
filled phantom. This phantom was designed as an outcome of the ORAMED (Op-
timization of RAdiation protection for MEDical staff) study and was intended to
represent an operator or patient head as recommended by the ICRP in ICRP Publica-
tion 139 for the purposes of calibrating eye lens dosimeters [61, 114]. This phantom was
chosen to further assess the MOSkin dosimeter for applications in operator dosimetry
and in neuro-angiographic procedures. The phantom was placed 100 cm from the ir-
radiation source to ensure uniform irradiation of the entire phantom volume, as shown
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in Figure 2.6. Four MOSkin dosimeters were fixed to the surface of the phantom
volume along the central axis of the front phantom surface in varying orientations.
This configuration is represented diagrammatically in Figure 2.7.
The MOSkin energy dependence was assessed using the full series of beam qualities
as delivered at normal incidence. The dose delivered to the MOSkin dosimeters during
irradiations was calculated using both the air Kerma at the measurement point and
air Kerma conversion coefficients as specified in ISO 4037-3[115]. The air Kerma de-
livered to the measurement point was measured in free air prior to each measurement
using a 1 litre PTW ionization chamber. The air Kerma values provided by the ioni-
sation chamber were converted into Hp(0.07), Hp(3) and Hp(10) dose quantities using
Equation 2.4. air Kerma conversion coefficients for the cylindrical phantom vol-
ume existed within the literature for the Hp(3) dose quantity, however, the conversion
coefficients for the Hp(0.07) measurement depth were unavailable for the cylindrical
phantom[116,117]. As such, the missing conversion coefficients were simulated using the
simulation framework developed in the previous section. Spectra for the Narrow Series
and RQR Series beam qualities were input as published by Physikalisch-Technische
Bundesanstalt in their DOS-34 report and using similar methodology to those em-
ployed by Grosswendt and Ginjaume et.al.[118 - 120]. The geometry and positioning of
scoring volumes used for these simulations has been represented diagrammatically in
Figure 2.8. The simulated conversion coefficients at normal incidence was compared
to the existing published air Kerma conversion coefficients for the cylindrical and slab
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Figure 2.6: Irradiation apparatus for characterisation of the MOSkin dosimeter using
standardised beam qualities using cylindrical PMMA water phantom
positioned with measurement point 100 cm from x-ray source
Figure 2.7: MOSkin dosimeter positioning on cylindrical phantom volume presented
with a) phantom at 0° orientation and b) phantom at 90° orientation.
Φ and θ angular axes marked on phantom and c) with respect to the
MOSkin pigtail
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Figure 2.8: Diagram representing the scoring volumes used during air Kerma sim-
ulations as positioned in a) free air and b) with the phantom volume
generated (yellow represents HP(0.07), green represents HP(3), purple
represents HP(10) and grey arrows represent uniform incident radiation
beam)
Figure 2.9: Irradiation apparatus for measuring angular response of the MOSkin
dosimeter to standardised beam qualities at a fixed source to dosimeter
distance of 1 meter (blue circle represents phantom in 0° incidence config-
uration, yellow circle represents phantom in 45° incidence configuration
and orange circle represents phantom in 90° incidence configuration)
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The response of the MOSkin dosimeter when irradiated from a range of incident
angles was assessed. Angle of incidence was adjusted by rotating the cylindrical phan-
tom about the MOSkin measurement point while maintaining a source to dosimeter
distance of 1 meter for all phantom configurations. This rotation method is presented
diagramatically in Figure 2.9. The dosimeters were irradiated over 7 phantom con-
figurations that covered the 0° to 90° angular range in 15° increments. Dose delivery
was measured using four MOSkin dosimeters aligned vertically at the measurement
point. Each MOSkin dosimeter pigtail was oriented in a different direction. This
enabled characterisation across a 180° degree over two rotational axes denoted as the
Φ axis and the θ axis. This dosimeter configuration has been presented in Figure
2.7 with an explicit definition of the Φ and θ axes relative to the MOSkin pigtail in
Figure 2.7c. Dose delivered to the measurement point in terms of Hp(0.07), Hp(3)
and Hp(10) dose quantities as calculated using air Kerma conversion coefficients speci-
fied by Behrens et.al., Principi et.al. and Ankerhold et.al.[116 - 118]. As the cylindrical
phantom is relatively new some air Kerma conversion coefficients required simulation
using the methodology specified earlier in this section. MOSkin response to varying
incident irradiation angles was assessed using the Narrow80 and RQR6 beam qualities.
These beam qualities were chosen as they are representative of the irradiation condi-
tions present in catheterisation laboratories[80, 121].
2.3 Results of the MOSkin Characterisation Study
2.3.1 Lifetime Linearity of MOSkin Sensitivity
The sensitivity of the MOSkin decreased as the dosimeters accumulated exposure as
shown in Figure 2.10. The average reduction in MOSkin sensitivity over the 30 Gy
irradiation period was 9.69% which can also be represented as 0.334% /Gy. The reduc-
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tion in MOSkin sensitivity was also consequently observed to decrease linearly with
threshold voltage. When considering MOSkin sensitivity as a function of threshold
voltage, it was observed that all irradiated MOSkins behaved to a common linear trend
which has been presented in Figure 2.11 and expressed in Equation 2.5. Regression
analysis of this linear trendline yielded an R-squared value of 0.97. All measurement
points were observed to be within 1.07% of the expected value based on this trendline
and therefore this data can be used to correct MOSkin desensitisation by inputting
the initial and measured threshold voltages.
2.3.2 Investigation of MOSkin response to clinical c-arm
beam qualities
When exposed to a consistent 93 kVp beam quality, the MOSkin dosimeter response
was observed to increase linearly with increasing x-ray tube current, as shown in
Figure 2.12. A linear trendline was established and using regression analysis, this
trendline yielded an R-squared value of 0.98. Error was assessed by generating a
95% confidence interval using the standard deviation of the MOSkin responses. The
MOSkin response was highly reproducible with individual responses varying by a max-
imum of 5% of the averaged value for the lowest dose settings.
The EBT2 film portions darkened proportionally with the total dose imparted to
the film. Linear trendlines were established for each individual beam quality assessed
and for a combined dataset comprised of data from all beam qualities assessed. Re-
gression analysis yielded R-squared values of 0.992, 0.988, 0.992, 0.992 and 0.973 for
the 50 kVp, 75 kVp, 100 kVp, 150 kVp and the combined datasets respectively. The
film response error was established by generating a 95% confidence interval based on
the standard deviation of pixel values within the region of interest. All film portions
observed individual error of within 10% and the majority of the film portions were
2.3. Results of the MOSkin Characterisation Study 58
Figure 2.10: Lifetime Dependence of MOSkin Sensitivity on Accumulated Absorbed
Dose using 6MV Linear Accelerator to a Total Dose of 30 Gy
Figure 2.11: MOSkin Sensitivity Expressed as a Function of Threshold Voltage
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within 10% of the combined dataset trendline values. The calibration trends with
calculated error values applied as presented in Figure 2.13. This error is potentially
related to minor energy dependence of EBT2 film in this x-ray energy range.
MOSkin calibration factors were established for the Philips Allura Xper FD20
and GE Innova 2100IQ c-arm systems based at Sutherland Heart Clinic. The Philips
Allura Xper FD20 c-arm system produced x-ray tube voltages ranging from 82 to 120
kVp. The average MOSkin calibration factors observed on this machine were 0.737
± 0.036 mV/mGy for acquisition mode and 0.691 ± 0.014 mV/mGy for fluoroscopy
mode. The GE Innova 2100IQ c-arm system produced x-ray tube voltages ranging
from 97 to 120 kVp. The average MOSkin calibration factors observed on this machine
were 0.738 ± 0.032 mV/mGy for acquisition mode and 0.711 ± 0.083 mV/mGy for
fluoroscopy mode. The full range of calibration factors and x-ray beam potentials for
both machines in all configurations is provided in Table 2.4 to Table 2.7
2.3.3 Simulated MOSkin Energy Dependence for Diagnostic
X-ray Spectra
The simulated c-arm beam spectra are presented graphically in Figure 2.14. The
energy dependence of the MOSkin to monoenergetic photons as simulated by Lian
et.al. is presented in Figure 2.15[102]. A logistic trendline was fit to the data. Figure
2.16 represents the expected MOSkin response to the simulated beam qualities relative
to the MOSkin response to monoenergetic 300 keV photons. A quadratic trendline was
applied for each filtration setting. This trend is represented in Equation 2.7 and the
relevant coefficients for each filtration setting is supplied in Table 2.8. The MOSkin
response values were then scaled using the clinical calibration data points measured
and presented in Section 2.3.2. The data point used was the 0.737 mV/mGy data
point which was measured when using the Philips Allura Xper c-arm system with an
















106 262.1 359 0.730
SID:110 cm
DFS:15 cm
116 331.8 462 0.718
SID:100 cm
DFS:20 cm
103 250.2 339.6 0.737
SID:110 cm
DFS:20 cm
107 294 403.3 0.729
SID:100
DFS:25 cm
98 216.8 290.1 0.747
SID:110 cm
DFS:25 cm
93 267.6 351.2 0.762
Average CF: 0.737 ± 0.036
Table 2.4: Calibration of the MOSkin dosimeter using the Philips Allura Xper FD20
















109 22.50 33.25 0.677
SID:110 cm
DFS:15 cm
120 28.61 52.60 0.544
SID:100 cm
DFS:20 cm
84 18.29 25.11 0.728
SID:110 cm
DFS:20 cm
91 26.52 38.19 0.694
SID:100
DFS:25 cm
82 13.98 18.45 0.757
SID:110 cm
DFS:25 cm
86 18.62 25.03 0.744
Average CF: 0.691 ± 0.140
Table 2.5: Calibration of the MOSkin dosimeter using the Philips Allura Xper FD20
c-arm system in fluoroscopy mode
















97 259.1 347.4 0.746
SID:110 cm
OFS:12 cm
105 326.0 445.1 0.732
SID:100 cm
OFS:15 cm
100 245.7 331.1 0.742
SID:110 cm
OFS:15 cm
104 306.3 411.5 0.744
SID:100 cm
OFS:17 cm
110 212.9 291.7 0.730
SID:110 cm
OFS:17 cm
113 274.8 375.6 0.732
Average CF: 0.738 ± 0.032
Table 2.6: Calibration of the MOSkin dosimeter using the GE Innova 2100IQ c-arm
















105 26.51 39.44 0.672
SID:110 cm
OFS:12 cm
115 32.76 47.07 0.696
SID:100 cm
OFS:15 cm
108 23.58 30.90 0.763
SID:110 cm
OFS:15 cm
117 29.19 43.02 0.678
SID:100 cm
OFS:17 cm
110 19.73 28.98 0.681
SID:110 cm
OFS:17 cm
120 23.93 30.78 0.777
Average CF: 0.711 ± 0.083
Table 2.7: Calibration of the MOSkin dosimeter using the GE Innova 2100IQ c-arm
system in fluoroscopy mode
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x-ray tube potential of 103 kVp and with 5mmAl of beam filtration. The data was
then extrapolated to provide MOSkin calibration factors for beam qualities from 80 to
120 kVp for filtration values from 1 to 10 mmAl in 1 mmAl increments. This data is
presented graphically in Figure 2.17 where it is also compared to the MOSkin clinical
calibration datapoints.
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Figure 2.12: MOSkin Dose Rate Linearity using a Toshiba Infinix C-arm System
producing a consistent beam quality at 93 kVp x-ray tube voltage
Figure 2.13: Energy and dose rate dependence of EBT2 film using 50, 70, 100 and
150 kVp orthovoltage beam qualities for doses of up to 200 cGy.
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Figure 2.14: Photon Spectra for x-ray tube potentials ranging from 60 kVp to 120
kVp with (A) no filter, (B) 2mmAl filter, (C) 5mmAl filter and (D)
10mmAl filter settings at a fixed x-ray tube current of 1mAs
Figure 2.15: MOSkin response to monoenergetic photons relative to the response at
300 keV as generated using Monte Carlo with logistics trendline fit to
data[102]
2.3. Results of the MOSkin Characterisation Study 65
Figure 2.16: Relative MOSkin response to the simulated c-arm beam spectra
Figure 2.17: MOSkin calibration factors as established by scaling the relative
MOSkin response data as scaled by and compared to clinically mea-
sured MOSkin Sensitivities
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0 mmAl 5.07 -4.54 Ö 10-2 1.79 Ö 10-4
2 mmAl 4.33 -3.81 Ö 10-2 1.55 Ö 10-4
4 mmAl 3.79 -3.24 Ö 10-2 1.36 Ö 10-4
10 mmAl 3.33 -2.72 Ö 10-2 1.16 Ö 10-4
Table 2.8: Coefficients for quadratic trendlines that describe MOSkin behaviour dur-
ing exposure to kilovoltage range beam qualities over four filtration values
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2.3.4 MOSkin Energy Dependence Using Standard
Diagnostic Beam Qualities
The simulated Narrow Spectrum Series and RQR Series air Kerma conversion coef-
ficients compared favourably to previously published data. The energy dependence
of the MOSkin dosimeter to the Narrow Series and RQR Series beam qualities is
presented in Figure 2.18. A peak MOSkin energy response of 1.37 mV/mGy was
observed for the native MOSkin measurement depth of 0.07 mm using the Narrow25
beam quality. The angular response of the MOSkin dosimeter for the Narrow80 and
RQR6 beam qualities is presented in Figure 2.19 to Figure 2.22.
Figure 2.18: Energy dependence of the MOSkin dosimeter at native measurement
depth with respect to Hp(0.07), Hp(3) and Hp(10) dose delivered to
measurement point
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2.3.5 MOSkin response to varying angle of irradiation
incidence using standard diagnostic beam qualities
The MOSkin response to varying angle of irradiation incidence has been presented
in Figure 2.19a for the Narrow80 beam quality and Figure 2.19 b for the RQR6
beam quality. The phantom orientations have been reiterated in Figure 2.19c for
ease of interpretation. The MOSkin response was proportional to within 5% of the
calculated HP(0.07) dose for angles of up to 70°. Maximum deviation occurred at
the 90° incidence angle where the MOSkin over responded to incident radiation by an
average of 16%.
Figure 2.19: MOSkin response to varying angle of incidence as irradiated using a)
the Narrow80 beam quality and b) the RQR6 beam quality with angles
simulated by c) rotating the cylindrical phantom volume.
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2.4 MOSkin Characterisation Discussion
Over the course of this chapter and through the results obtained during these studies
the MOSkin dosimeter behaviour has been comprehensively characterised for use in
the catheteritisation laboratory. Sensitivity of the MOSkin dosimeter was established
for linear accelerator beam qualities, c-arm system generated x-ray beams and for
standardised radiation protection beam qualities. In Table 2.9 and Table 2.10, the
MOSkin calibration factors established during this study have been compared to and
are in close agreement with relevant literature published values.
During the linear accelerator response testing, the sensitivity of the MOSkin dosime-
ters was observed to decrease with dose accumulation. Over the course of the 30
Gy irradiations, the sensitivity of the MOSkin dosimeters reduced by an average of
10.442%, or 0.334% per Gy. This figure is in close agreement with results published by
Wei Loong Jong et.al., a study that reported that MOSkin sensitivity reduced by an
average of 0.340% per Gy after a total of 30 Gy irradiation via a linear accelerator[108].
When correlating MOSkin sensitivity with the MOSkin threshold voltage recorded
pre-irradiation, a common highly linear trend was identified that on regression anal-
ysis yielded an R-squared value of 0.97 and could be used to describe the combined
sensitivity dataset to within 1.07% of the trendline predicted values. The average
MOSkin sensitivity to these megavoltage exposures was 0.263 ± 0.003 mV/Gy which
corresponded to a threshold voltage of 16.262 V. The total life span of the MOSkin
dosimeter observed during this experiment was 9.640 V to 22.670 V or a total of ∼13
V which represents a minimum lifespan of ∼17.5 Gy when using the average angio-
graphic sensitivity measured during the clinical characterisation, however, this lifetime
may differ depending on irradiation source and on the initial threshold voltage values
of the selected MOSkin batch. Desensitisation of the MOSkin dosimeter, if not cor-
rected, could result in an underestimation in dose of at maximum 3.5% during a 2 Gy
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Irradiation Source MOSkin Calibration Factor Source of Data
6 MeV Linac 0.263 ± 0.003 mV/mGy Experimental data Section 2.3.1
6 MeV Linac 0.263 ± 0.001 mV/mGy Hardcastle et.al. (2010)[99]
6 MV TomoTherapy Unit 0.257 ± 0.006 mV/mGy Alnaghi et.al. (2015)[122]
Table 2.9: Experimental and Published MOSkin calibration factors for radiothera-
peutic megavoltage beam qualities
Irradiation Source MOSkin Calibration Factor Source of Data
103 kVp c-arm beam
Filtration = 5 mmAl , Eeff = keV
0.737 ± 0.036 mV/mGy Experimental data Section 2.3.2
150 keV Orthovoltage
Filtration = 0.6mmCu, Eeff = 64.87 keV
0.670 mV/mGy Lian et.al. (2013)[123]
RQR7 Beam Quality
Eeff = 34.73 keV
1.127 ± 0.028 mV/mGy Experimental data Section 2.3.4
RQR7 Beam Quality
Eeff = 36.1 keV
1.156 ± 0.036 mV/mGy Safari et.al. (2015)[103]
Table 2.10: Experimental and Published MOSkin calibration factors for diagnostic
kilovoltage beam qualities
procedure. Correction of this effect can be performed by incorporating Equation 2.5
into the readout process.
The MOSkin dosimeter displayed favourable characteristics during the clinical eval-
uation of the dosimeter. The MOSkin was observed to exhibit radiation transparency
in all beam qualities observed. In Figure 2.20, the visibility, or lack thereof, of the
MOSkin dosimeter has been compared to two paperclips. The MOSkin responses were
highly reproducible to within 2% of an average measurement value and when exposed
to a fixed x-ray tube current while incrementing current, the dosimeters response in-
creased proportionally to beam current. This was observed even for lower dose rates
and during both pulsed and continuous beam types.
The clinical calibration of the MOSkin dosimeter was performed through compari-
son to EBT2 film as the study’s gold standard comparative dosimeter. The EBT2 film
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Figure 2.20: MOSkin radiation transparency and visibility as compared to paper-
clips on images acquired by the Phillips Allura Xper FD20 c-arm sys-
tem[124]
exhibited low levels of energy and dose rate dependence during the orthovoltage cali-
bration, which was consistent with the reference study performed by Butson et.al.[110].
There was some divergence of the calibration trendlines, all data points were within
10% value of the combined calibration trendline. These properties made EBT2 an
ideal option for the initial clinical diagnostic calibration of the MOSkin dosimeter.
Ultimately, the 100 kVp film calibration curve was chosen for performing readout of
the film irradiated using the Sutherland Heart Clinic c-arm systems. This curve was
deemed the most appropriate to use as the 100 kVp beam quality was the closest
representative to the range beam qualities observed using the Sutherland Heart Clinic
c-arm systems, that is, these c-arms operated within an x-ray tube energy range of 80
to 120 kVp. The energy dependence of EBT2 film was considered negligible in this
range as both the 70 kVp and 150 kVp calibration curves were both within 10% of
the 100 kVp calibration curve.
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The MOSkin dosimeter was compared to EBT2 film over a total of sixteen beam
qualities produced by the clinical c-arm systems using clinically-used protocols and
settings. MOSkin calibration factors were established for each beam quality individ-
ually and were averaged by machine and imaging modality. The MOSkin sensitivity
varied depending on machine, imaging modality, field size and general irradiation
setup. This variation was less pronounced in acquisition mode as this mode utilised
additional beam filtration and a narrower range of x-ray tube voltages than the fluo-
roscopy mode. The results indicate that while it would be possible to produce simple
machine and protocol specific MOSkin calibration factors in acquisition mode without
introducing significant levels of error, these calibration factors would not necessarily
be transferable between machines or protocols and would most likely be unsuitable
for fluoroscopy mode measurements. The results indicate that this form of calibra-
tion is not ideal for clinical use but nonetheless was a useful initial investigation for
developing a more sophisticated methodology. Furthermore, while not relevant to the
characterisation of the MOSkin dosimeter performed in this chapter, this study fur-
ther illustrated the need for real-time dosimetry in catheterisation laboratories after
an expanded phantom dosimetry survey with additional local c-arm systems revealed
significant differences in dose delivery between different c-arm systems[124].
The MOSkin calibration was further developed through use of the simulation frame-
work developed in Section 2.2.2. This framework allowed for MOSkin calibration
factors to be estimated as a function of x-ray tube voltage and total beam filtration.
The simulation results were validated through comparison to the clinically measured
MOSkin calibration factors and close agreement between the datasets was established.
There were limitations to this simulation, for instance, the c-arm x-ray tube filtration
settings were represented in terms of equivalent thickness of aluminium when in real-
ity the x-ray tube filtration was composed of a combination of aluminium and copper
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material. This could affect the beam quality and result in some error introduced to the
simulated spectra. These results effectively provide a transferable MOSkin calibration
function that with proper input can be applied to any c-arm system and protocol
within reason with relative ease.
When calibrating the MOSkin using standard diagnostic radiation protection beam
qualities, the MOSkin was observed to experience energy dependence at low energies.
At the measurement depth of 0.07 mm, the MOSkin energy dependence peaked at
1.37 mV/mGy when using the Narrow25 beam quality. When considering the x-ray
tube energy range observed at Sutherland Heart Clinic, 80 to 120 kVp, meaning the
Narrow80 to Narrow120 and RQR6 to RQR8 beam qualities are potentially the closest
representatives of the c-arm system beam qualities. Furthermore, previous studies in
the literature have used the Narrow80, RQR6 and RQR7 beam qualities to represent
clinical c-arm system beam qualities[80,121]. As such, it is reasonable to assume that
the MOSkin energy dependence would result in MOSkin calibration factors ranging
from 0.479 to 1.152 mV/mGy to be suitable for use in catheterisation laboratories.
This range encapsulated all diagnostic range MOSkin calibration factors observed in
this study and presented from the literature in Table 2.10.
The MOSkin angular response was modelled using a parabolic trendline of form
k · x2 where x is the angulation of the dosimeter and k is a function of MOSkin
orientation/positioning and the measurement depth, as presented in Equation 2.8.
Using this formulation, k was observed to increase with the simulated measurement
depth used and as such an increase in the gradient of the trendline was observed.
A slight asymmetry was present across the dosimeter volume, resulting in an ap-
proximate offset of 3.5% in the parabolic trend observed between either side of the
dosimeter, as presented in Figure 2.21. This difference was more pronounced for the
Φ axis measurements than for the θ measurements. For the measurement depth of
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Figure 2.21: MOSkin response to standard beam qualities when varying a) θ axis
angulation and b) Φ axis angulation with as simulated by c) rotating
the cylindrical phantom volume.
0.07 mm, the MOSkin dosimeter response was within 10% of expected dose response
for angles of up to 70° deviation from normal incidence. Maximum deviation was ob-
served at 90° incidence resulting in MOSkin over response of up to 20%.
Finally, the MOSkin dosimeter response was compared to dose values at differ-
ent reference depths. These depths included the native HP(0.07) reference depth, the
HP(3) reference depth and the HP(10) reference depth. For simplicity, the θ axis mea-
surements were considered in isolation and each dataset was subsequently converted
into a parabolic trendline of the form given in Equation 2.7. The resulting graphs
have been presented in Figure 2.22 with k-values presented in Figure 2.22c. For
each subsequent reference depth, the k-values increased resulting in a steeper trendline.
2.4. MOSkin Characterisation Discussion 75
Despite this, values for the HP(3) reference depth were within 10% expected response
for angles up to 30° deviation from normal and were within 20% expected response for
angles up to 45° deviation from normal. K-values also did not vary significantly be-
tween the Narrow80 and RQR6 beam qualities. These results suggest that the MOSkin
could be calibrated with respect to HP(3) reference depth and could reliably measure
doses delivered from near-normal incidence. This option would not be practical for
the HP(10) reference depth as the MOSkin angular response was too steep for this
reference depth and because k-values deviated significantly based upon beam quality
used. This was likely caused by the low energy photon contribution that the MOSkin
dosimeter was subject to for each beam quality. At the HP(10) reference depth, this
low energy contribution would not be present and as such extrapolating to this depth
is complicated. Chapter 5 will consider the potential for MOSkin capping materials
to enable measuring accurately at specifically the HP(3) reference depth.
MOSkin Angular Response = kx2 + 1 = f(p, d)× A2 + 1 (2.7)
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Figure 2.22: Comparison of MOSkin response at reference depths HP(0.07), HP(3)
and HP(10) during a) Narrow80 and b) RQR6 irradiation when varying
the θ axis with c) degree of angular dependence for each reference depth
represented in terms of parabolic k-values
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2.5 Conclusions
The MOSkin dosimeter proved itself as an ideal candidate for patient dosimetry. The
dosimeter exhibited dose rate independence, radio-transparency, minimal energy de-
pendence and minimal angular dependence. The lifetime of the MOSkin was observed
to span more than 30 Gy, potentially enabling each MOSkin to be used in at least 9
procedures if deterministic thresholds of 2 Gy are not exceeded during each procedure.
Through simulation, characterisation to standard beam qualities and comparison to
EBT2 film in a diagnostic setting, a comprehensive understanding of the dosimeter’s
behaviour when irradiated using diagnostic beam qualities was established. While
the MOSkin exhibited features favourable for measuring operator dose, the highest
diagnostic range MOSkin sensitivity measured was 1.37 mV/mGy, meaning that the
MOSkin would not be suitable for measuring operator dose. Regardless, the results
will be useful in developing a dosimeter for operator specific usage.
Chapter 3
Development of Dose Minimisation
Strategies via the Optimisation of
Operator Modifiable Parameters
Selected During Procedure
As previously established in Chapter 1, the literature reports that patient radia-
tion exposures experienced during interventional procedures can vary considerably
depending on complexity of the procedure, sophistication of the c-arm system technol-
ogy deployed within the specific catheterisation laboratory and the type and level of
clinical training undertaken by the staff performing the procedure[9]. While the devel-
oping complexity of angiographic procedures is beyond the scope of this physics-based
research project, Chapter 3 and Chapter 4 will focus on evaluating the efficacy
of dose reduction initiatives made through deployment of dose minimisation strate-
gies and through technological advances and innovations respectively. In Chapter
2, the c-arm x-ray beam characteristics and entrance doses observed by the MOSkin
dosimeter changed significantly when field size and SID were adjusted. As such, dose
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delivery is affected by the clinical setup chosen by c-arm system operators. Chapter
3 explored a broad range of operator modifiable parameters, assessed the impact of
adjusting these parameters on dose delivery in a meaningful way, produced a series of
best practice recommendations for c-arm system operators based upon the findings of
the study and compared to the recommendations presented by other prominent studies
within the literature.
3.1 Clinical Equipment, Patient Representative
Phantom Volumes, defining ‘Dose’ Delivery
and Identifying Operator Modifiable
Parameters
The measurements were performed using a Philips Allura Xper FD20 c-arm system
and a GE Innova 2100IQ c-arm system. The c-arm systems were operated using clin-
ician suggested imaging protocols. There were two phantoms used during this study,
a custom made 30 Ö 30 Ö 30 cm3 PMMA phantom which was previously described
in Section 2.2.2 and a CIRS 702-C Atom phantom provided by Liverpool Hospi-
tal. Images of these phantoms are provided in Figure 3.1. The 30 Ö 30 Ö 30 cm3
PMMA slab phantom was composed of several Perspex blocks. By reconfiguring and
subtracting blocks from the phantom volume the phantom thickness could be adjusted
in 1 cm increments. The CIRS 702 Atom phantom is an anthropomorphic head and
torso phantom[125]. This phantom is composed of tissue-equivalent epoxy resins which
have been shaped into 21 defined organ volumes encased within a dense skeletal frame.
Design of the phantom volume was based upon recommendations issued within ICRP
Publication 23 and ICRU Report 48[126,127].
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Figure 3.1: The a) PMMA Slab Phantom and the b) CIRS 702 Atom Phantom
3.1.1 Measuring ‘Dose’ in the Coronary Catheterisation
Laboratory
Recommendations on optimal clinical setup can be found in the literature, however, the
results of these studies are not always clear and can appear to contradict each other due
to the use of broad or general terminology. Terms such as peak skin dose, maximum
skin dose, air Kerma at reference point, entrance skin dose, dose area product, Kerma
area product and the more general term ‘dose’ are easily conflated which can lead to
confusion between results. To develop effective dose minimisation solutions, radiation
exposure must be assessed in a clear and meaningful way.
During this study, dose delivery was assessed using two quantities: entrance skin
dose rate (ESDR) and dose area product rate (DAPR). The ESDR was defined as
the dose delivered to the measurement point at the surface of the phantom volume as
measured by a dosimeter and normalised to time while the DAPR was defined as the
product of the measured ESDR value and the cross-sectional area of the c-arm beam at
the measurement point. The cross-sectional area was calculated through trigonometric
interpolation and through the properties of similar triangles. The parameters needed
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to calculate this cross-section are represented graphically in Figure 3.2.
3.1.2 Indexation of Operator Modifiable Parameters
This study observed the impact on dose delivery introduced by adjusting the following
factors:
 Field Of View (FOV)
 Beam Collimation
 Wedge Filtration
 Source to Image receptor Distance (SID)
 Patient to image-receptor (Air gap)
 Table height
 Phantom thickness
 C-arm gantry angulation
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Figure 3.2: Diagrammatic representation of variables relevant to calculating cross-
sectional area of the c-arm beam
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3.2 Specific Methodologies for Monitoring Each
Operator Modifiable Parameter
Specific methodologies have been devised for monitoring dose delivery with respect
to each of the parameters listed in Section 3.2. The results were presented in two
graphs, each representing change in ESDR and DAPR respectively. Where the selected
operator modifiable parameter was assessed over multiple settings or configurations,
error was assessed using a 95% confidence interval about the average change in dose
delivery. For each operator modifiable parameter assessed, ESDR and DAPR were
labelled as correlating, inversely correlating or as uncorrelated. These behaviours were
represented on each graph with use of the colours green, red and grey respectively.
3.2.1 Field of View
The impact of adjusting the FOV settings was observed with the Philips Allura Xper
FD20 system using the 30 Ö 30 Ö 30 cm3 PMMA phantom. During these mea-
surements, the phantom’s centre was aligned to the rotational isocentre of the c-arm
gantry. The MOSkin dosimeter was placed on the underside of the phantom at a
point central to the incident c-arm beam. All measurements were performed using the
posterior-anterior c-arm angulation setting. Measurements were performed using the
15, 20 and 25 cm DFS settings.
3.2.2 Beam Collimation
During procedures, the c-arm beam can be collimated using two pairs of lead shutters.
These shutters completely attenuate beam contribution in the collimated areas. The
impact of adjusting the beam collimation was observed with the Philips Allura Xper
FD20 c-arm system using the 30 Ö 30 Ö 30 cm3 PMMA phantom. During these
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measurements, the phantom’s centre was aligned to the rotational isocentre of the
c-arm gantry. The MOSkin dosimeter was placed on the underside of the phantom at
a point central to the incident c-arm beam. All measurements were performed using




× 100 % (3.1)












DAPCol = DMP × ACol =
ACol
ACS
×DAPPBE, Gy · cm2 (3.4)
The collimated beam area, that is, the beam area transmitted through the beam
collimator was described as a fraction of the total uncollimated primary beam area as
calculated in Equation 3.1. Raw images of each of the collimation settings acquired
are presented in Figure 3.3.
Figure 3.3: a) No Collimation b) 73% of Primary Beam Area c) 52% of Primary
Beam Area d) 22% of Primary Beam Area e) 9% of Primary Beam Area
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Matlab (https://www.mathworks.com/products/matlab.html) was used to
threshold each of the images into binary values of either 0 or 255. The thresholded
images were then normalised to maximum pixel value, 255, to provide a pixel count
of the collimated beam area, as shown in Equation 3.2. The ratio of the collimated
beam area pixels to the total pixels in the image was then multiplied by the area of the
primary beam cross-section at measurement point which was then used to calculate
the DAP at measurement point, as formulaically represented in Equation 3.3 and
Equation 3.4. Measurements were performed with beam area collimated to 100%,
73%, 52%, 22% and 9% of the primary beam area.
3.2.3 Wedge Filtration
During procedures, the c-arm beam can be partially attenuated using two tapered lead-
rubber/lead-acrylic sheets commonly known as wedges. These wedge filters remove low
energy beam contribution and balance image glare when imaging high contrast regions
(eg. lung material, air). The impact of adjusting the degree of wedge filtration was
observed with the Philips Allura Xper FD20 c-arm system using the 30 Ö 30 Ö 30
cm3 PMMA phantom. During these measurements, the phantom’s centre was aligned
to the rotational isocenter of the c-arm gantry. The MOSkin dosimeters were placed
on the underside of the phantom at points that corresponded to the placement of the
wedge filters. All measurements were performed using the posterior-anterior c-arm
angulation setting. The entrance dose delivered to three types of filtered areas was
assessed: no wedge filters present, 1 wedge filter present and 2 wedge filters overlaid.
DAP was assessed for five different wedge filter configurations, as shown in Figure
3.4. The position of each MOSkin dosimeter has been presented in Figure 3.4F
through the superposition of MOSkin icons on an unfiltered image. The DAP for
each configuration was calculated by summating the DAP delivered to three separate
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regions of interest that corresponded to each filtered area type. The area for each of
these regions of interest was calculated by thresholding each image using the Matlab
software package using a similar methodology to that found in Section 3.2.2. Using
this methodology, the area of the three different filtered regions was calculated. The
DAP values for each region were weighted using the corresponding ratio of filtered






×Dcolx × ACS, Gy · cm2 (3.5)
Figure 3.4: a) acquisition with no additional filters b) acquisition with one filtration
wedge applied c) acquisition with two filtration wedges applied sepa-
rately d) acquisition with two filtration wedges overlaid e) acquisition
with two filtration wedges partially overlaid f) acquisition with MOSkin
dosimeters superimposed to represent the three dosimetric measurement
points utilised
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3.2.4 Source to Image-receptor Distance, Table Height and
Air Gap
The impact of adjusting the SID settings was observed with the Philips Allura Xper
FD20 c-arm system using the 30 Ö 30 Ö 30 cm3 PMMA phantom. The MOSkin
dosimeter was placed on the underside of the phantom at a point central to the incident
c-arm beam. All measurements were performed using the posterior-anterior c-arm
angulation setting. Measurements were performed by adjusting the table height as
measured from the focal point of the c-arm system’s x-ray tube and the SID, or, image-
receptor height. Measurements were performed using SID settings that ranged from
91-120 cm and using table height settings that ranged from 56.5-80.5 cm as measured
relative to the focal point of the x-ray tube. Some SID/table height configurations were
physically impossible to produce and as such these configurations were not recorded.
The SID and table height configurations allowed for several air gap thicknesses, that is,
distances between the phantom volume and image-receptor plate. Air gap thicknesses
ranging from 1-30 cm as incremented in 1 cm intervals were observed. Air gap values
were calculated using Equation 3.10. The table height, SID and air gap parameters
are diagrammatically represented in Figure 3.5. The cross-sectional FOV for each
of these configurations was calculated using the methodology established in Section
3.2.2. These area values were used to calculate DAPR at measurement point.
Air Gap = SID − (hMP + hPhantom), cm (3.6)
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Figure 3.5: Diagram representing the operator modifiable parameters of SID, Table
Height and Air Gap relative to the c-arm gantry
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3.2.5 Phantom Thickness
The impact of adjusting phantom thickness was assessed with the Philips Allura Xper
FD20 and GE Innova 2100IQ c-arm systems with the 30 Ö 30 Ö 30 cm3 PMMA phan-
tom. All measurements were performed using clinician preferred protocols. During
these measurements, the phantom’s centre was aligned to the rotational isocentre of
the c-arm gantry. The MOSkin dosimeter was placed on the underside of the phantom
at a point central to the incident c-arm beam. All measurements were performed using
the posterior-anterior c-arm angulation setting. Measurements were performed using
the 15, 20 and 25 cm DFS settings when using the Philips Allura Xper FD20 c-arm
system and the 10, 15 and 17 cm OFS settings when using the GE Innova 2100IQ
c-arm system. As mentioned in Section 2.2.2, these field settings allow for effectively
similar FOV projections to be used between machines. The initial measurements were
performed using the full volume 30 cm phantom height configuration with each subse-
quent measurement performed after subtracting one 1 cm of height in PMMA blocks
until reaching the 19 cm phantom height configuration. This reduction of phantom
volume is diagrammatically represented in Figure 3.6. The cross-sectional FOV for
this configuration was calculated using the methodology established in Section 3.2.2.
Only one value was necessary in this experiment as the c-arm system gantry configu-
ration did not change with phantom thickness. This area value was used to calculate
DAPR at measurement point.
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Figure 3.6: Diagrammatic representation of phantom thickness diminishing by 1 cm
with each measurement for EPT ranging from 19-30 cm (PMMA phan-
tom aligned with c-arm rotational isocentre
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3.2.6 C-arm Angulation using the CIRS 702 Atom Phantom
The impact of adjusting the c-arm gantry angulation was assessed with the Philips
Allura Xper FD20 using the CIRS 702 Atom phantom. All measurements were per-
formed using clinician preferred protocols. During these measurements, the phantom’s
heart was aligned to the rotational isocentre of the c-arm gantry, as diagrammatically
represented in Figure 3.7. The MOSkin dosimeter was placed on the underside of the
phantom at a point central to the incident c-arm beam and was repositioned for each
specific c-arm projection used. The c-arm gantry was varied around the left anterior
oblique/right anterior oblique (LAO/RAO) and the cranial/caudal axis (CRA/CAU).
A total of fifteen measurement points were observed. These measurement points have
been identified on cross-sectional DICOM imagery of the phantom volume in Figure
3.8a (for LAO/RAO axis measurement points) and Figure 3.8b (for cranial/caudal
(CRA/CAU) axis). The c-arm angulation was defined in these measurements using
the angular offset of the x-ray tube from the anterior-posterior x-ray tube position with
respect to the gantry axis of interest. All c-arm angulations were specified by clini-
cians based at Sutherland Heart Clinic to ensure clinical relevance. When measuring
dose area product delivered to the CIRS ATOM phantom, the DAPR was calculated
consistent with traditional DAP methodologies and as such was defined as the product
of the ESDR delivered to the measurement point with the cross-sectional beam area
at measurement point, as calculated using the methodology established in Section
3.2.2.
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Figure 3.7: Diagrammatic representation of the CIRS 702 phantom with heart
aligned to the c-arm gantry rotational isocentre and with ESD mea-
sure by the MOSkin
Figure 3.8: CT DICOM of the CIRS 702 Atom Phantom representing the phantom
heart aligned to c-arm rotational isocenter presented as a) axial cross-
section in plane of measurement points with LAO/RAO measurement
points identified and as b) sagittal cross-section in plane of measurement
points with CRA/CAU measurement points identified
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3.3 The Impact of Operator Modifiable
Parameters on Dose Delivery
The results of this study have been presented in Section 3.3.1 to Section 3.3.6 with
each subsection representing a specific operator modifiable parameter. Each subsec-
tion specifies a corresponding figure and notes both the maximum and average change
in the dose quantities with respect to the change in operator modifiable parameter
settings. Each figure depicts dose delivery in terms of ESDR and DAPR separately. A
trend line, typically linear, was generated for each graph. These trend lines may not
be representative of the behaviour depicted by the data but were useful in establishing
a general increasing or decreasing trend with respect to the parameter being assessed.
An error of ±10% of the trend line values was applied to the trend line to account for
the many sources of variance. Each graph was also assigned colours to represent cor-
relation (green), inverse-correlation (red) or no correlation (grey) between the ESDR
and DAPR for each specific operator modifiable parameter.
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3.3.1 The Impact of Field of View on Dose Delivery
The ESDR decreased with increasing FOV, as shown in Figure 3.9a. Over the full
range of 15-25 cm DFS settings and for all observed phantom thicknesses, ESDR
decreased by a maximum of -44% and decreased by an average of -33%. The DAPR
increased with increasing field size, as shown in Figure 3.9b. Over the full range of
15-25 cm DFS settings and for all observed phantom thicknesses, DAPR increased by
a maximum of +116% and increased by an average of +86%. When adjusting FOV,
the ESDR and DAPR were observed to inversely correlate.
3.3.2 The Impact of Beam Collimation on Dose Delivery
The c-arm system did not adjust beam characteristics upon introduction of beam
collimation. Collimating the beam to an area between 22% and 100% of the primary
beam area did not significantly affect ESDR, as shown in Figure 3.10a. Collimation
to 9% of the primary beam area resulted in an average increase in ESDR of +15%.
The DAPR decreased with increasing beam collimation, as shown in Figure 3.10b.
Collimating the beam to 9% of the primary beam area resulted in a reduction in DAPR
of -86.7% for the 25 cm field size setting, -85.8% for the 20 cm field size setting and
-85.5% for the 15 cm field size setting. ESDR and DAPR were not correlated.
3.3.3 The Impact of Wedge Filtration on Dose Delivery
The c-arm system did not adjust beam characteristics on introduction of wedge filtra-
tion. Adding one layer of filtration caused the ESDR to reduce by -62%, while adding
two layers of filtration caused ESDR to reduce by -78%, as shown in Figure 3.11a.
The total DAPR decreased as the wedge filtration area increased, as shown in Figure
3.11b. ESDR and DAPR were not correlated.
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Figure 3.9: Impact of adjusting the FOV on the a) ESDR and b) DAPR delivered
to the 30 Ö 30 Ö 30 cm3 PMMA phantom volume by the Philips Allura
Xper FD20 c-arm system with linear inversely-correlating linear trend
lines applied
Figure 3.10: Impact of adjusting beam collimation on the a) ESDR and b) DAPR
delivered to the 30 Ö 30 Ö 30 cm3 PMMA phantom volume by the
Philips Allura Xper FD20 c-arm system
Figure 3.11: Impact of adjusting wedge filtration settings on the a) ESDR and b)
DAPR delivered to the 30 Ö 30 Ö 30 cm3 PMMA phantom volume by
the Philips Allura Xper FD20 c-arm system. (For visual reference to
wedge filtration configurations, refer to Figure 3.4)
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3.3.4 The Impact of Source to Image-receptor Distance,
Table Height and Air Gap on Dose Delivery
The ESDR increased with increasing SID, as shown in Figure 3.12a. Over the full
range of 91-120 cm SID for all observed table height settings, the ESDR increased
by a maximum of +49% and increased by an average of +1.9% per cm. The DAPR
decreased with increasing SID, as shown in Figure 3.12b. Over the full range of
91-120 cm SID for all observed table height settings, DAPR decreased by a maximum
of -14% but increased by an average of +0.03% per cm. When adjusting SID, ESDR
and DAPR were observed to inversely correlate. The ESDR decreased with increasing
table height, as shown in Figure 3.13a. Over the full range of table height from
56.5-80.5 cm for all observed SID settings, ESDR decreased by a maximum of -61%
and decreased by an average of -3.6% per cm. The DAPR decreased with increasing
table height, as shown in Figure 3.13b. Over the full range of table heights from
56.5-80.5 cm for all observed SID settings, DAPR decreased by a maximum of -21%
and decreased by an average of -0.95% per cm. When adjusting table height, ESDR
and DAPR were observed to correlate. The ESDR increased with increasing air gap, as
shown in Figure 3.14a. Over the full range of 34.5-63.5 cm Air gap, ESDR increased
by a maximum of +49% and increased by an average of +7.29% per cm with increasing
Air gap. The DAPR on average decreased with increasing detector to imager distance,
as shown in Figure 3.14b. Over the full range of 34.5-63.5 cm air gap values, DAPR
decreased by a maximum of -14% and decreased by an average of -1.51% per cm.
When adjusting air gap, ESDR and DAPR were observed to inversely correlate. The
ESDR decreased with increasing table height when a constant air gap was maintained,
as shown in Figure 3.15a. Over the full range of table heights from 56.5-80.5 cm for
all observed air gap values, ESDR decreased by a maximum of -45% and decreased
by an average of -31%. Over the full range of table heights from 56.5-80.5 cm for all
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observed air gap values, DAPR decreased by a maximum of -30% and decreased by
an average of -19%, as shown in Figure 3.15b. When adjusting table height with a
constant air gap maintained, ESDR and DAPR were observed to correlate.
3.3.5 The Impact of Phantom Thickness on Dose Delivery
The ESDR and DAPR increased with increasing phantom thickness, as shown in
Figure 3.16. When using the Philips Allura Xper FD20 c-arm system over the
full range of 19-30 cm phantom thickness, the dose delivered to the phantom surface
increased by a factor of 5.15 for the 15 cm DFS setting, 4.74 for the 20 cm DFS setting
and 5.34 for the 25 cm DFS setting. When using the GE Innova 2100IQ c-arm system
over the full range of 19-30 cm phantom thickness, the dose delivered to the phantom
surface increased by a factor of 12.65 for the 12 cm OFS setting, 10.31 for the 15 cm
OFS setting and 12.00 for the 17 cm OFS setting.
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Figure 3.12: Impact of adjusting the SID on the a) ESDR and b) DAPR delivered
to the 30 Ö 30 Ö 30 cm3 PMMA phantom volume by the Philips Allura
Xper FD20 c-arm system with linear inversely correlating linear trend
lines applied
Figure 3.13: Impact of adjusting table height on the a) ESDR and b) DAPR deliv-
ered to the 30 Ö 30 Ö 30 cm3 PMMA phantom volume by the Philips
Allura Xper FD20 c-arm system with correlating trend lines applied
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Figure 3.14: Impact of adjusting air gap thickness on the a) ESDR and b) DAPR
delivered to the 30 Ö 30 Ö 30 cm3 PMMA phantom volume by the
Philips Allura Xper FD20 c-arm system with inversely correlating trend
lines applied
Figure 3.15: Impact of adjusting table height with constant air gap thickness on the
a) ESDR and b) DAPR delivered to the 30 Ö 30 Ö 30 cm3 PMMA
phantom volume by the Philips Allura Xper FD20 c-arm system with
correlating trend lines applied
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Figure 3.16: Impact of adjusting EPT on the dose delivered to the 30 Ö 30 Ö 30
cm3 PMMA phantom volume by the a) Philips Allura Xper FD20 and
b) the GE Innova 2100IQ c-arm systems with trend lines applied
3.3.6 The Impact of c-arm Angulation using the CIRS 702
Atom Phantom
The LAO/RAO axis angulation measurements were observed over the range of RAO
90° through to LAO 90° while CRA/CAUD angulation was maintained at 0°, as shown
in Figure 3.17. The results were normalised to the dose delivered at LAO/RAO 0°.
Dose was observed to be minimised at the angles RAO 45° and LAO 40° with the
lowest dose observed at RAO 45°. The dose recorded at RAO 45° was -54% lower
than the dose observed at LAO/RAO 0°. The highest doses were observed at three
points: At RAO 90°, LAO 90° and at LAO/RAO 0°. The highest dose was observed
at 90° LAO. The dose recorded at LAO 90° was +48% higher than the dose observed
at LAO/RAO 0°. The CRA/CAUD axis angulation measurements were observed over
the range of CRA 45° to CAUD 45° while LAO/RAO angulation was maintained at
0° incidence. The lowest dose was observed at 0° CRA/CAUD, as shown in Figure
3.18. The highest dose was observed at CRA 45° where dose increased to +456%
higher than the dose recorded at CRA/CAUD 0°. Dose delivery to CAUD 45° was
observed to be +350% higher than the dose recorded at CRA/CAUD 0°
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Figure 3.17: Impact of adjusting LAO/RAO angulation on the ESDR and DAPR
delivered to the CIRS 702 Atom phantom volume by the Philips Allura
Xper FD20 c-arm system
Figure 3.18: Impact of adjusting CRA/CAU angulation on the ESDR and DAPR
delivered to the CIRS 702 Atom phantom volume by the Philips Allura
Xper FD20 c-arm system
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3.4 Relative Importance of Operator Modifiable
Parameters
3.4.1 Summary of Experimental Data and Subsequent
Clinical Recommendations
A comprehensive summary of the parameters adjusted, the changes to ESD and DAP
observed on adjusting the parameters and the correlation between the changes to ESD
and DAP can be found within Table 3.1. This study observed that ESDR and DAP
are very different measures that often exhibit independent behaviours in the catheter-
isation laboratory.
Parameter From To ESDR DAPR ESDR
DAPR
Relationship
Field Diagonal 15 cm 25 cm _ 30.5% ^ 93.0% Inverse Correlation
Collimation 0% 91% ^ 2% _ 98.3% Uncorrelated
Wedge Filtration No Filtration Maximum Filtration _ 79% _ 28% Uncorrelated
SID 91 cm 121 cm ^ 49% _ 6% Inverse Correlation
Air Gap 1 cm 30 cm ^ 49% _ 7% Inverse Correlation
Table Height 55 cm 80 cm _ 59% _ 16% Positive Correlation












^ 456% ^ 370% Positive Correlation
Table 3.1: Averaged Impact on Dose Delivery from Manipulation of Operator Mod-
ifiable Parameters
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Based on the outcome of this study, the following dose minimisation strategies
should be recommended in the angiographic catheterisation laboratory:
1. EPT was the largest determinant of dose delivery. ESD and DAP were observed
to increase by up to a factor of 5.5 for the Philips Allura Xper FD20 c-arm system
and by up to a factor of 12.65 for the GE Innova 2100IQ c-arm system when 11
cm was added to EPT. Using steep angles will substantially increase dose to the
patient and, as such, shallow angles that avoid spinal structures should be used
where possible. For large patients, additional shielding should be utilised and
high exposure protocols should be used with caution.
2. DAP reduction should be implemented in general practice to reduce operator
dose and stochastic risk to the patient. To reduce DAP, field size should be
minimised, collimation and wedge filtration should be applied where possible,
table height should be maximised and SID should be maximised. Reducing DAP
may also reduce ESD delivery in an optimised configuration (ESD: _47.2%, DAP:
_58.0%).
3. ESD reduction is important for patients at risk of developing radiation-induced
skin injuries. This can occur during long procedures or when there are limited
useful acquisition angles. In these cases, field size should be maximised, table
height should be maximised, SID should be minimised and air gap should be
minimised. Minimising ESD may significantly increase the patient volume irra-
diated resulting in an increase in DAP delivery (ESD: _74.5%, DAP: ^56.6
4. Collimation and wedge filtration should be applied where possible to further
reduce dose delivery. ESD can be reduced by increasing collimation and layering
wedge filtration while DAP was most effectively reduced by increasing the area
covered by collimation and wedge filtration.
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5. This study outlines recommendations to guide dose minimisation strategies within
the catheterisation laboratory, however, it is important that the operator per-
forms procedures in a setting that is comfortable so that they may perform the
procedure efficiently and effectively.
6. Further development of dose minimisation strategies should be developed for
catheterisation laboratories using site-specific reference data provided by com-
prehensive dosimetry solutions.
These recommendations were compared to four established reviews into dose reduction
in angiographic catheterisation laboratories. In general, the recommendations made
by these authors, Mettler et.al., Stecker et.al., Chambers et.al. and Hertault et.al.,
compare favourably to the recommendations made above from the experimentally
derived data[128 - 131].
3.4.2 Impact of Field Related Operator Modifiable
Parameters
All reviewed authors recommended using larger field size settings where possible. Ac-
cording to Mettler et.al., reducing the field size, also referred to as increasing magni-
fication/zoom settings, reduces the image ‘brightness’, the photon flux, incident upon
the image-receptor[128]. The c-arm system will adjust other parameters to compensate
for this effect which results in a higher entrance skin dose imparted to the patient.
Hertault et.al. suggest that dose delivery changes as a function of the magnification
factor, that is, the ratio of the maximum field size to the selected field size[129]. Her-
tault et.al. also suggested that for uncorrected image intensifier systems dose will
change proportionally to the square of the magnification factor while corrected image
intensifier systems and newer flat panel systems will attempt to adjust dose deliv-
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ery as a linear function of magnification factor. Experimentally the linear correlation
between ESDR and magnification factor assessed using regression analysis. Regres-
sion analysis established linearity to an r-squared value of greater than 0.90 for all
EPT configurations and to an r-squared value of greater than 0.98 for 75% of EPT
configurations. All reviewed authors recommended using collimation where possible
to reduce scatter radiation, improve accuracy of iodine contrast imaging and limit
exposure to surrounding tissue. Hertault et.al. cite a study by Haqqani et.al. that
observed that dose delivery to operators decreases proportionally to the reduction of
image size, which correlates well with the trend in DAPR values observed experimen-
tally[129, 132]. Mettler et.al. specify that while increasing collimation does decrease
total patient exposure by reducing the irradiation volume, collimation does not reduce
entrance skin dose rate[128]. Mettler et.al. also note that highly collimated beams
may produce higher entrance skin dose rates to compensate for the lower photon flux
incident on the image-receptor and the effects this has on images. This effect was
observed experimentally when ESDR was observed to increase by an average of 15%
when the collimated beam area reached 9% of the primary beam area.
No reviewed author mentioned the impact of wedge filtration on dose delivery
which is probably as this mechanism is primarily used to improve image quality rather
than as a dose reduction tool. Despite this, implementation of wedge filtration was
observed to effectively reduce dose. Introduction of a single filtration wedge caused
the ESDR of the filtered area to drop by 62% while overlaying two filtration wedges
caused the ESDR of the filtered area to drop by 78%. The DAPR was minimised in
configurations which prioritised area coverage rather than configurations where wedge
filters were overlaid. The experimental results suggest that collimation should remain
the preferred method to reduce and shape the beam area but wedge filtration could be
used in conjunction with collimation to reduce dose delivery to the periphery of the
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field of view and retain partial visibility of the filtered region.
3.4.3 Impact of C-arm Gantry related Operator Modifiable
Parameters
Stecker et.al. were the only authors to provide recommendations regarding SID and
recommended that SID should be maximised during procedures[130]. Mettler et.al.
caution that a practical maximum source to image-receptor distance should be estab-
lished as maximising SID may adversely affect image quality which may prolong imag-
ing time and may cause the c-arm system to select higher dosage characteristics.[128].
Mettler et.al. and Chambers et.al. suggest that table height is a critical factor to dose
delivery[128, 131]. Mettler et.al. note that optimal practice should involve positioning
the x-ray tube as far from the patient volume as possible. Metter et.al. caution that
sub-optimal positioning of the x-ray tube can result in ESDR delivery increasing by
a factor of ten and can cause fluoroscopic injury to occur within a very short period
of time. Hertault et.al. suggest that the table should be positioned so that operators’
heads and chests are not too close to the patient volume as these are the primary
sources of operator scatter exposure[129]. All reviewed authors recommended that the
air gap between the patient and image-receptor should be minimised[128 - 131]. From
an image quality perspective, reducing the air gap thickness would minimise the scat-
tering and divergence of photons transmitted through the patient volume. This would
reduce the number of photons discriminated against by the anti-scatter grid and would
maximise photon flux incident on the image-receptor plate. In terms of dose delivery,
larger air gaps would result in reduced photon flux incident upon the image-receptor
plate which would drive the c-arm system to select higher dose delivering x-ray tube
characteristics. Larger air gap thicknesses may also increase operator exposure due
to a higher proportion of the x-ray beam would contribute to the radiation scatter
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field. The experimental results demonstrated that both the ESDR and DAPR were
most effectively reduced by maximising the distance of the measurement point to the
x-ray tube. As per inverse square law, the degree of dose reduction decreased with
increasing table height. This loss in effectiveness was more prominent for the mea-
sured DAP as a competing effect was noted in that the cross-sectional area of the
c-arm beam increased with increasing table height. As such, while maximising the
distance between the patient and x-ray tube minimised dose, it was especially im-
portant to avoid low table positions. While these results concern selection of table
height, this recommendation should also be taken into consideration when selecting
angulation as some projections may result in the x-ray tube being placed closer to
the patient volume. The ESDR could also be reduced by minimising the SID and
the air gap thickness, however, on average this also increased the DAP delivery. This
behaviour was not established in all observed configurations. Similarly to when table
height was adjusted, the effect of adjusting image-receptor height on DAP delivery
was representative of the complicated and competing interplay between the trend in
ESD delivery and the geometric deformation of the cross-sectional beam area at mea-
surement point. While the trend in ESD delivery was dominant when table height
was adjusted, the effect on the cross-sectional area at measurement either balanced or
outweighed the effect on ESD delivery when image-receptor height is adjusted and as
such DAP delivery behaved counter to ESD delivery for these settings. As with the
selection of field size, minimisation of one dose quantity will result in an increasing to
the other. Despite the effects on DAP, consideration of the significantly greater impact
increasing image-receptor height and air gap thickness has on ESD delivery, the effect
on radiation scatter and the potential effects on image quality suggests minimisation
of these parameters is the optimal practice to recommend.
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3.4.4 Impact of Patient Thickness and C-arm angulation
All authors recommended caution when irradiating larger patient volumes and cross-
sections [128 - 131]. Mettler et.al. explain that thicker patient volumes require greater
radiation dose delivery to achieve adequate penetration of their bodies[128]. Hertault
et.al. suggest that c-arm systems adjust dose production settings to provide a con-
sistent signal to noise ratio at the lowest possible exposure rate which causes higher
dose delivery at larger patient thicknesses[129]. Stecker specify that consideration of
radiation risk should be discussed in further depth for patients weighing more than
135 kg[130]. Mettler et.al. specify that ESD has been observed to reduce by a fac-
tor of two for each 4.5 - 5.0 cm of tissue depth[128]. This figure compared well to
the experimental results where ESDR was observed to halve when reducing the 30
cm phantom thickness by 5.36 cm when using the Philips Allura Xper FD20 c-arm
system and by 5.70 cm when using the GE Innova 2100IQ c-arm system. All authors
revised recommended that steep angles that maximise patient cross-section should be
avoided or treated with caution where possible[128 - 131]. These angles increase the
effective patient thickness driving the c-arm system to deliver higher radiation expo-
sures, reducing image quality and adding greater contributions to scatter fields. The
revised authors each recommend using tightly collimated beams, intelligent selection
of beam projections. The experimental angulation results were compared to a previ-
ous study undertaken by Kuon et.al. in 2004 that attempted to comprehensively map
both operator and patient doses as a function of angulation using a Rando-Alderson
torso phantom and measuring dose using a PTW ionisation chamber[133]. Excerpts of
the data published by Kuon et.al. have been compared to the DAPR values observed
using the CIRS 702 phantom in combination with the MOSkin dosimeter in Figure
3.20. The comparison observes similarities in the asymmetries in the LAO/RAO axis
where lower doses were observed at shallow LAO projections and in the CRA/CAU
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axis where dose was observed to increase more steeply when imaging in the higher CRA
projections. There were discrepancies between the datasets. Interestingly, the Kuon
et.al. data does not observe the same increase in dose seen when imaging the CIRS
702 phantom in the PA projection, as shown in Figure 3.20a. This is most likely
caused by differences in bone density between the CIRS 702 Atom phantom used in
this study as compared with the Alderson Rando phantom used by Kuon et.al.. These
differences could occur due to the differences in age, sex and size of the human model
that each phantom is based on. The discrepancy could have more specifically occurred
as the CIRS 702 Atom phantom design incorporates a homogenous bone substitute in
contrast to Alderson Rando phantoms which are designed with cortical and trabecular
bone volumes modelled separately. Homogenous bone substitutes produce consistent,
reproducible and simple phantom volumes. The density of the homogenous bone sub-
stitute has been developed as an average of cortical and trabecular bone densities
as weighted by the volume ratio of these bone structures. These ratios are specific
for different age and gender demographic. The density of the homogenous bone sub-
stitute is calculated as a weighted average which is based upon published values of
the density and volume ratio of cortical and trabecular bone content as observed for
people of specific age and gender demographics[125]. Other contributing factors to the
discrepancies between data sets may include differences in phantom geometry, dosime-
try methods and the c-arm systems used during the Kuon et.al. study. Varying the
imaging projection is another method to reduce, or ‘spread’, the ESD during a pro-
cedure. This method involves adjusting the angulation of the c-arm system regularly
to avoid causing localised points of radiation over exposure. Mettler et.al. advocate
use of this technique as it can greatly reduce the risk of local overexposure, however,
studies performed by Pasciak et.al. and Koenig et.al. recommend that great care is
taken in ensuring the selected projections do not overlap as this would unknowingly
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and greatly increase the risk of fluoroscopic injury[38, 134, 134]. The risk of acciden-
tally overlapping fields could be mitigated through the installation of dose contouring
software or through deployment of real-time array type dosimetry[135]. By using a
real-time dosimetry system such as the MOSkin dosimeter in a 2D array arrangement
peak skin dose could be monitored effectively, DAP delivery to the patient could be
measured conformal to the patients’ surface and inhomogeneity of the incident imag-
ing beam could be accounted for. Such solutions could provide dose distributions and
organ-specific assessments of stochastic risks with greater accuracy than traditional
methodologies in either a stand-alone or supplementary format.
Figure 3.19: Comparison of experimental angulation data around the a) LAO/RAO
axis and the b) CRA/CAU axis[125]
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3.4.5 The Importance of clear terminology
As mentioned previously in Section 3.2.2, there are sources of confusion within the
literature as to how to optimise and reduce ‘dose’ delivery in the angiographic catheter-
isation laboratory. Mettler et.al. cite one such fallacy and explain that recommen-
dations to utilise collimation to reduce ‘exposure’ are often misunderstood to mean
the use of collimation reduces the dose rate delivery to the patients’ exposed skin[128].
While all reviewed authors did explain the difference between ESD and DAP within
their publications, their recommendations used the more general term ‘dose’ to inter-
changeably refer to ESD and DAP. This loose use of language contributes to confusion
regarding the issues of radiation safety in the catheterisation laboratory. This vague
use of terminology is problematic as within this study it was observed that there is
often no clear relationship between ESD and DAP delivery when adjusting opera-
tor modifiable parameters. While correlation was observed between ESD and DAP
when adjusting table height, EPT and angulation, there were complex inverse rela-
tionships between ESD and DAP when adjusting field size, SID and air gap thickness.
The results of this study and the state of the literature suggest that clearer expo-
sure terminology is necessary and that clinicians may benefit from increased access
to dosimetry tools in order to better develop dose minimisation strategies tailored to
their own laboratories.
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3.4.6 Limitations of this study
This study featured several key limitations:
1. This study was performed using phantom volumes: Phantom volumes
are a simplified representation of a patient volume. The effects of adjusting
operator modifiable parameters on dose delivery may not translate exactly to an
equivalent patient volume.
2. This study did not directly measure operator dose: This study focused
on assessing radiation exposure to angiography patients. Commentary on dose
delivered to operators was limited and relied on an assumption of proportionality
between the DAP, the scatter radiation produced during a procedure and the
operator dose. This proportionality does not take into consideration operator
position with respect to the x-ray tube, direction of the x-ray beam, effects
related to positioning of the image receptor or the effect of radiation protective
shielding equipment. Further commentary on operator dose was beyond the
scope of this study. There are operator-specific studies that exist within the
literature that can provide further commentary on operator dose.
3. This study was performed primarily using one c-arm system: Catheter-
isation laboratories vary significantly. Different laboratories may feature differ-
ent c-arm systems, different room geometries and different c-arm system protocol
tailored to the preferences of different clinicians. As such, individual catheteri-
sation laboratories may observe that dose delivery is affected to differing extents
than those observed during this specific study. The effect these differences can
have on c-arm dose delivery was exemplified in Figure 3.16 where the Philips
Allura Xper FD20 and GE Innova 2100IQ c-arm systems were observed to re-
spond differently to a selection of phantom EPT configurations.
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4. The calculation of DAP assumed that the FOV was homogeneous:
The calculation of DAP assumed that the x-ray beam was homogeneous across
the FOV. In reality the x-ray spectrum is heterogeneous, that is, photon fluence
and photon energies will vary depending on measurement point. The most sig-
nificant contribution to heterogeneity is beam hardening effect. Beam hardening
occurs because lower energy photons are attenuated at a greater rate than higher
energy photons. As a consequence of x-ray beam divergence, beam hardening
will affect photon fluence and photon energies differently depending on their tra-
jectory. This typically results in a higher intensity of x-rays at the center of the
FOV and a lower intensity of x-rays at the edges of the FOV. Beam hardening
is highly dependent on the x-ray tube potential, field size, the filtration utilised
and the attenuative material that the x-rays pass through. As such, the degree
of beam hardening will vary between acquisitions/projections and would have
introduced inaccuracies, specifically when introducing wedge filtration.
Fortunately, the energy dependence of the MOSkin dosimeter was thoroughly in-
vestigated in Chapter 2. In Chapter 2 it was observed that the MOSkin energy
dependence was minimal for the x-ray beam spectral range of interest. This can be
exemplified with two conservative examples:
 addition of 2 mmAl filtration to a 70 kVp unfiltered x-ray beam reduces the
relative MOSkin response by <10.
 shifting the x-ray tube voltage by 20 kV (e.g. from 100 kVp to 80 kVp reduces
the relative MOSkin response by <10.
Either of these examples would have a greater impact on the x-ray beam spectrum
than beam hardening from introducing the rubber/silicone wedges to the FOV and as
such the MOSkin response can be expected to be accurate within 10% of the readout
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value. Furthermore there were no observed changes to the system reported DAPR,
air Kerma or x-ray tube characteristics wedge filtration configurations. This feature
illustrates another application where MOSkin measurements would provide a more
accurate representation of skin dose than the default c-arm system exposure metrics,
especially when considering future array-type MOSkin dosimetry solutions.
In some instances, the limitations of this study restrict the applicability of these
results to a clinical environment. This study was never intended as a substitute for
implementation of comprehensive dosimetry solutions. Instead, this study establishes
general trends in dose delivery with respect to the clinical configuration used during
procedures. The recommendations produced by the results of this study are a solid
foundation for developing dose minimisation strategies informed by physically mea-
sured data points.
3.5 Conclusions
This study was performed to improve knowledge and awareness of the differences
between the ESD and DAP. The results challenge popular held beliefs about ‘dose’
reduction in the catheterisation lab. This study exemplifies how the gantry, beam and
table settings chosen during procedure can significantly affect patient and operator
doses and adoption of this study’s recommendations may reduce exposures in general
practice. When adjusting operator modifiable parameters, the ESDR and DAPR dose
quantities either behaved independently or shared a complex relationship. Minimisa-
tion of both ESDR and DAP was not always possible and there is a need for prioritising
the type of dose reductions needed on a case by case basis. The strongest contributing
factor to dose delivery was the EPT value of the phantom volume. Additional care
should be undertaken when choosing projection angle during imaging and when per-
forming procedures with larger patients. The results provide a basis for developing
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dose minimisation strategies. Improving awareness of the dose reduction that clinical
setup, projection choice and patient thickness can provide may change operator be-
haviour during procedures, resulting in reduced risk of radiation-induced conditions
to patients and operators. Implementation of comprehensive real-time dosimetry so-
lutions are a necessity for further development of dose minimisation strategies. Future
development of 2D real-time array-type dosimeters that conform to the shape of the
patient’s body, are not acquired during imaging and do not increase radiation expo-
sure during procedures will provide operators with real-time dosimetric feedback and
allow for accurate measurement of the DAP exposure, ESD distribution and maximum




Performance and the Efficacy of
C-arm Systems by Measuring Dose
and Image Quality Simultaneously
In Chapter 3, the concept of ‘dose’ delivery as an indicator of c-arm system per-
formance was discussed in depth, the importance of dose minimisation strategies was
emphasised and the role of image quality in an optimised clinical setup was alluded
to. This chapter aims to define image quality in a clinical context, to discuss the
relationship between image quality and dose delivery and to develop a methodology
to assess both image quality and dose delivery simultaneously. This chapter will also
provide commentary on the efficacy of c-arm system upgrades in improving c-arm sys-
tem performance.
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4.1 Introduction to Evaluating C-arm System
Performance
4.1.1 Defining C-arm System Performance through Image
Quality
Image quality is a concept used to evaluate and compare groups of images. The metrics
used to determine image quality depend on the purpose of the acquired images. In
the context of angiographic c-arm imaging, acceptable image quality should meet the
following clinical criteria:
1. The acquired images must adequately depict iodine contrast as used to enhance
imagery of a patient’s vascular system,
2. The acquired images must be of high spatial resolution to enable operators to
examine small vascular structures of interest,
3. The acquired images must enable clear visual discrimination between different
tissues, organs, and vascular structures,
4. The impact of motion-induced artefacts, temporal averaging and other imaging
distortions should be minimised where possible,
5. The image noise should be minimised where possible while signal to noise ratio
and contrast to noise ratio should be maximised where possible, and,
6. An acceptable standard of image quality should be maintained while minimising
dose delivery during procedures.
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4.1.2 Factors that Influence C-arm System Performance
C-arm system performance can be reduced to two independent metrics, dose delivery
and image quality. In general, functionality of an angiographic c-arm system is de-
termined firstly by the sophistication of the image processing chain (hardware) and
secondly by both the image processing algorithms and image acquisition protocols in-
stalled on the system that determine the x-ray tube output during imaging (software).
This means that c-arm system performance is limited by independent hardware and
software constraints and c-arm systems can be tuned to meet the image quality stan-
dards required by clinicians at the site of commission. This also means that c-arm
system performance is periodically improved through advances in c-arm technologies
which are provided by vendors through the commission of newer c-arm system models
and as upgrades to existing c-arm systems. This study aimed to evaluate the perfor-
mance of three c-arm systems based at local angiographic catheterisation laboratories
that were subject to post-processing and image acquisition protocol upgrades provided
by their respective vendors. This evaluation was performed using an existing c-arm
system performance standard set by the National Electrical Manufacturers Associa-
tion (NEMA), the NEMA XR 21 protocol[136].
4.2 Simultaneous Measurement of Dose Delivery
and Image Quality
4.2.1 The NEMA XR 21 Protocol
Image quality was assessed using the NEMA XR 21 protocol in combination with
the CIRS Model 901 phantom, a phantom volume that was developed specifically for
voluntary compliance with the NEMA XR 21 protocol[136 - 138]. The NEMA XR 21
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Figure 4.1: Diagram of the CIRS Model 901 phantom configured in the a) 20 cm
EPT configuration and in the b) 30 cm EPT configuration
protocol enables simultaneous measurement of c-arm system image quality and dose
delivery using a range of patient representative phantom configurations. There are five
configurations recommended in the NEMA XR 21 protocol: a 5 cm EPT configuration,
a 10 cm EPT configuration, a 20 cm EPT configuration, a 30 cm EPT configuration
and a 30 cm phantom configuration with an additional lead plate that ensures that
the c-arm system produces its’ maximum output. For relevance to the clinical appli-
cations of the evaluated c-arm systems, testing was performed using the 20 cm EPT
configuration and the 30 cm EPT configuration. These configurations represent the
commonest range of adult patient sizes. These configurations are depicted in Figure
4.1.
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4.2.2 CIRS Model 901 Phantom Configurations
The c-arm performance was assessed using the two aforementioned CIRS Model 901
phantom configurations. For both configurations, the CIRS Model 901 phantom vol-
ume was positioned as per instructed by the NEMA XR 21 protocol.
1. The phantom was placed on the patient couch at a position consistent with the
expected position of the patient torso during a procedure. The NEMA XR-
21 protocol suggests positioning the phantom centrally to the c-arm system’s
rotational isocenter.
2. The c-arm image receptor height was set to produce a 5 cm air gap between the
phantom and the image receptor.
3. The phantom was positioned so that the spatial resolution plate was positioned
centrally to the acquired image area.
4. The phantom was positioned so that the spatial resolution plate was at a 45°
offset to the image receptor positioning. This positioning reduces the occurrence
of aliasing effects and moiré patterns on acquired images. These effects can
significantly affect assessments of c-arm system spatial resolution[136].
All imaging was performed with the c-arm system set to the posterior-anterior pro-
jection angle. During imaging, the MOSkin dosimeter was taped to the underside of
the phantom at a point central to the incident c-arm beam. The MOSkin was used
to measure the ESD delivered to the underside of the phantom during imaging. ESD
was calculated using previously established calibration methods. Image quality was
assessed using a range of image acquisition protocols, imaging modalities and field
sizes. The settings used for each of the c-arm systems appraised are discussed in Sec-
tion 4.3.1 through to Section 4.3.3. The c-arm systems were evaluated using the
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five standard image quality tests recommended in the NEMA XR 21 protocols. These
tests assessed iodine contrast resolution (ICR), spatial resolution, working thickness
range (WTR), static motion target resolution (MTR) and dynamic MTR. During the
GE c-arm system evaluation, additional digital assessments were performed to sup-
plement these tests. Each of the image quality tests are discussed in further detail in
Section 4.2.3 through to Section 4.2.8.
4.2.3 Quantifying Image Quality: Iodine Contrast
The c-arm system ICR was assessed using the image quality target plate, represented
by the x-ray image shown in Figure 4.2a. This target plate contained a total of
32 iodinated cavities. There were 8 of these cavities in each quadrant of the target
plate. These cavities were grouped into four dot pairs, each pair of successively smaller
diameter than the last. The diameter of the first iodine dot pair was 4 mm. Each sub-
sequent dot pair decreased in diameter by 1 mm with the smallest dot pair measuring 1
mm in diameter. Iodine concentration in these cavities varied with quadrant. The first
quadrant cavities contained iodine concentrations of 200 mg/cm3. This concentration
halved with each subsequent quadrant with the lowest concentration measuring to 25
mg/cm3 in quadrant four. In this test, the assessors recorded the number of iodine
dots that were resolved in the acquired images.
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4.2.4 Quantifying Image Quality: Spatial Resolution
The c-arm system spatial resolution was assessed using the image quality target plate,
represented by the x-ray image shown in Figure 4.2a. The image quality plate was
fitted with a Nuclear Associates Model 07-538 lead bar plate. The plate consisted
of 0.1 mm thickness lead and featured several densities of line pair patterns cut through
the plate. These line pairs varied in density from 1.6 to 5 line pairs per millimeter
(lp/mm). In this test, the assessors recorded the highest density of line pairs that
could be resolved in the acquired images.
Figure 4.2: CIRS Model 901 phantom equipped with the a) image quality target
plate Configuration and equipped with the b) motion target plate
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4.2.5 Quantifying Image Quality: Working Thickness Range
The c-arm system WTR was assessed using the image quality target plate, represented
by the x-ray image shown in Figure 4.2a. The CIRS model 901 phantom incorporated
several embedded objects and cavities within the phantom volume. Each quadrant
featured an air column and a metal object column.
1. The air columns were composed of several large air-filled cylinders cut through
the PMMA plates and represented low density imaging targets such as lung
tissue or air pockets. Each air cylinder was paired with a smaller air-filled pin
positioned above the larger air column.
2. The metallic columns were composed of several large aluminium-filled cylinders
embedded within the PMMA plate volumes and represented high density imaging
targets such as bone or iodine contrast. Each alumiinium column was paired with
a smaller lead pin positioned above the larger metallic column.
The thickness of the larger cylinders varied with quadrant, all of which have been
recorded in Table 4.1. The upper WTR threshold of the c-arm system was determined
by noting the number of air-filled pins that were resolved against the larger air-filled
cylinders while the lower WTR threshold of the c-arm system was determined by
noting the number of lead pins that were resolved against larger aluminium cylinders.
Selection of an appropriate WTR prevents image clipping when imaging high/low
density imaging targets.






Quadrant 1 175 40
Quadrant 2 150 47
Quadrant 3 125 53
Quadrant 4 100 60
Table 4.1: Air cylinder and aluminium cylinder thicknesses embedded within each
quadrant of the CIRS model 901 phantom for c-arm WTR assessment
4.2.6 Quantifying Image Quality: Static and Dynamic
Motion Target Resolution
The c-arm system MTR was assessed using the motion target plate, as shown in
Figure 4.2b. In this configuration, the motion target plate replaced the previously
used image quality target plate. The motion target plate consisted of a motorised
plate with five strands of piano wire embedded within the plate volume. These wires
were of diameters 0.56 mm, 0.41 mm, 0.30 mm 0.23 mm and 0.13 mm respectively.
The wires extended from the center of the phantom to the diameter of the phantom
and were spaced at even intervals of 72° around the face of the motion target plate.
During imaging, the plate rotated at a rate of 30 revolutions per minute. In this test,
the assessors noted the thinnest wire that was observable in the image. The assessors
evaluated images as presented as a series of still frame images (static) and at the real-
time framerate (dynamic).
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4.2.7 Quantifying Image Quality: Digital Assessment
Digital assessment of image quality was performed during the GE ‘Dose Map’ upgrade
evaluation only. Digital assessment was performed on images acquired using the Mo-
tion Target plate. This configuration was chosen to maximum homogeneity of the
imaging area. For each DICOM image set, a region of interest (ROI) was established
using the FIJI software package. The ROI area was chosen by selecting a large ho-
mogenous area in the imaging area. This area typically encompassed approximately
10% of the imaging area. The mean pixel value and standard deviation of pixel values
for this region were calculated and averaged for all frames included in each image set.
The standard deviation of pixel values was used as a measure of image noise, as shown
in Equation 4.1 where χi represents each pixel value in the range of pixel 1 to pixel
N. An example of a typical ROI and the corresponding sampling distribution have
been provided in Figure 4.3.
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Figure 4.3: Depiction of a typical ROI through use of a) a graphical representation of
a typical selection area and b) the corresponding sampling distribution
of the ROI area
4.2.8 Comparison of Image Quality Scores Between Protocols
The c-arm system protocols were categorised as high detail protocols or low dose
protocols. The pre-upgrade protocols were then paired with their equivalent post-
upgrade protocols. Dosimetry/image quality scores were compared in a graphical
format and a tabular format. In tabular format, the protocols were compared directly
by taking the ratio of the post-upgrade score (Score B) to the pre-upgrade score (Score
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4.3 C-arm Specific Methodologies
4.3.1 The Philips ‘Clarity’ Upgrade
The Philips Allura Xper FD20 c-arm system commissioned at Sutherland Heart Clinic
underwent a post-processing systems upgrade dubbed the ‘Clarity’ upgrade. Pre-
upgrade, the Philips Allura Xper FD20 c-arm system had been commissioned with
two common use imaging protocols; the high imaging quality ‘Cardiac 4’ protocol and
the low dose rate ‘Cardiac Low’ protocol. Both of these imaging protocols included
an acquisition protocol and a fluoroscopy protocol. The fluoroscopy mode could be
operated using one of three different exposure levels. Post-upgrade, the new Philips
Allura ‘Clarity’ FD20 c-arm system replaced these protocols with with three different
acquisition protocols; the boosted high detail ‘Clarity Boost’ protocol, the high detail
‘Clarity Normal’ protocol and the low dose rate ‘Clarity Low’ protocol. The ‘Clarity’
fluoroscopy mode protocol was common to all acquisition protocols and could also be
operated using one of three exposure settings. A table of the Philips protocols observed
has been provided in Table 4.1. The Philips c-arm system imaging protocols were
assessed using the following metrics:
1. Dose delivery,
2. Iodine contrast resolution,
3. Spatial resolution,
4. Working thickness range,
5. Static motion target resolution, and,
6. Dynamic motion target resolution.








































































Table 4.2: Pre- and post- upgrade protocols installed on the Philips c-arm system
commissioned at Sutherland Heart Clinic
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The Philips c-arm system’s assessment was performed using the 20 cm EPT and 30 cm
EPT phantom configurations and using the 15 cm and 20 cm DFS FOV settings. The
c-arm systems were evaluated in acquisition mode, fluoroscopy mode dose level 1 and
fluoroscopy mode dose level 2. Fluoroscopy mode dose level 3 was not assessed as this
imaging modality was not in common clinical use. The image quality of the acquired
image sets was assessed in the clinic at the time of acquisition. This assessment was
performed using the in-clinic monitors, the control room monitors and the DICOM files
exported by the laboratory picture archiving and communication system (PACS). This
test was performed to establish any variation in image quality introduced by differences
in the viewing monitors and to ensure no image quality was lost during the conversion
or compression of image sets into DICOM files by the PACS. The DICOM files were
then exported from the PACS, anonymised, renamed and randomised before further
assessments were performed. This minimised any bias which could occur when asses-
sors read the names of the image set under evaluation. The DICOM files were assessed
by a cohort of 20 assessors selected from the staff and student bodies of the University
of Wollongong’s School of Physics. Choosing a large selection of assessors was impor-
tant to reduce dependence of the results on individual proficiency. The assessment was
performed using a designated desktop computer system using the RadiANT DICOM
Viewer software package (Medixant, 2011, https://www.radiantviewer.com/) viewed
in evaluation mode. The assessors were instructed to view each image set in full screen
mode and without using any image enhancement tools offered by the RadiANT DI-
COM Viewer software package. These limitations ensured that variations due to the
monitor type and monitor settings were minimised, that software proficiency based
variations were minimised and that viewing conditions were as similar as possible to
the those experienced in the catheterisation laboratory.
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4.3.2 The GE Innova 2100IQ c-arm system and the GE
‘Dose Map’ Upgrade
A similar upgrade was performed on the GE c-arm systems commissioned at Suther-
land Heart Clinic and Eastern Heart Clinic. During this upgrade, the post-processing
and imaging protocols were updated and dose contouring software, the ‘Dose Map’
software package, was installed on each system. In reference to this software package,
the upgrade was referred to as the ‘Dose Map’ upgrade. The primary c-arm system
studied during the ‘Dose Map’ upgrade was a GE Innova 2100IQ c-arm system based
at Sutherland Heart Clinic. Pre-upgrade, the GE Innova 2100IQ c-arm system had
been commissioned with two common use imaging protocols; the high imaging quality
‘CoroPlus’ protocol and the low dose rate ‘RDLS’ protocol. Each of these protocols
included an acquisition mode and a fluoroscopy mode which could be then operated us-
ing one of two exposure settings, the dose level 1 or dose level 2 setting. Post-upgrade,
the c-arm system featured three imaging protocols; the high detail ‘Standard’ proto-
col, the low dose rate ‘Low’ protocol and the low dose rate ‘Very Low’ protocol. All
post-upgrade protocols were observed to operate using a default frame rate of 7.5 FPS
as opposed to the 15 FPS frame rate used by all pre-upgrade protocols. Each of these
protocols included an acquisition mode and a fluoroscopy mode. All post-upgrade
protocols could also be operated in either the dose level 1 setting or the dose level 2
setting. All GE protocols assessed have been referenced in Table 4.2. The GE ‘Dose
Map’ assessment was performed using the 20 cm and 30 cm EPT phantom configu-
rations, the 12 cm and 15 cm OFS settings, both imaging modalities and both dose
level settings. The post-upgrade fluoroscopy mode protocol ‘Low’ was also assessed
separately with the imaging frame rate set to 15 FPS.
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4.3.3 Comparing the GE Innova 2100IQ and GE IGS 520
c-arm systems
At the request of the vendor, the GE Innova 2100IQ was compared to a GE IGS 520
c-arm system commissioned at Eastern Heart Clinic. The primary difference between
these two c-arm systems was firstly that the GE IGS 520 system featured a newer
image-receptor detector plate and secondly that the system was installed with a dif-
ferent set of imaging protocols. Post-upgrade, the GE IGS c-arm system featured two
imaging protocols; the high detail ‘IQ+’ protocol and the low dose ‘RDLS’ protocol.
To differentiate this protocol from the pre-upgrade ‘RDLS’ protocol on the GE Innova
2100IQ c-arm system, this second ‘RDLS’ protocol was denoted as ‘EHC-RDLS’. These
EHC protocols have been included in Table 4.3. The assessment was performed us-
ing the EHC protocols in acquisition mode only. A comparison was formed between
the two of the post-upgrade IGS 520 protocols and two of the post-upgrade Innova
2100IQ protocols. For all GE ‘Dose Map’ related protocols, c-arm system performance
was assessed using the standard NEMA XR21 protocol tests and using the digital
assessment of noise as described in Section 4.2.7. Assessment was again performed
using the in-clinic monitors, the control room monitors and the DICOM files exported
by the PACS. The selection of protocols observed during the ‘Dose Map’ upgrade
assessment was much more extensive than the protocol selection observed during the
Philips ‘Clarity’ upgrade. This rendered visual assessment by a cohort as too time and
resource consuming and as such visual assessment was performed by a single assessor.
This enabled timely processing of the results.







































7. EHC IQ+ GE IGS 520 Eastern Heart
High Detail
Protocol
8. EHC-RDLS GE IGS 520 Eastern Heart
Low Dose
Protocol
Table 4.3: Pre- and post- upgrade protocols installed on the GE c-arm systems com-
missioned at Sutherland Heart Clinic and Eastern Heart Clinic
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4.4 Summary of the Results
In this section the summaries of the image quality study results have been provided.
These summaries presented the results in a condensed, easy to read format. The
section has been divided into the following subsections:
 The Philips System Upgrade
 The GE System Upgrade
 Comparison of the Upgraded GE protocols
 GE intersystem comparison
Some of the discussion points have referenced the results in greater details than
provided in these summaries.
For the complete dataset analysed, please refer to Appendix A for the extended
Philips system results and Appendix B for the extended GE system results.
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4.4.1 The Philips System Upgrade
The Philips Allura Clarity upgrade summary is presented in Table 4.4. In acquisition
mode, the upgraded Clarity protocols produced:
 + similar or lower ESDs delivered to the phantom.
 + higher iodine contrast resolution
 + higher spatial resolution
 - A narrower working thickness range
 - Lower motion target resolution
In fluoroscopy mode, the upgraded Clarity protocols produced:
 ≈ similar ESDs to the Cardiac 4 protocol
 - higher ESDs than the Cardiac Low protocol
 + higher iodine contrast resolution
 ≈ similar spatial resolution
 ≈ similar working thickness range
 - Lower motion target resolution
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4.4.2 The GE System Upgrade
The GE post-processing upgrade summary is presented in Table 4.5. In acquisition
mode, the upgraded GE protocols produced:
 + similar or lower ESDs delivered to the phantom.
 + higher iodine contrast resolution
 - lower spatial resolution
 ≈ similar or broader working thickness range
 ≈ similar motion target resolution
 + lower image noise levels
In fluoroscopy mode, the upgraded GE protocols performed as follows:
 Coronary Standard protocol significantly reduced ESD delivered to the phantom
when compared to the CoroPlus protocol. This protocol produced similar or
better working thickness ranges and motion target resolution, however, lower
iodine contrast resolution and spatial resolution were observed and image noise
was higher for this protocol.
 The Coronary Low protocol produced higher ESDs delivered to the phantom
than the RDLS protocol. This improved iodine contrast resolution and motion
target resolution while maintaining identical working thickness ranges and simi-
lar levels of image noise. Spatial resolution was reduced when imaging with this
protocol.
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4.4.3 The Upgraded GE System
The upgraded GE Innova 2100IQ system performance summary is presented in Table
4.6. In acquisition mode:
 ESD was ranked Standard < Low < Very Low
 Iodine contrast resolution was ranked Standard > Low > Very Low
 Working Thickness range was ranked Standard > Low > Very Low
 Motion target resolution was ranked Standard > Low > Very Low
 Image noise similar between protocols
In fluoroscopy mode:
 No consistent trend was observed for ESDs in fluoroscopy mode.
 Iodine contrast resolution was ranked Standard > Low > Very Low
 Working thickness range was ranked Standard > Low = Very Low
 Motion target resolution was ranked Low ≥ Standard > Very Low
 Image noise was ranked Standard > Low > Very Low
Increasing framerate in fluoroscopy mode resulted in:
 - doubled ESD values
 + higher iodine contrast resolution
 ≈ similar spatial resolution
 ≈ similar working thickness range
 + higher motion target resolution
 - higher image noise levels
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4.4.4 The GE Intersystem Comparison
The GE intersystem comparison is presented in Table 4.7. This comparison was per-
formed between the upgraded GE Innova 2100IQ and the GE IGS 520 c-arm systems.
For the high detail acquisition protocol the IGS 520 produced:
 ≈ Similar ESD values
 + higher iodine contrast resolution
 ≈ identical spatial resolution
 - similar or narrower working thickness range
 - similar or lower motion target resolution
 + reduced image noise
For the low dose acquisition protocol the IGS 520 produced:
 - higher ESD values
 + higher iodine contrast resolution
 + higher spatial resolution
 + broader working thickness range
 - similar or lower motion target resolution
 + reduced image noise




















































4.5.1 Clinical impact of the Philips upgrade results
The ‘Clarity’ upgrade acquisition mode protocols were observed to produce similar or
lower ESD deliveries than the previous Xper series protocols; the ‘Clarity Low’ proto-
col observed an average ESD comparable to the ‘Cardiac Low’ protocol, the ‘Clarity
Normal’ protocol observed an average ESD reduction of 53.8% and the ‘Clarity Boost’
protocol observed an average ESD reduction of 22% relative to the relevant Xper se-
ries protocols. Despite this ESD reduction, the ‘Clarity’ protocols were observed to
produce similar or better standards of image quality through improved iodine con-
trast resolution and spatial resolution. Static MTR was in general similar between
the Clarity and Xper series protocols, however, the Clarity series protocols did on av-
erage score slightly lower for the dynamic MTR category and did observe a narrower
WTR range resulting from both reduced upper and lower WTR threshold limits. The
‘Clarity Boost’ acquisition mode protocol was observed to produce similar x-ray tube
characteristics to the ‘Clarity Normal’ acquisition mode protocol but with reduced
x-ray tube filtration utilised during imaging. Overall, image quality was quite similar
between protocols. As expected from a lower filtration x-ray beam, the ‘Clarity Boost’
protocol did increase ESD delivery to the surface by an average of 66.8% but also pro-
vide enhanced iodine contrast resolution by an average of 10.6%. Despite the reduced
filtration, the ‘Clarity Boost’ protocol still delivered significantly less ESD delivery
than the ‘Cardiac 4’ protocol, averaging ESD delivery values 22.9% lower than the
Xper series protocol. The ‘Clarity’ upgrade fluoroscopy mode protocol were observed
to produce higher ESD deliveries than the ‘Cardiac Low’ fluoroscopy mode protocols
and lower ESD deliveries than the ‘Cardiac 4’ fluoroscopy mode protocols with ex-
ception to the ‘Cardiac 4’ protocol operated in fluoroscopy mode dose level 2 setting
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when imaging the 20 cm EPT configuration which appeared to produce similar ESD
deliveries as the ‘Cardiac 4’ protocol operated in fluoroscopy mode dose level 1 setting.
This anomalous behaviour may have resulted from an algorithm imposed dose limit
triggered when performing fluoroscopic imaging of smaller patient volumes. The Clar-
ity series fluoroscopy mode protocol appeared to produce higher ESD delivery than the
Xper series specifically when imaging the 20 cm EPT configurations which suggests
the Xper series protocols were better optimised for imaging smaller patient volumes
than the Clarity series fluoroscopy mode protocol. The Clarity series fluoroscopy mode
protocol produced mixed image quality results relative to the Xper series fluoroscopy
mode protocols with no consistent trends in comparative performance for the image
quality tests. The Clarity series fluoroscopy protocols did on average perform better
relative to the Xper protocols imaging the 20 cm EPT configuration which may have
been related to the higher relative ESD deliveries observed when imaging 20 cm EPT
configuration. Overall, the ‘Clarity’ upgrade successfully maintained or reduced the
ESD delivery of the c-arm system while maintaining or improving upon the standard
of image quality resolved in the acquired images. The published literature suggests
that the Clarity upgrade has resulted in similar dose reduction capabilities in other
angiographic catheterisation laboratories, however, the level of dose reduction achieved
appears to vary depending both on patient and procedure type. The reviewed litera-
ture suggests that the ‘Clarity’ upgrade technology has reduced dose delivery in clinics
by between 43 – 83% as based on clinician sampling of the air Kerma and dose area
product metrics during procedures[139 - 146].
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Highlight conclusions from these collected studies have been compiled as follows:
 Cate et.al. observed the ‘Clarity’ upgrade reduced cine-acquisition DAP expo-
sure by an average of 53%[141].
 Spink et.al. observed the ‘Clarity’ upgrade reduced mean DAP by 57% and mean
air Kerma by 58% during TIPS procedures[142].
 de Ruiter et.al. observed 61% reduction in KAP per digital subtraction angiog-
raphy frame when upgrading from a fixed Allura series c-arm system[143].
 de Ruiter et.al. also observed that in fluoroscopy mode the Clarity series c-arm
system produced comparable KAP values as their previous fixed Allura series c-
arm system but observed KAP to triple when compared to their previous mobile
c-arm system[143].
 The Cate et.al. study also assessed image quality through blind review using a
subjective semi-quantitative method. The panel of six experienced independent
reviewers observed 85% of the ‘Clarity’ c-arm system image sets had either main-
tained or improved their standard of image quality when compared to similar
image sets acquired by the contemporary c-arm system[141].
Due to the use of different dosimetric metrics, which ranged from air Kerma, KAP,
DAP and ESD, and due to the differences in imaging targets, procedure types and
imaging projections, the level of dose reduction presented by these studies should not
be conflated. That said, some degree of proportionality between these results can be
assumed. The literature compares well to the results of the ‘Clarity’ upgrade c-arm
system study, especially when comparing the Xper series ‘Cardiac 4’ protocol and the
Clarity series ‘Clarity Normal’ protocol where an average decrease ESD of 54.2±6%
was observed (error calculated using the 95% confidence interval method). The de
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Ruiter et.al. study suggests that the ‘Clarity’ upgrade featured a greater emphasis on
improving acquisition mode performance while fluoroscopy mode performed compara-
bly or even worse than previously utilised imaging protocols, suggesting that there is
further room to optimise the Clarity series imaging protocols before hardware limits
are reached[143]. The Cate et.al. study potentially provided the most extensive com-
mentary on image quality performance of the ‘Clarity’ upgrade and concluded that
85% of the ‘Clarity’ image sets were better or comparable to comparable image sets
acquired using their previous c-arm system[141]. The referenced studies also noted that
images were visually cleared on the upgraded Allura Clarity c-arm system. While this
was not evidenced in our study through any specific test, subjective visual evaluation
of the Xper series and Clarity series image sets were consistent with the published
claims of reduced image noise. The reduction in noise was may have improved overall
image quality as test features were observed to be easier to distinguish in the ‘Clarity’
image sets. A comparison of the Xper series images and Clarity series images has been
provided in Figure 4.4. to visually present this difference in image quality between
the two image sets. The algorithms used to produce this image noise reduction effect
are discussed in detail by Söderman et.al.[144, 145]. The contribution of image noise
to image quality was not quantifiable using the established methodology suggesting
a limitation in the NEMA XR 21 protocol assessment method. This resulted in a
new digital-based test being implemented during the GE upgrade assessment that
attempted to quantify image noise through sampling homogenous regions of the GE
image sets.
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Figure 4.4: Example of acquisition mode image quality when using the a) Cardiac 4
protocol as compared to the b) Clarity Normal protocol
4.5.2 Clinical impact of the GE upgrade results
The GE ‘Dose map’ upgrade introduced three new imaging protocols, the ‘Standard’,
‘Low’ and ‘Very Low’ protocols. As the primary clinical protocols, the ‘Standard’
protocol was compared directly to the pre-upgrade ‘CoroPlus’ protocol as high detail
imaging protocols and the ‘Low’ protocol was compared directly to the pre-upgrade
‘RDLS’ protocol as low dose protocols. As a secondary low dose clinical protocol, the
‘Very Low’ protocol was only discussed through the context of the ‘Low’ protocol.
The post-upgrade ‘Standard’ protocol provided significant reduction in ESD delivery
when compared to the pre-upgrade ‘CoroPlus’ protocol, averaging an ESD reduction of
26% when operated in the acquisition modes and 61.9% when operated in fluoroscopy
mode. In acquisition imaging modalities, iodine contrast resolution improved by an
average of 13.3% and image noise decreased by an average of 41.8%, however, in fluo-
roscopy mode, these aspects of image quality were observed to depreciate by averages
of 39.3% and 17.9% respectively, likely resulting from photon deprivation at the image
receptor. Spatial resolution was observed to reduce consistently for the ‘Standard’
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protocol across all EPT/FOV configurations and imaging modalities by an average of
14.6%. Working thickness range was similar for most EPT/FOV configurations and
imaging modalities, however, in some configurations the ‘Standard’ protocol exhibited
improved capabilities in imaging high density WTR targets. Motion target resolution
was similar between protocols with the exception of when imaging using the ‘Stan-
dard’ protocol operated in the acquisition mode dose level 2 setting where an average
of 22.5% less motion targets were acquired when imaging the 12 cm OFS configura-
tions. The GE ‘Dose map’ upgrade ‘Low’ protocol ESD deliveries were comparable
to the ‘RDLS’ protocol in acquisition mode, averaging to within 1% of the ‘RDLS’
dose values. When imaging using fluoroscopy mode, the ‘Low’ protocol dose values
were also similar to the ‘RDLS’ protocol dose values when imaging the 30 cm EPT
configurations, scoring an average of 4.4% higher than the ‘RDLS’ protocol, but was
significantly higher when imaging the 20 cm EPT configurations, scoring an average
of 249.4% higher than the ‘RDLS’ protocol dose values. Iodine contrast resolution
improved for all ‘Low’ protocol images by an average of 34.4% with exception to when
imaging the 20 cm EPT configurations in fluoroscopy mode where iodine contrast res-
olution was observed to depreciate by 26.8%. Spatial resolution was consistently lower
by an average of 12.6% with exception to when imaging the 30 cm EPT configurations
using the fluoroscopy mode where spatial resolution was observed to improve by an
average of 5.6%. WTR/MTR was generally similar or improved upon when using the
‘Low’ protocol. Image noise decreased by an average of 24.8% in the acquisition modes,
decreased by an average of 8.9% when imaging in fluoroscopy mode using the 12 cm
OFS configurations and increased by an average of 25.4% when imaging in fluoroscopy
mode using the 15 cm OFS configurations. When using fluoroscopy mode to image
the 20 cm EPT configurations, the ‘Low’ protocol results appeared to perform worse
than the ‘RDLS’ protocol despite outperforming the ‘Low’ protocol in every other
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imaging modality, EPT configuration and FOV configurations which suggests that the
‘Low’ protocol may not be suitably optimised for imaging smaller patient volumes.
The GE ‘Dose map’ upgrade ‘Very Low’ protocol ESD deliveries were lower than the
‘Low’ protocol ESD deliveries by an average of 34.1% when imaging the 20 cm EPT
configuration in acquisition mode, lower than the ‘Low’ protocol ESD deliveries by an
average of 8.1% when imaging the 30 cm EPT configuration in acquisition mode, lower
than the ‘Low’ protocol ESD deliveries by an average of 53.0% when imaging with the
fluoroscopy mode dose setting 1 and higher than the ‘Low’ protocol ESD deliveries by
an average of 9.7% when imaging with the fluoroscopy mode dose setting 2. When
imaging in the acquisition modes, the ‘Very Low’ protocol produced similar or worse
standards of iodine contrast resolution and dynamic MTR compared to the ‘Low’ pro-
tocol by averages of 13.8% and 11.4% respectively. The ‘Very Low’ acquisition mode
protocol also produced a similar standard of spatial resolution, static MTR, image
noise and upper WTR threshold, however, the ‘Very Low’ acquisition mode protocol
was capable of acquiring an average of 17.5% more high density imaging targets than
the ‘Low’ protocol when imaging the 20 cm EPT configuration and an average of 30%
less high density imaging targets than the ‘Low’ protocol when imaging the 30 cm
EPT configurations. In the fluoroscopy modes, the ‘Very Low’ protocol produced a
similar or lower standard of iodine contrast resolution, spatial resolution and MTR and
acquired less image noise than the ‘Low’ protocol image sets by an average of 4.1%. It
was noted that the ‘Very Low’ protocol performed significantly worse when imaging
the 30 cm EPT configurations using the fluoroscopy modes. Three out of four of these
configurations produced images that failed to acquire even a single iodine dot. This
constituted extremely poor image quality, prevented an accurate comparison to other
protocols using the established ratio method and further adds to evidence that certain
post-upgrade protocols could be optimised to specific EPT ranges. Some general be-
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havioural trends were observed between the post-upgrade protocols. The x-ray tube
kVp and x-ray tube current were observed to increase with phantom EPT. Increas-
ing kVp would increase the penetration of the x-ray beam while increasing the x-ray
tube current would increase the number of photons incident on the image receptor
plate, both of which would be necessary to maintain a standard of image quality when
imaging larger, more attenuative, patient volumes at the cost of increasing exposure
to the patient, which was reflected in the results. When changing from the dose level
1 to the dose level 2, the x-ray tube kVp was observed to be invariable for each pro-
tocol, suggesting kVp was primarily selected based on EPT, while x-ray tube current
was observed to increase and x-ray tube filtration either reduced or was maintained
at the previous filtration level. The change in these settings would increase number
of photons incident to the patient volume, increase the photons transmitted to the
image-receptor and increase the low energy photon contribution of the beam which
would increase image contrast. These effects increase image quality at the expense of
increasing the ESD delivered to the patient volume, which was reflected in the results.
In all instances, the Very Low protocol was observed to utilise a similar level
of beam filtration as the ‘Standard’ protocol for all EPT/FOV configurations and an
increased level of beam filtration as the ‘Low’ protocol with exception to when imaging
the 30 cm EPT configurations in acquisition mode where all protocols were observed
to utilise no additional beam filtration. The ‘Very Low’ protocol was also observed
to generate similar kVp values to the ‘Standard’ and ‘Low’ protocols when imaging
the 20 cm EPT configurations but the ‘Very Low’ protocol kVp values were lower
when imaging the 30 cm EPT configuration, suggesting that the relationship between
kVp values and EPT changed differently depending on the protocol used. When
considered with the fact that the ‘Very Low’ protocol performed better than the ‘Low’
protocol when imaging the 20 cm EPT configuration but worse when imaging the 30 cm
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EPT configuration and that the ‘Low’ protocol performed better than the ‘Standard’
protocol when imaging the 20 cm EPT configuration but worse when imaging the 30
cm EPT configuration, the results could suggest that rather than the protocol naming
convention outlining a specific dose delivery hierarchy, the protocol naming convention
could instead indicate that the ‘Standard’ protocol is in fact used for ‘standard’ sized
patients while the ‘Low’ and ‘Very Low’ protocols are instead used for smaller sized
patients which as previously established, would constitute lower dosed procedures just
by being less attenuative than larger patients, however, this line of thinking is purely
speculative based upon generalisations of the observations. In fluoroscopy mode, the
post-upgrade fluoroscopy protocols were observed to perform at a lower framerate of
7.5 FPS as opposed to the pre-upgrade default setting of 15 FPS. This change was
only observed in the fluoroscopy modes. The impact of decreasing the framerate of
the ‘Low’ protocol was evaluated at the request of the local clinicians. Increasing the
framerate by a factor of two more than doubled the ESD delivery but also resulted
in small improvements to both ICR and spatial resolution. Increasing frame rate
also produced a similar or better standard of MTR and resulted in reduced temporal
artefacts, specifically imaging after-shadows. Increasing framerate did not improve
image noise and instead resulted in an average increase in image noise of 17.6%.
4.5.3 Direct system comparison: Innova 2100IQ vs IGS 520
The EHC IGS520 c-arm system had undergone a similar post-processing upgrade as
the SHC Innova 2100IQ c-arm system. As mentioned previously, the primary differ-
ence between these two c-arm systems was that the IGS520 c-arm system included an
upgraded image-receptor plate which featured a greater number of detector elements
than included in the Innova 2100IQ image-receptor plate. As such, this c-arm sys-
tem comparison provides interesting insights both into the differences in c-arm system
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commissioning between different clinical environments and into the impact of software
upgrades versus incremental hardware upgrades. The ‘Standard’ protocol produced
higher ESD deliveries than the ‘IQ+’ protocol when imaging the 20 cm EPT configu-
rations using the acquisition mode 1 setting by an average of 22.5%, produced lower
ESD deliveries than the ‘IQ+’ protocol when imaging the 30 cm EPT configurations
using the acquisition mode 1 setting by an average of 12.4% and produced lower ESD
deliveries than the ‘IQ+’ protocol when imaging using the acquisition mode 2 setting
by an average of 16.8%. The ‘Standard’ protocol also produced an improved standard
of both iodine contrast resolution and image noise by averages of 21.9% and 35.1%
respectively. In general, when imaging using the acquisition mode dose level 1 setting,
both protocols produced comparable spatial resolutions, working thickness ranges and
MTR values. In general, when imaging using the acquisition mode dose level 2 setting,
both protocols produced comparable spatial resolutions, working thickness ranges and
dynamic MTRs, however, the ‘Standard’ protocol resolved 17.5% less static motion
targets than the ‘IQ+’ protocol image sets. Image noise was lower when imaging
using the ‘Standard’ protocol by an average of 35.1%. The ‘Low’ protocol produced
higher ESD deliveries than the ‘EHC-RDLS’ protocol when imaging the 20 cm EPT
configurations by an average of 41.8% when imaging in the acquisition mode dose level
1 setting and by an average of 55.6% in the acquisition mode 2 dose level 2 setting.
When imaging the 30 cm EPT configurations, the ‘Low’ protocol produced similar or
lower ESD deliveries than were on average 4.3% lower than the ‘EHC-RDLS’ proto-
col ESD deliveries. Iodine contrast resolution was in general higher when using the
‘Low’ protocol, averaging 14.6% higher than the ‘EHC-RDLS’ protocol. Spatial res-
olution and WTR scores were similar between protocols with exception to the 20 cm
EPT, 12 cm OFS configuration where the ‘Low’ protocol resolved more line pairs and
more high density imaging targets than the ‘EHC-RDLS’ protocol. MTR was similar
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between protocols when imaging the 20 cm EPT configurations and was similar or
reduced when using the ‘Low’ protocol to image the 30 cm EPT configurations. Image
noise was lower when using the ‘Low’ protocol for all configurations by an average of
39.3%. Overall, the SHC Innova 2100IQ c-arm system produced image sets with bet-
ter iodine contrast resolution and image noise scores than the IGS-520 c-arm system
but otherwise the two c-arm systems produced comparable image quality scores. This
was despite the IGS520 c-arm system being a newer hardware revision that included
an improved image-receptor plate with a greater number of detector elements. The
results suggest that current improvements in post-processing techniques may impact
image quality more significantly than incremental hardware releases and may suggest
that c-arm system upgrades may be a more efficient route to updating catheterisation
laboratories than replacing existing units, although, further c-arm system image qual-
ity studies would be necessary to prove this to be the case.
4.5.4 Developing a better definition of ‘Image Quality’
The results of this study enable reflection on what defines good image quality. When
comparing the high detail ‘Standard’ protocol and the low dose ‘Low’ protocol, the
primary differences between the two protocols were dose delivery, iodine contrast reso-
lution and image noise. The results suggest that iodine contrast resolution and image
noise are the most apparent indicators of image quality and that these factors are
inversely proportional to ESD delivery. Other image quality factors, such as spatial
resolution, imaging working thickness range and motion target resolution were largely
consistent between the ‘Standard’ and ‘Low’ protocols, suggesting that these param-
eters are a product of hardware and algorithmic limitations. The results have proved
that c-arm system efficiency can be improved upon, however, to some extent the ESD
delivery and image quality produced by the c-arm system is largely dependent on the
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preferences of the operators performing the procedures and there is a trade-off pre-
sented when selecting the level of c-arm system performance. Image noise reduction
was an important aspect for both the ‘Clarity’ and ‘Dose Map’ upgrades. The ‘Clarity’
upgrade attempted to achieve this through an improved reconstruction methodology
while the ‘Dose Map’ upgrade seemed to achieve this through application of imaging
smoothing filters. If smoothing filters were implemented in the GE ‘Dose Map’ up-
grade, it could also explain the consistent reduction in spatial resolution observed in
the majority of post-upgrade image sets. These techniques resulted in images appear-
ing less granular than the pre-upgrade image set, as shown in Figure 4.4. In addition,
several other post-processing effects were noted post-upgrade on the GE Innova 2100IQ
c-arm system. The boundaries of high contrast regions, such as the WTR test features,
were observed to exhibit edge enhancement effects. These effects were observable as
a visual glow or shadow around the test features. This effect accentuated these fea-
tures creating a sharp visual distinction between mediums. This edge enhancement
effect has been presented in Figure 4.5. This figure includes two plot profiles gen-
erated in the FIJI image analysis software package that graphically present the edge
enhancement effects as seen applied to the high and low density WTR targets. Visu-
ally homogenous regions of the post-upgrade protocol image sets were also observed
to feature a slight radial gradient that extended centrally to the edges of the image.
This inhomogeneity effect has been presented in Figure 4.6. This effect could have
been a result of beam hardening as previously discussed or potentially resulted from
the presence of the contrast objects in field. As such, sampling noise could potentially
be improved through use of an equivalent water phantom. That said, the ROI was se-
lected centrally to minimise the impact of this gradiation of the field and the sampling
distribution was of the expected Gaussian trend as presented in Figure 4.3b. This
fostered confidence in the testing methodology which will be improved upon further
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in future work through measurement of the signal to noise ratio, the contrast to noise
ratio and the modulation transfer function.
4.5.5 The efficacy of this study’s methodology
This study compared performance of c-arm system protocols using a ratio method.
The ratio method was highly effective for comparing similar protocols. Unfortunately,
the magnitudes of the ratio method results were, in part, dependent on the scale of
the protocol, imaging modality, phantom and c-arm configurations used. For low scor-
ing protocols or configurations, small variations in score affected the magnitude of
the ratios more significantly than when comparing high scoring protocols. This was
a purely mathematical consequence of comparing such a broad range of score values.
The ratio method was also not capable of providing a sense of relative performance
ranking when comparing individual protocols to the full range of protocols evaluated.
The graphical representation provided in Appendix B. successfully depicted perfor-
mance ranking between protocols, however, the graphs were complicated to read due
to the number of variables displayed. This complexity of the graphical representation
would only compound with an increasing number of comparative protocols, hence why
the graphical representation was not used to compare the GE c-arm system results.
A more effective scoring methodology could involve developing scoring thresholds, or
scoring brackets, based upon images that were considered to be, for example, of good,
acceptable or bad quality by a consensus of clinicians. Such a method would require
sampling of a broader c-arm system performance range than was observed in this study
and would require collaboration with a range of clinical experts, both of which were
conditions beyond the scope of this study but may be revisited for future measure-
ments. According to a study by Balter et.al. in 2001, a study that introduced the
NEMA XR21 methodology, the Society for Cardiac Angiography and Interventions
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Figure 4.5: a) An isolated post-upgrade GE Innova 2100IQ protocol acquisition frame
presenting edge enhancement effects at the boundary of high contrast
image features with line profiles provided for a b) low density WTR
imaging target and a c) high density WTR imaging target
Figure 4.6: a) An isolated post-upgrade GE Innova 2100IQ protocol acquisition frame
presenting radial gradient effects as shown graphically through b) line
profile
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initially intended to establish a system performance registry based on standardised
NEMA XR21 protocol testing[138]. To date, this performance registry project does
not appear to have been established. From the findings of this study, the most signifi-
cant hurdle to developing a performance registry based on the NEMA XR21 protocol is
the methodologies reliance on the ability and availability of trained human observers.
The number of machines, protocols, and standardised imaging configurations that are
necessary to evaluate performance generates a considerable quantity of data to assess.
Widespread implementation of the existing methodology would be time consuming,
resource intensive and open to assessor proficiency biases. The methodology could
be streamlined through development of an image assessment software package that
deploys sophisticated feature recognition algorithms and calculates digital indications
of image quality such as image noise, signal to noise ratio and contrast to noise ratio.
Such a software package would enable operators to processes image set batches signifi-
cantly faster than could be performed by trained human observers. The NEMA XR 21
protocol design could also improved upon. During the c-arm upgrade evaluations, the
ESD delivery, image quality and the general c-arm system performance varied greatly
between the 20 cm EPT and 30 cm EPT phantom configurations. C-arm systems and
imaging protocols may be optimised to specific expected patient thicknesses. An ex-
panded range of EPT configurations using the NEMA XR21 image test specifications
would provide better resolution to these results and improve clinical understanding
of the strengths of specific protocols. The evaluation methodology could be further
improved by increasing the range of existing tests. A study by Simon et.al. compared
two of most popular c-arm system evaluation phantoms, the American NEMA XR21
protocol test object and the European Leeds TOR 18FG test object[146]. Simon et.al.
considers that there are more sophisticated test objects, but asserts that these test
objects are simple enough to enable routine quality assurance image quality evalua-
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tions. The study used a digital sampling methodology to establish image quality and
measured dose delivery using the incident air Kerma metric as measured by an Unfors
Xi detector. In their discussion of the results, Simon et.al. commented that the iodine
circled embedded in the NEMA XR21 protocol test object were smaller than the Leeds
test object circles and contained less iodine content which resulted in greater sources
of error in the NEMA XR21 results, especially when assessing larger field sizes. The
Leeds test object also included both a larger range and resolution of iodine contrast
samples and, as iodine contrast resolution was a primary indicator of image quality,
may provide greater details regarding this aspect of c-arm system performance than
the currently existing NEMA XR21 protocol specified tests. Other studies yet have
attempted to adapt the specified phantom volume to new testing criteria or have used
the phantom volume as a teaching tool in clinic, a notion that represents the latent
value in the NEMA XR21 protocol [147, 148].
4.5.6 Air Kerma and the importance of implementing real-
time surface dosimetry solutions
For all post-upgrade GE Innova 2100IQ and GE IGS 520 measurements, the machine
calculated air Kerma at reference point was recorded and compared to the ESD de-
livery as measured by the MOSkin. air Kerma and ESD are by no means equivalent
dosimetric quantities, however, dose contouring software, such as the ‘Dose Map’ soft-
ware package, rely on the air Kerma quantity to advise clinicians of deterministic risk
and as such direct comparison of these quantities was of interest to this study. For the
purposes of this comparison, the quantities will be compared using the ratio described
in Equation 4.3. The results of the comparison have been presented in Table 4.8
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The results observed that in general, the machine estimated air Kerma underes-
timates the surface ESD. In acquisition mode, the air Kerma estimation values were
an average of 28% lower than the MOSkin measured ESD values. This falls within
the expected error range for dose map of 40% as calculated in a verification study
performed by Bordier et.al. in 2015 and was similar in magnitude to their verification
that found dose map values were within 24.9% of their EBT3 based measurement of
the patient ESD[149]. Errors were much larger during fluoroscopy mode measurements
and overestimated the surface ESD delivered to the phantom volume in some of the 20
cm EPT configuration measurements. This increase in error may have resulted from
the reduced x-ray beam filtration used when imaging in fluoroscopy mode affecting
beam quality and scatter. The 20 cm EPT configurations may also have been affected
more significantly due to geometric differences in the measurement and reference point











FOV = 12 cm
Dose Level 1
0.79 0.69
FOV = 12 cm
Dose Level 2
0.88 0.69




FOV = 15 cm
Dose Level 2
0.94 0.75
FOV = 12 cm
Dose Level 1
0.76 0.66
FOV = 12 cm
Dose Level 1
0.77 0.67
Low FOV = 15 cm
Dose Level 1
0.82 0.69
0.80 0.81 SHC Innova2100IQ
FOV = 15 cm
Dose Level 2
0.87 0.69
FOV = 12 cm
Dose Level 1
0.69 0.67
FOV = 12 cm
Dose Level 2
0.72 0.66


















FOV = 12 cm
Dose Level 1
0.64 0.70
FOV = 12 cm
Dose Level 2
0.71 0.69




FOV = 15 cm
Dose Level 2
0.73 0.72




FOV = 12 cm
Dose Level 2
0.62 0.69










Table 4.8: Air Kerma to ESD ratio as recorded for each acquisition mode measure-






Protocol Settings EPT = 20 cm EPT = 30 cm
Protocol
Average
FOV = 12 cm
Dose Level 1
0.72 0.45
FOV = 12 cm
Dose Level 2
0.42 0.47




FOV = 15 cm
Dose Level 2
0.63 0.53
FOV = 12 cm
Dose Level 1
1.87 0.61
FOV = 12 cm
Dose Level 1
0.50 0.55




FOV = 15 cm
Dose Level 2
1.29 0.60
FOV = 12 cm
Dose Level 1
1.28 0.65
FOV = 12 cm
Dose Level 2
0.81 0.57
















FOV = 15 cm
Dose Level 2
1.32 0.60
FOV = 12 cm
Dose Level 1
1.28 0.45
FOV = 12 cm
Dose Level 2
1.36 0.54










Table 4.9: Air Kerma to ESD ratio as recorded for each fluoroscopy mode measure-
ment performed during the c-arm system performance study
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4.6 Conclusions
This study established that significant improvements to c-arm system performance can
be achieved through post-processing imaging chain upgrades, refinement of image re-
construction algorithms and optimisation of clinical imaging protocols. This study also
concluded that c-arm system upgrades enable older machines to perform comparably
to newer hardware revisions which suggests that upgrading c-arm systems may in some
cases be more efficient than replacing older c-arm systems with incremental hardware
upgrades. The NEMA XR21 protocol was an effective measure for c-arm system per-
formance and was capable of providing a clear comparison between individual c-arm
systems and protocols, however, the protocol lacked any established simple method to
clearly rank multiple c-arm systems and their imaging protocols. The NEMA XR21
protocol could be improved upon through the inclusion of digital image quality assess-
ment software, expanded testing parameter ranges and additional phantom thickness
configurations. Future modifications or revisions of the NEMA XR21 protocol would
be useful for benchmarking and optimising c-arm system performance and would ben-
efit catheterisation laboratories both in informing prospective purchase decisions and
in enabling routine quality assurance testing. The MOSkin results were comparable
to similar literature based reviews of the Philips issued ‘Clarity’ upgrade. The c-arm
system calculated air Kerma value, which is often used for estimating deterministic
risk to patients, was observed to overestimate ESD deliveries in acquisition mode.
The observed discrepancy of air Kerma to ESD ranged within established error limits,
however, fluoroscopy mode error values observed a much broader range, potentially
due to the lower filtration values used in acquisition mode protocols. air Kerma values
were also in general higher relative to the measured ESD when using the 20 cm EPT
phantom configuration as compared to the 30 cm EPT phantom configuration results
with some protocols observed to overestimate the ESD deliveries to the phantom. As
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such, methods for assessment and prevention of deterministic risk would clearly ben-







In previous chapters there has been a focus on patient risk during interventional angio-
graphic procedures, however, recent studies have reported that experienced clinicians
could be developing their own radiation-induced symptoms. Over the course of a
decades long career clinicians may be at even greater risk of radiation-induced condi-
tions negatively impacting their quality of life than their patients are. This chapter
will discuss radiation-induced conditions reported by interventional clinicians, estab-
lished and developing methods to measure clinician exposures and considerations that
are necessary for developing better operator dosimetry solutions.
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5.1 Operator Specific Dosimetry Solutions
5.1.1 Radiation-induced risks to interventional clinicians
Throughout decades of ICRP publications, the ICRP has chronicled the ever-developing
understanding of radiation-induced risks to the general population2. Radiation-induced
risk modelling was first developed on observation of uranium/radon exposures primar-
ily in mining industry. These models have been improved upon as new information
has been presented. When classifying radiation-induced conditions, the ICRP cite
epidemiological studies that detail the health outcomes of atomic weapon survivors,
radiotherapy patients, patients undertaking therapeutic/diagnostic procedures and oc-
cupationally exposed workers. As an example, Shimizu et.al. reported that low dose
exposures increased incidence of stroke and heart disease bomb survivors from radi-
ation exposures exceeding 500 mSv[150]. Unfortunately, the ICRP lists the following
limitations to this approach2:
 epidemiological studies are open to interpretation
 stochastic conditions can take decades to manifest
 confounding factors may contribute to or cause the condition under study
 stochastic conditions occur with statistical distribution
 individuals may exhibit susceptibility or resistance to radiation-induced condi-
tions which could affect the conclusions of the study.
These limitations have meant that the understanding of radiation-induced condi-
tions, especially for low dose exposures, has been a developing area of study under
constant revision. As an example, ICRP Publication 103 proposed significant changes
to the ICRP Publication 60 tissue weighting factors due to the publication of further
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epidemiological studies2,3. Innovations in imaging technology and techniques have also
affected the working conditions and workloads of clinicians significantly.
There are many reports of potentially radiation-induced conditions affecting in-
terventional clinicians. Publicised conditions have included erythema, loss of hair on
legs, hands and arms, heart disease, neurological disorders including brain tumours
or stroke and rear eye lens cataract formation[151 - 159]. Of these, studies on cataract
formation have lead to the most significant revision to ICRP guidance since ICRP
Publication 103. This chapter will focus specifically on the issue of eye lens dose in
catheterisation laboratories and potential solutions to protect clinician health.
5.1.2 Radiation-induced injury to Clinician Eye Lens
Of all radiation-induced conditions currently under scrutiny, there is a specific interest
in monitoring eye lens exposures. Clinical case studies have observed that retiring
interventional operators have been developing rear eye lens cataracts at a rate four to
five times than the general public control group[61]. These observations suggest that
the eye lens is considerably more sensitive to radiation than previously anticipated.
These reports triggered a worldwide revision of eye lens exposure limits with the
ICRP recommending in ICRP Publication 118 (2012) that eye lens exposures should
be reduced to beneath 20 mSv/year as averaged over 5 years with no yearly exposures
exceeding 50 mSv/year as compared to the previous standard of 150 mSv/year as
averaged over 5 years[32].
Eye lens doses came under scrutiny on the publication of several multi-centre stud-
ies including the ORAMED and RELID studies[160, 161]. The retrospective evaluation
of eye lens injuries and dose study (RELID) was an international study implemented
by the IAEA in 2008. The aims of the RELID study were to retrospectively evalu-
ate the history of clinician eye lens exposure and radiation induced injury. This was
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achieved by reviewing dosimetric records, by assessing the past behaviours of clini-
cians and by assessing clinician eye lens health using a variety of tests. Interventional
cardiologists of ages 30-60 years old with clinical careers up to 40 years in length were
assessed. The RELID study discovered 45% of interventional cardiology respondents
exhibited damage to the posterior subcapsular lens in one or both eyes with evidence
suggesting radiation-induced cause, 57% reported never using eye protection and 61%
reported never using lead shielded screens. The induced condition rate compared to
a control group incident rate of 12%. The conclusions of this study demonstrated the
prevalence of eye lens issues in cardiologists, exemplified the history of behaviours in
interventional fields and exemplified the necessity to change behaviours through im-
proving awareness of radiation-induced risks and occupational exposures. Currently
the understanding of how radiation-induced cataracts form is still developing. Com-
peting perspectives have debated whether this is a stochastic or deterministic effect[61].
Conversely, the ORAMED project studied staff eye lens exposures, developed a phan-
tom for calibrating future eye lens dosimeters and developed the specifications for an
eye lens dosimeter enclosure that could measure at the HP(3) measurement depth.
To further bolster understanding, eye lens dose needs to be measured regularly in
clinics and common methodologies need to be adopted on a broader scale so that the
information collected is useful to researchers.
5.1.3 Requirements for eye lens specific dose monitoring
Despite published concerns, information regarding clinician exposures is limited. The
primary measures of operator exposure are currently through correlation with c-arm
system reported air Kerma or HP(10) depth personal radiation monitors worn at chest
or collar height. Studies performed by Estathopoulos et.al. and Nikodemová et.al.
observed that air Kerma was a poor indicator of the extremity dose[161, 162]. For eye
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lens dose, Sanchez et.al. observed that eye lens dose could be conservatively estimated
as approximately a factor 0.8 of the chest level HP(10) monitor readout but such
estimations can introduce large variations and errors (>>40%) due to geometry related
factors[163]. From their findings, Sanchez et.al. concluded that with proper radiation
protective equipment and appropriate in-room shielding, most clinicians should not
exceed current occupational dose limits, however, clinics that do not utilise appropriate
radiation protection strategies, especially clinics that specialise in more complicated
procedures, could easily exceed the dose limits unintentionally during their standard
workloads[163].
Eye lens dose can be monitored in the clinic in a variety of ways. Landauer include
provide HP(3) dose estimates based on HP(10) dosimeter readouts for occupationally
exposed workers. The ICRU recommends eye lens dose should be measured using
the HP(3) measurement depth however the ICRP have also suggested that HP(0.07)
dosimeters could be used as appropriate substitutes for HP(3) dosimeters
[61, 97]. Com-
mercially there are only two HP(3) dosimeter enclosures available to clinics at this
time, the Radcard Eye-D and the Landauer Vision TLD enclosures[164 - 166]. Both en-
closures are pictured in Figure 5.1 alongside the MOSkin dosimeter. The dosimeters
are implemented by some clinics but are not a required measure of dose.
Instructions on placement of these dosimeters varies with Radcard recommending
that the Eye-D dosimeter should be worn on the side of the operators’ radioprotective
glasses and Landaur recommending that the Vision should be worn on the underside
of the operators’ radioprotective glasses [164, 166]. ICRP Publication 139 also specified
studies that measured eye lens exposures from the operator’s left eyebrow and the
operator’s forehead[61]. While there is general consensus that eye lens dosimeters
should measure exposure to the eye closest to the c-arm system, typically the left eye,
the measurement point itself is yet to be standardised [160]. The ICRP concluded that
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the appropriate position may vary depending on the procedure [160].
To further protect clinicians, operator eye lens doses must be monitored to ensure
compliance to the new dose limits. Barnard et.al. have suggested that while compli-
ance with the new dose limits are achievable on a clinical basis, many clinics in 2016
were at risk of non-compliance [168]. The authors of this study recommended that re-
newed radiation safety training courses, exposure monitors and appropriate personal
protective equipment must be deployed to ensure clinician safety. They also recom-
mended that cataract reporting methodologies needed to be standardised. The aims
of the studies performed in this chapter include:
1. To compare different eye lens dose reference points using clinically representative
beam qualities and phantom configurations.
2. To compare the efficacy of the MOSkin dosimeter in comparison to existing gold
standard TLD dosimetry solutions.
3. To test a prospective HP(3) MOSkin encapsulation intended for operator dosime-
try specific applications.
4. To assess the suitability of MOSkin technologies in operator dosimetry applica-
tions.
5. To investigate considerations for development of future operator dosimetry so-
lutions.
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Figure 5.1: Eye lens dosimeters that have been used clinically include the a) Radcard
Eye-D, b) the Landauer Vision, HP(10) depth chest monitors (estimated)




The MOSkin dosimeter was the primary dosimeter used during measurements. Dose
delivery was assessed at native depth HP(0.07) using calibration data reported on in
Chapter 2. Dose delivery was verified through comparison to an established operator
dosimeter, the TLD-100 dosimeter encapsulated within a Radcard Eye-D enclosure.
The TLD-100 dosimeter was an ideal comparative measure of the MOSkin dosimeter
performance when using diagnostic standard beam qualities. While OSL and RPL
dosimeters have been popular in operator dosimetry studies, the traditional TLD-100
(LiF:Mg, Ti) is still the most commonly used dosimeter in the clinical environment
due to how comprehensively established and understood the TLD-100 dosimeters have
become over the last several decades. Measurements were performed at the SCK-CEN
calibration facilities and readout of the TLD-100 was performed with assistance from
SCK-CEN personnel.
5.2.1 Calibration of the TLD-100 Eye-D Dosimeter
Similarly to the MOSkin in Section 2.2.4, the Eye-D dosimeters were calibrated for
energy dependence using the full range of Narrow Spectrum Series and RQR Series
beam qualities available at the SCK-CEN calibration facilities. Angular dependence
was assessed using the Narrow80 and RQR6 beam qualities. These qualities were
chosen for their reported similarity to interventional beam qualities [121]. Irradiation
was performed using an Xstrahl dual x-ray tube system equipped with a 100 keV and a
300 keV x-ray tube using a variety of filtration settings and with a collimated Cesium-
137 (Cs-137) point source at distance of 1 meter from the irradiation source. Before
irradiation, air Kerma delivery to the measurement point in free air was measured
using a 1 litre PTW ionization chamber for each beam quality used. After measuring
the air Kerma in free air, the Eye-D was attached to the 20 Ö 20 cm cylindrical
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phantom volume and irradiated for an appropriate exposure time. For the Narrow
Spectrum Series beam qualities, this exposure time varied depending on dose rate for
each specific beam quality due to time constraints. On average the Eye-D dosimeters
were irradiated to an exposure of ∼56 mGy in air Kerma. The RQR Series beam
qualities provided much higher dose rates and, as such, the Eye-D dosimeters were
irradiated to a threshold of 120 mGy for all RQR Series beam qualities. Angular
response was measured with the Eye-D dosimeter positioned at a fixed distance from
the irradiation source. During these measurements, the phantom was positioned on
a rotatable turntable. The angle of the Eye-D dosimeter with respect to normal
incidence of the x-ray beam was manipulated by rotating the turntable. For further
description and schematics of this apparatus, please refer to Section 2.2.4. TLD
Readout was performed by the SCK-CEN calibration facility with results provided as
counts contributing to glow peak 5. Error was calculated using the standard deviation
of the TLD Eye-D dosimeters irradiated for each beam quality. HP(3) equivalent dose
to the measurement point was calculated using the ISO 4037-3 methodology outlined in
Section 2.3.4. Air Kerma conversion coefficients for the cylindrical phantom volume
were primarily sourced from Behrans et.al. for Narrow Spectrum Series beam qualities
and from Principi et.al. for RQR Series beam qualities[116, 117]. Missing conversion
coefficients were simulated using Monte Carlo methodology. The energy dependence
datasets were presented normalised with respect to the response to the Cs-137 source
so as to compare to similar published calibration studies.
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5.2.2 Measuring Eye Lens Dose from Several Recommended
Reference Points
The clinicians’ head was simulated using a Rando-Alderson head phantom171. Pho-
tographs of the phantom have been presented in Figure 5.2. The phantom was
irradiated in three equipment configurations; without radioprotective glasses, wearing
standard radioprotective glasses (Glasses A) and wearing side shielded radioprotective
glasses (Glasses B). Photographs of the Rando-Alderson phantom and the two types
of radiation protective glasses have been provided in Figure 5.2. The phantom was
mounted on the rotatable turntable, as represented diagrammatically in Figure 5.3,
and positioned with the right eye lens at a distance of 1 meter from the irradiation
source. The phantom was then irradiated in each equipment configuration for an an-
gular range of -90° to 90° degrees relative to the incident x-ray beam as incremented
in 15° degree steps. For the purposes of these measurements, 90° was defined as when
the phantom was facing right relative to the incident x-ray beam. All irradiations were
performed using the higher dose rate RQR6 beam quality rather than the Narrow80
beam quality due to time constraints. Each irradiation delivered an air Kerma of 120
mGy in free air to the measurement point. HP(0.07) and HP(3) doses were calculated
using the aforementioned ISO 4037-3 protocol 115.
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Figure 5.2: Photographs of a) Glasses A, b) Glasses B (with side shielding) and c)
the Rando Alderson phantom equipped with Glasses type A
Figure 5.3: Diagrammatic representation of head phantom mounted to the turn table
apparatus a) with angle measured marked and b) in the 45° configuration
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During irradiation, the Eye-D dosimeter was used to measure HP(3) dose deliv-
ered to the left eye lens for all phantom equipment configurations and all angular
configurations. Conversely, the MOSkin dosimeter was used to measure HP(0.07) dose
delivered to five measurement points; the eye lens, under-glasses, over-glasses, forehead
and side of glasses measurement points. These measurement points are identified in
Figure 5.4. The MOSkin measurement points were monitored for both of the glasses
configurations for all angular configurations specified previously. The eye lens dose
measurement point dose values were compared to and verified using the Eye-D re-
sponse. Each of the other MOSkin measurement points were compared directly to
the eye lens dose MOSkin measurement point. Each measurement point was assessed
using qualitative metrics that considered how representative the response at the mea-
surement point was of the eye lens measurement point response.
5.2.3 Development of an HP(3) equivalent MOSkin enclosure
The MOSkin dosimeter measures dose at a native HP(0.07) measurement depth. As
mentioned previously, the most appropriate depth for measuring eye lens dose is the
3 mm measurement depth. To more accurately measure eye lens dose delivery, an
appropriate encapsulation solution was designed for the MOSkin dosimeter. This
encapsulation cap was produced from solid water material. The capping geometry
resembled a half dome/half oblong shape and was designed to provide a consistent 3
mm thickness of solid water around the sensitive volume of the MOSkin dosimeter.
The design of the capping material is presented in Figure 5.5.
The capping material was tested at ARPANSA calibration facilities based in Yal-
lambie Melbourne. The cylindrical phantom methodology used at SCK-CEN was
reproduced as faithfully as possible. Narrow Spectrum Series beam qualities were lim-
ited to the Narrow40 to 250 beam qualities due to limitations of the x-ray apparatus. A
5.2. Methodology 175
singular HP(0.07) MOSkin was irradiated in addition to the HP(3) MOSkins to ensure
that MOSkin response to the ARPANSA beam qualities was consistent with MOSkin
response to the SCK-CEN beam qualities. Energy dependence and angular response of
the HP(3) MOSkin was compared to the performance of the native HP(0.07) MOSkin
results presented in Section 2.3.4.
Figure 5.4: a) Annotated diagram of MOSkin measurement points with b) photo-
graph of phantom fitted with MOSkin dosimeters
Figure 5.5: HP(3) MOSkin capping material represented schematically a) in isomet-
ric view, b) in isometric view (internal borders visible), c) from the side
view (cross-section with MOSkin cavity visible), d) from the front view
(MOSkin position marked, dimensions marked) and e) as positioned on
the phantom volume during characterisation (photograph)
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5.3 Results
5.3.1 TLD Eye-D calibration values
The TLD Eye-D, reference depth ∼3 mm, response to the Narrow Spectrum Series
and RQR Series beam qualities are presented in Figure 5.6a and Figure 5.6b re-
spectively using red diamond points. The results were validated through comparison
to simulation data published by Bilski et.al.[165]. The Bilski et.al. study included sim-
ulated TLD Eye-D response values generated via a custom MCNP-χ code, represented
by the dotted line and six measured data points, denoted by crosses, obtained through
irradiation with Narrow Spectrum Series and RQR Series beam qualities. All data
points were presented on a logarithmic scale of the mean beam energy and normalised
to Cs-137 response. Peak response was observed when using the Narrow30 (Mean
energy = 24 keV) and RQR2 (Mean energy = 27.54 keV) beam qualities. Angular
response of the Eye-D dosimeter to the Narrow80 and RQR6 beam qualities has been
presented in Figure 5.7. All values were normalised to the 0° incidence response
values. Eye-D response per unit of the calculated HP(3) doses, as calculated for each
angle of incidence, increased with angulation and peaked at 90° where response was
23.7% higher than the expected value for the Narrow80 beam quality and 67.8% higher
than expected for the RQR6 beam quality.
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Figure 5.6: Eye-D response to the a) Narrow Spectrum series and b) RQR series
beam qualities available at the SCK-CEN calibration facilities as com-
pared to data published by Bilski et.al.[165]
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Figure 5.7: Eye-D angular response to the Narrow80 and RQR6 beam qualities
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5.3.2 Comparison of Eye Lens Dose Measurement Points
Eye lens dose to the phantom was measured using the Eye-D dosimeter for all phan-
tom configurations and was considered the gold standard for eye lens dosimetry in
this experiment. The eye lens dose delivered to the phantom without radioprotective
equipment equipped has been presented in Figure 5.8. Eye-D response peaked when
irradiating the -30° configuration where doses were 20.9% higher than observed at
normal incidence. Eye lens dose to the phantom configurations when equipped with
radioprotective glasses as measured by the MOSkin and by the Eye-D has been pre-
sented in Figure 5.9. For the angular range of -60° to 60°, the MOSkin dosimeter
measured doses that were on average 3% lower when using Glasses A and 12% lower
when using Glasses B. For the angular range of -60° to 60°, eye lens dose was on av-
erage ∼90% lower when wearing the radioprotective glasses. The efficacy of Glasses
A as compared to Glasses B has been presented in Figure 5.9c. Glasses B pro-
vided slightly more radiation protection than Glasses A did. The MOSkin response
at all measurement points for the two phantom equipment configurations have been
presented in Figure 5.10 and Figure 5.11. Each MOSkin measurement point was
compared individually to the eye lens measurement point using a dual-Y axis graph
format to better visualise how closely each measurement point represented the eye lens
dose delivery. The ratio of dose delivered to the measurement point with respect to
eye lens dose was calculated and averaged over an angular range of -60° to 60°. The
exception to this general rule was the side lens measurement point in which the 0°
to 60° range of measurement points were not included in the calculation as dosimeter
response trended towards negligible for these angles. The formula for this ‘Ratio of
Response’ variable has been presented as Equation 5.1.






Figure 5.8: Phantom eye lens dose without any personal protective equipment
(normalised to 0° angle of incidence)
Figure 5.9: HP(0.07) and HP(3) doses measured at the eye lens reference point with
the Rando-Alderson phantom equipped with both a) Glasses A and b)
Glasses B with c) comparative graph included.
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Figure 5.10: Comparison of MOSkin response for a) all measurement points and for
eye lens measurement point compared to b) the under-glasses measure-
ment point c) the over-glasses measurement point d) the side-glasses
measurement point and the e) forehead measurement point for Glasses
configuration A
Figure 5.11: Comparison of MOSkin response for a) all measurement points and for
eye lens measurement point compared to b) the under-glasses measure-
ment point c) the over-glasses measurement point d) the side-glasses
measurement point and the e) forehead measurement point for Glasses
configuration B
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5.3.3 HP(3) MOSkin Calibrations
The HP(3) MOSkin encapsulation energy dependence has been presented in Figure
5.12. HP(3) MOSkin response was observed to peak for the RQR4 beam quality
where the sensitivity of the dosimeter was 1.25 mV/mSv. Angular response of the
HP(3) MOSkin with respect to the θ rotational axis has been presented in Figure
5.12a and angular response of the HP(3) MOSkin with respect to the Φ rotational
axis has been presented in Figure 5.12b. the MOSkin response was within 5% of
expected values for incident angles of up to 60°.
Figure 5.12: Angular response of HP(3) encapsulated MOSkin to Narrow80 and
RQR6 beam qualities with respect to the a) θ rotational axis and the
b) Φ rotational axis
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5.4 Discussion
5.4.1 The Accuracy of the TLD Eye-D Calibration
The Eye-D dosimeters performed comparably to data published by Bilski et.al.[165].
The peak response of the TLD- Eye-D dosimeters occurred somewhere between the
Narrow30 and RQR2 beam qualities, that is, within a mean energy range of 24 - 27.5
keV. This peak in response occurred at lower energies than the Bilski et.al. simulated
energy response which peaked when using the Narrow40 beam quality (33 keV). This
was a result of each study using different composition TLD dosimeters. The calibration
was performed using the more traditional LiF:Mg, Ti type TLD while Bilski et.al. used
newer high sensitivity LiF:Mg,Cu,P type TLDs. The difference between these two
types of TLD is well understood and the lower energy response peak is consistent with
results published previously by Bilski et.al.[172]. The angular response of the Eye-D
dosimeter was observed to increase with increasing angulation from normal incidence.
TLD response remained within ±15% of response at normal incidence for angles up
to the 75° configuration for the Narrow80 beam quality and for angles up to the 60°
configuration for the RQR6 beam quality which was consistent with results published
by Bilski et.al. for the RQR7 beam quality
[165].
5.4.2 Operator Phantom Eye Lens Doses
The eye lens dose delivered to the Rando-Alderson head phantom peaked when irradi-
ating the -30° incidence configuration. This angle maximises the profile of the Eye-D
dosimeter to the incident beam and minimises obstructions between the incident beam
and the dosimeter. Equipping the phantom with radioprotective glasses reduced dose
delivered to the ±60° configurations significantly by an average of 91.2%. When irra-
diating the phantom in angular configurations beyond ±60° range, the radioprotective
5.4. Discussion 184
glasses only provided partial protection to the eye lens measurement point. When
irradiating the phantom in the Glasses A configuration from the 75° angular configu-
ration, the dosimeters experienced a significant spike in response which represented an
increase in dose be a factor of 4.65, or alternatively, 52.1% of the no-glasses phantom
configuration value. The Glasses B configuration also recorded a spike in eye lens dose
at the -90° angle. These increases in dose delivery demonstrate radiation incident from
broad angles can potentially bypass the coverage of the radiation protective glasses
and irradiate the eye lens directly. Radioprotective glasses do not provide protection
for all angles and the results have demonstrated that gaps in protection differ based on
the geometry of glasses. The results emphasise the need for eye lens dose monitoring
to ensure compliance with operator dose limits.
Of the two styles of glasses reviewed in this study, the Glasses B, the side shielded
glasses, were observed to provide a more homogenous protective coverage than Glasses
A. The MOSkin and Eye-D dosimeters produced very similar dosimetric responses.
The results suggested that the MOSkin dosimeter was able to accurately represent the
eye lens dose and that the HP(0.07) and HP(3) measurements depths were comparable
measures of eye lens doses for interventional range beam qualities which was consistent
with the guidance provided by ICRP Publication 13961.
When assessing the utility of different eye lens dose measurement points, each
measurement point exhibited different benefits and limitations. The most difficult
challenge in monitoring the eye lens dose effectively was in finding a measurement
point that provided representative response of the clinician head and glasses geome-
tries. The highest doses were measured at the over-lens and forehead measurement
points. As such, these measurement points would enable use of less sensitive dosime-
ters to measure operator eye lens dose. These measurement points would require a
scaling factor to properly estimate eye lens dose. In this study, that scaling factor was
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a factor of roughly 10-12 times the phantom eye lens dose. Conversely, the under-
glasses measurement point accounted for the attenuation of incident radiation by the
radioprotective glasses. Due to how close this measurement point was to the radio-
protective glasses, this measurement point was not able to detect variance in eye lens
dose resulting from the geometry of the glasses used and, as such, this measurement
point may potentially underestimate eye lens dose. The side lens measurement point
was a good compromise in measurement points as this measurement point received the
higher dose from being on the outside of the glasses and was closely representative of
the eye lens dose for angles for -90° - 0°. Unfortunately, the side glasses was completely
incapable of accurately measuring eye lens dose when exposed from angles in the 0
- 90° range. For Glasses A, the side glasses measurement point observed decreasing
response with increasing angulation from normal while for Glasses B, the side glasses
measurement point observed negligible response for all angulations >0°. This result
suggests that passive dosimeters positioned on the side of an operator’s glasses may
underestimate eye lens dose depending on type of glasses and on the directions an
operator faces during the procedure. The impact of this effect on accuracy could be
reduced through comparison to a second complimentary measurement point, however,
this would require a more sophisticated measurement. The results indicate that there
is no clearly superior measurement point and the most appropriate measurement point
depends on variables such as operator behaviour, procedure undertaken, type of glasses
worn and dosimetry solution implemented.
5.4.3 Performance of the HP(3) MOSkin enclosure
The HP(3) MOSkin dosimeter performed comparably to the native HP(0.07) mea-
surement depth MOSkin. Comparison of the HP(3) and HP(0.07) MOSkin energy
dependence has been provided in Figure 5.13. The primary differences observed
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Figure 5.13: Comparison of energy dependence between the native HP(0.07) MOSkin
dosimeter and the encapsulated HP(3) MOSkin dosimeter
were in the energy response of the HP(3) MOSkin. Peak energy response was observed
for the RQR4 beam quality which represented a shift in peak response to higher beam
energies (∆ E = 12 keV). The HP(3) MOSkin also observed reduced sensitivity at
peak of ∼9%. Low energy dependence of the HP(3) MOSkin could not be assessed
as low energy beam qualities were unavailable at the ARPANSA calibration facili-
ties. The HP(3) MOSkin did provide greater angular homogeneity than the HP(0.07)
MOSkin. Asymmetry was observed when rotating with respect to the Φ axis due to
radiation entering the dosimeter MOSkin cavity directly and therefore bypassing the
capping material. This should be taken into consideration when positioning the HP(3)
MOSkin.
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5.4.4 Consideration for Future Operator Dosimetry MOSkin
Design Iterations
5.5 Conclusions
The results of this operator dosimetry study provided insights to the requirements of
an operator specific dosimeter. Investigation regarding eye lens measurement points
observed unique benefits and drawbacks to use of each measurement point. Glasses
geometry had a significant effect eye lens dose and should be considered when choosing
an eye lens dose measurement point. HP(3) capping reduced angular dependence of the
MOSkin dosimeter at cost of ∼9% sensitivity. Peak response shifted to higher beam
energies which may not be beneficial for operator specific applications but would ben-
efit neuro-interventional or CT applications. The sensitivity of the MOSkin dosimeter
remains the primary challenge to operator dosimetry specific implementations.
Chapter 6
Floating Gate MOSFET
Dosimeters: A Prospective Study
The final measurement focused chapter of this research thesis will focus on the future
of diagnostic dosimetry solutions. This chapter will focus on characterisation of a novel
prospective dosimetry solution, the Floating Gate MOSFET dosimeter. This chapter
will assess stability, dose response and reproducibility of the new dosimeter and will
showcase detector stability, dose response to a range of sources and identify potential
applications going forward from this research thesis.
6.1 Overview of Floating Gate MOSFET devices
A Floating Gate MOSFET, referred to hereafter as FG-MOSFET, is a MOSFET type
device differentiated from conventional MOSFET designs by a ‘floating gate’ isolated
within the oxide material. A diagram of the FG-MOSFET structure has been provided
in Figure 6.1. Under normal operation, charges cannot conduct between the floating
gate and other terminals, however, there are methods for manipulating charge within
the floating gate structure. Depending on context, adjusting charge within the floating
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gate intentionally is referred to as a ‘write’ operation while readout is referred to as
a ‘read’ operation. By accumulating charge carriers within the floating gate, the
electric field generated by floating gate will change, affecting the conductivity of the
channel between the source and drain terminals. Charge can be manipulated using
the following methodologies:
 Fowler-Nordheim tunnelling
A quantum mechanical effect that occurs when valence electrons near a suffi-
ciently thin insulative barrier are subjected to a sufficiently strong electric field.
These conditions enable charge carriers to tunnel through the insulator in the
direction dictated by the electric field. In FG-MOSFET devices, this interaction
is used to accumulate or remove charge from the floating gate via the tunnelling
oxide. Excess charges are supplied and removed via the source and drain termi-
nals [173].
 Hot-carrier injection
In hot-carrier injections, charge carriers are accumulated within the floating gate
by attracting excited charge carriers toward the control gate. If the charge
carriers are sufficiently energised, there is a chance of the charge carrier tunnelling
through the tunnelling oxide[174].
 Annealing
FG-MOSFETs can be annealed through applying temperature or, more com-
monly, with ultraviolet light. This process imparts energy to charge carriers
isolated within the floating gate structure. If these charge carriers exceed an
energy threshold the annealing process will enable conduction through the tun-
nelling oxide[175].
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Figure 6.1: a) Diagram of the FG-MOSFET structure and visual representation of
the Fowler-Nordheim tunnelling effect used to b) deposit and c) remove
charge from the floating gate structure.
Typically a write operation will cause degradation to the gate oxide as such there
is a limit to the number of write operations possible in the lifetime of the device.
Read operations do not cause significant damage and can be performed ad infinitum.
Fowler-Nordheim tunnelling is the least damaging methodology to adjust floating gate
charges followed by UV annealing and as such these are more commonly used in
dosimetric applications.For further reference, the roles of Fowler-Nordheim tunnelling,
annealing and hot-carrier injection in FG-MOSFET dosimetry applications are dis-
cussed comprehensively in publications by Peters et. al., Martin et.al. and McNulty
et.al. respectively[173 - 175]
An FG-MOSFET based dosimeter functions similarly to a standard MOSFET
dosimetry solution; charge accumulates within the gate oxide due to ionisation events
from incident radiation, the charges are trapped within the gate oxide and contribute
to the conduction characteristics of the device. FG-MOSFETs enable two distinct
advantages over traditional MOSFET devices in that an FG-MOSFET is able to ac-
cumulate charges within the isolated floating gate structure and that the charge on
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the floating gate structure can be manipulated using the above methods. This means
a FG-MOSFET is resettable and reusable to a greater and much more accessible ex-
tent than traditional MOSFET dosimetry solutions. The FG-MOSFET, by design, is
a highly stable and customisable device. In the absence of stimulation, the isolated
floating gate retains net charge indefinitely. This functional stability has resulted in
widespread use of FG-MOSFETs in EPROM/EEPROM flash memory applications.
Through adjusting the design of the gate geometry, fabrication process, size and bi-
asing voltage, the FG-MOSFET sensitivity, linearity and noise characteristics can be
customised for specific applications.
6.2 FG-MOSFET Characterisation methodologies
This chapter will focus on characterising several prospective Application-specific in-
tegrated circuit (ASIC) designs each featuring unique FG-MOSFET active sensitive
volumes. A total of 12 devices underwent the characterisation and these ASICS have
been designated in the format ASIC###.The specifics of each design are beyond the
scope of this research thesis. The characterisation was performed to assess the follow-
ing performance metrics:
1. Temperature dependence of FG-MOSFET readout
2. FG-MOSFET Output Stability at thermostable ambient temperature
3. FG-MOSFET response to radiotherapeutic γ irradiation
4. FG-MOSFET response to diagnostic x-ray irradiation
5. FG-MOSFET reproducibility and desensitisation effects
During irradiation, the dosimeters were socketed into a National Instruments daugh-
terboard. Threshold voltage and readout was performed using proprietary software
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developed in Lab View (https : //www.ni.com/en− au/shop/labview.html). An al-
ternative configuration featuring wireless readout was also available, however, the
daughterboard configuration was intentionally used for all tests to provide best re-
sults. Ambient temperature was monitored at all times via four on-daughterboard
temperature sensors. Before and after each experiment the FG-MOSFETs were pre-
charged to produce a threshold voltage of 1.300 V.
6.2.1 FG-MOSFET Characterisation: Output Stability and
Temperature Dependence
The output stability and temperature dependence of the FG-MOSFET devices were
assessed over long acquisition periods in the absence of ionising stimulus. The mea-
surement was performed over a 24-hour period. At commencement of the monitoring
period, threshold voltage was initialised at 1.300 V. During the monitoring period,
threshold voltage was sampled once every two seconds. Ambient temperature was
recorded using the on-board temperature sensors which was used to establish the in-
fluence of temperature on dosimeter readout. Readout stability was assessed over a
1-hour monitoring period at a thermostable ambient temperature. Readout stability
was by assessed by measuring the variance of the readout from average readout value.
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6.2.2 FG-MOSFET Characterisation: Mega-Voltage range
Gamma Characterisation
The FG-MOSFETs were irradiated using the clinical 6 MV Varian Truebeam Linear
Accelerator commissioned at the Illawarra Cancer Care Centre used in Chapter 2.
Ten of the FG-MOSFETs were positioned on the patient couch within a Solidwater
slab phantom. This phantom was composed of several 30 Ö 30 cm2 Solidwater plates
arranged to provide a 10 cm thickness build-up layer and a 20 cm thickness backscatter
layer. A 20 Ö 20 cm2 irradiation field was selected to ensure all dosimeters were within
the irradiation field. The phantom configuration has been represented graphically in
Figure 6.2a.
The FG-MOSFETs were irradiated over the course of four 35-minute cycles. These
cycles consisted of three 10-minute irradiation periods with five minutes of rest allo-
cated before and after each irradiation. Each irradiation delivered a dose of 10 Gy
to the FG-MOSFETs at a rate of 2 Gy per minute. At the end of each cycle, the
FG-MOSFETS had been exposed to a total dose of 30 Gy. This irradiation cycle was
performed four times and as such a total cumulative dose of 120 Gy was delivered to
the FG-MOSFETs. At the start of each cycle, the FG-MOSFETs were reinitialised at
a threshold voltage of 1.300 volts. Readout operations were performed every second
continuously throughout each cycle. Output stability was assessed before and after
each irradiation to assess stability and identify potential dose fading effects. Sensitivity
of the FG-MOSFETs was assessed by averaging readout values within 6-second inter-
val blocks. Sensitivity was monitored for any potential desensitisation caused by oxide
degradation or charge trap saturation effects. The results were compared directly to
the MOSkin sensitivity results reported in Chapter 2 from a similar characterisation
methodology.
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Figure 6.2: Irradiation apparatus for irradiating the FG-MOSFET using a) a 6 MV
linear accelerator and b) an angiographic c-arm system (dose verified
with MOSkin)
6.2.3 FG-MOSFET Characterisation: Kilovoltage Range
X-ray Characterisation
The FG-MOSFETs were irradiated using a Philips Allura Clarity angiographic c-arm
system commissioned at Southern Heart Clinic. Ten FG-MOSFETs were positioned
on a daughterboard fixed centrally beneath a 30 Ö 30 Ö 30 cm3 Perspex slab phantom.
The c-arm x-ray tube and couch were positioned to align the center of the phantom to
the c-arm system’s rotational isocenter. X-ray tube parameters including x-ray tube
voltage, x-ray tube current and fluoroscopic pulse width were selected automatically
by the c-arm system and, as such, the phantom EPT was adjusted throughout the
measurements to produce a range of irradiation conditions. Phantom EPT was reduced
in 2 cm increments for the 30 to 18 cm EPT range and was reduced in 4 cm increments
for the 18 10 cm range. The irradiations were repeated using three different imaging
protocols, ‘Low’, ‘Normal’ and ‘Boost’. These protocols affected the x-ray tube voltage,
x-ray tube current, pulse width and filtration selected the c-arm x-ray tube. The most
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consistent impact of changing protocol was the beam filtration utilised: ‘Low’ protocol
using 5 mmAl filtration, the ‘Normal’ protocol using 2 mmAl filtration and the ‘Boost’
protocol using 0 mmAl filtration. The c-arm system was positioned at the posterior-
anterior angle for all phantom configurations. An FOV of 25 cm DFS was selected to
ensure all FG-MOSFETs were irradiated uniformly. All irradiations were performed
in cine-acquisition mode at an imaging frame rate of 15 FPS. The FG-MOSFETs were
irradiated for a minimum of 30 seconds per phantom configuration. Irradiation was
continued after the 30 second period for low dose exposures until a minimum air Kerma
at reference point (as estimated by the c-arm system) of 50 mGy was achieved. This
ensured better statistics for the dosimeter. Dose delivered to the FG-MOSFET devices
was verified using the MOSkin dosimeter using calibration data reported in Section
2.3.4. Irradiation time was calculated by dividing the number of cine-acquisition
frames by the imaging frame rate. The MOSkin was positioned centrally to the FG-
MOSFET daughter board during the irradiations.
6.3 Results of the FG-MOSFET Characterisation
6.3.1 Output Stability and Temperature Dependence
The FG-MOSFET readout and ambient temperature over the 24-hour monitoring
period has been presented graphically in Figure 6.3. In this figure, the FG-MOSFET
outputs have been each been offset by 5 mV to clearly represent the variation in
each device. A relationship between ambient temperature and FG-MOSFET readout
was observed through comparing the maximum and minimum values for each quantity.
The 1-hour stability monitoring period has been presented in Figure 6.4. During this
1-hour period, temperature was measured constant at 22.65 C°. The 95% confidence
interval has been denoted using dashed lines.
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Figure 6.3: a) FG-MOSFET readout stability over 24-hour period and b) the ambi-
ent temperature as measured by onboard resistors
Figure 6.4: FG-MOSFET readout stability over 1-hour period at constant tempera-
ture (T=22.7C°)
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6.3.2 Megavoltage Range Gamma-ray Sensitivity
The increase in FG-MOSFET threshold voltage with increasing dose deposition to the
device from the 6MV linear accelerator has been presented graphically in Figure 6.5.
It should be noted that the FG-MOSFETs were reinitialised to a threshold volatage of
1.3 V on finalisation of each 30 Gy cycle, a milestone marked by a partitioning line in
figure. The FG-MOSFET sensitivity from the real-time data is presented graphically
in Figure 6.6. FG-MOSFET sensitivity was also calculated in terms of each 10 Gy
irradiation step. This interpretation of the results is presented in Table 4.1.Similar to
the MOSkin, a linear trend was observed between desensitisation and FG-MOSFET
threshold voltage. This linear trend has been presented graphically in Figure 6.7 us-
ing data from irradiation cycles 3 and 4. FG-MOSFET desensitisation with increasing
charge accumulation was calculated to be 22.99 mV per volt of increasing threshold
voltage. Regression analysis of this trend yielded and R-squared value of 0.81.
Figure 6.5: Accumulated FG-MOSFET response to 6MV linear accelerator beam
quality (Threshold Voltage reset at 30, 60 and 90 Gy)
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Figure 6.6: FG-MOSFET sensitivity to 6MV linear accelerator beam quality with
respect to accumulated dose delivered
Figure 6.7: FG-MOSFET sensitivity to 6MV linear accelerator beam quality with
respect to threshold voltage before irradiation
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6.3.3 Kilovoltage Range X-ray Sensitivity
The FG-MOSFET response to diagnostic range x-ray beam qualities has been pre-
sented in Figure 6.8. The FG-MOSFET sensitivity was calculated by measuring the
change in FG-MOSFET threshold voltage over each minute-long irradiation and di-
viding by dose delivered as measured by the MOSkin dosimeter. The FG-MOSFET
has been presented with respect to peak beam energy as reported by the c-arm system
for each phantom configuration.
Figure 6.8: FG-MOSFET energy dependence with respect to clinical diagnostic x-
ray beam qualities
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6.4 Discussion of FG-MOSFET Performance
The FG-MOSFET performance was acceptable for dosimetric applications. The results
produced during this prospective study cover three distinct discussion points: Output
stability, radiation sensitivity and lifetime.
6.4.1 FG-MOSFET Output Stability
The FG-MOSFET was observed to retain threshold value over the 1-hr thermostable
monitoring period. The maximum deviation from average was observed at 630 µV
above the average value and a 95% confidence intervals was established at ±310 µV
from average value. Over the extended monitoring period the FG-MOSFET did vary
more significantly. Threshold voltage varied in a range of∼ 12 - 25 mV over the 24-hour
monitoring period. This corresponded closely with changes in the ambient temper-
ature, as shown in Figure 6.3b. From this data, a temperature shift in threshold
voltage of ∼2 - 4 mV/°C was established. As this correlation was consistent through-
out the 24-hour monitoring period, this data may in future be used to develop a
temperature correction method to compensate for this effect.hod.
6.4.2 FG-MOSFET Sensitivity
On irradiation the following average FG-MOSFET sensitivities were observed:
 γ-ray (E6 MV): 73 mV/Gy.
 X-ray (E65-100 kVp): 300 - 600 mV/Gy.
The FG-MOSFET response during kilovoltage x-ray irradiation resulted in minimal
energy dependence observed in the 70-100 kVp range of filtered beam qualities. Low
energy photons appeared to produce higher FG-MOSFET responses and as such low
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energy photon sensitivity should definitely be explored further, potentially with the
Narrow Spectrum Series and RQR beam qualities used to characterise the MOSkin
dosimeter in Chapter 2
The most comprehensive display of the FG-MOSFET capabilities was the gamma.
Initial sensitivity @ VTh = 1.300 V in Irradiation Cycle 1 was observed to be 75.1
mV/Gy as averaged over all devices over the initial 10 Gy irradiation period. Sensi-
tivity compared well to the lower limit literature reported sensitivity values. Peters
et.al. observed their FG-MOSFET designs were capable of sensitivities between 80-280
mV/Gy 173. Peters et.al. also suggested that sensitivity in the higher region of this
range was constrained by collection efficiency of FG-MOSFET devices. Live readout of
the FG-MOSFET was possible and accumulative dose delivery is presented in Figure
6.7.
6.4.3 FG-MOSFET Desensitisation
The following observations regarding the FG-MOSFET mega-voltage gamma-ray sen-
sitivity were noted:
 FG-MOSFET sensitivity decreased with increasing cumulative dose delivered to
the devices. Over each 30 Gy irradiation cycle this drop in sensitivity averaged
to ∼36.6% of the response recorded @ VTh = 1.300 V.
 FG-MOSFET sensitivity was mostly restored on reinitialising the FG-MOSFET
to VTh = 1.300 V. FG-MOSFET sensitivity did decrease during each subsequent
irradiation cycle with Irradiation Cycle 2, 3 and 4 observing initial sensitivities
5.6%, 10.5% and 10.6% lower than Irradiation Cycle 1 initial sensitivities respec-
tively.
 There was significantly less impact on sensitivity when reinitialising the FG-
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MOSFETs for Irradiation Cycle 4, suggesting that this desensitisation effect
could reach saturation and as such a pre-irradiation of ∼100 Gy may improve
reproducibility of the FG-MOSFET on subsequent reinitialisation.
 FG-MOSFET sensitivity was observed to reduce linearly with per volt increase
in threshold voltage at a rate of 22.99 mV/V. This conclusion was made from
data collected during Irradiation Cycles 3 and 4 to minimise the impact of de-
sensitisation effects.
 Readout stability was greater in the threshold voltage range of 1.500 V to 2.500
V.
The results suggest that desensitisation could potentially be minimised by per-
forming pre-irradiation to 100 Gy cumulative dose, that dose reporting accuracy could
be increased by implementing sensitivity correction based on threshold voltage and
reinitialising the FG-MOSFET after exposure to minimise variations in sensitivity.
FG-MOSFET MOSkin
Initialisation VTh 1.3 V ∼9 V
Useful Lifetime > 2.2 V ∼20 V
(per initialisation) 30 Gy 50 Gy
Initial γ Sensitivity 75.1 mV/Gy 285.3 mV/Gy
Sensitivity Reduction Rate 0.94%/Gy 0.334%/Gy
Single or Multiple Use Multiple Use Single Use
Table 6.2: Comparison of FG-MOSFET characteristics to MOSkin Dosimeter
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6.5 FG-MOSFET Conclusions
The FG-MOSFETs were observed to effectively measure exposures produced from
both megavoltage therapeutic range and kV diagnostic range x-ray sources. The FG-
MOSFETs were observed to produce stable threshold voltage responses to within 400
µV of the average value as measured over an hour period at static ambient temper-
ature conditions. The FG-MOSFET threshold voltages were observed to be affected
by temperature at a rate of 2 - 4 mV/°C depending on chip design. As such it is
advised to operate the chip in static ambient temperature conditions and at a time
after initialising readout to ensure that variations in response due to temperature are
avoided. Future readout software could incorporate readout from onboard temperature
monitors similar to the ones used during these experiments to compensate for tem-
perature effects. Some ASICs produced anomalous responses during measurements.
These anomalies were considered outside the scope of this report and can be discussed
in a separate meeting but may indicate refinement of the chip design or production is
necessary going forward.
The FG-MOSFETs exhibited reduced observed lifetime (30 Gy vs 50 Gy), reduced
radiation sensitivity (∼25% - 35%) and increased rates of desensitisation (∼1%/Gy vs
0.33%/Gy) when compared to the MOSkin dosimeter, however, the FG-MOSFET can
be reinitialised to the initial threshold voltage multiple times. This expands the life-
time of the FG-MOSFET significantly enabling the FG-MOSFET to easily eclipse the
MOSkin lifetime. On reinitialisation there was some initial desensitisation observed,
however, on irradiating to a threshold of 100 Gy, desensitisation on reinitialisation was
insignificant and FG-MOSFET results were reproducible to within 5% on subsequent
reinitialisation. Further testing is required to confirm this effect is permanent. Desen-
sitisation of the FG-MOSFET was significantly (3x) higher than on standard MOSkin
devices, however, this desensitisation was observed to correlate linearly with threshold
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voltage at time of readout and is therefore predictable and can be compensated for
in readout software. For high dose applications, such as multifractionate radiotherapy
regimes, it is suggested that the FG-MOSFET is reinitialised regularly for maximum
consistency and efficacy.
Kilovoltage range calibration of the FG-MOSFET indicate that the FG-MOSFET
can measure 4 mGy per mV of threshold voltage. This low sensitivity may mean the
current FG-MOSFET is unsuitable for low and very low dose diagnostic applications.
The device may however be suitable for high dose diagnostic applications such as
CT and angiography. The FG-MOSFET was observed to exhibit energy dependence
at x-ray tube voltages lower than ∼80 kVp. Sensitivity of the FG-MOSFET was
observed to increase at these low voltage tube settings at a steeper rate than the
traditional MOSkin dosimeters. The number of measurements/phantom and x-ray
tube configurations utilised enabled a preliminary characterisation of the FG-MOSFET
devices. This data could be used in future modelling of FG-MOSFET behaviour and
could be used to compared to standardised beam qualities similar to how diagnostic
data was utilised in Chapter 2.
Chapter 7
Conclusions and the Future of
Diagnostic Dosimetry Solutions
In 2017, Rivera and Uruchurtu identified radiation monitoring for patients in interven-
tional cardiology procedures as a requirement for the field going forward, stating that
“radiation exposure is a significant concern for interventional cardiologists and patients
due to the increasing workloads and the complexity of procedures”[176]. Until now, all
dosimetry solutions have had limitations. Passive dosimetry solutions do not provide
real-time feedback and as such cannot identify or prevent accidental exposures. Active
personal dosimeters have poor response to low energy x-ray spectrum which prevents
the APD from being an effective quantitative exposure tool[80, 121]. Dose contouring
software solutions currently estimate dose to a reference point rather than report on
a measured dose value which can result in significant inaccuracies [149]. Traditional
MOSFET dosimeters are visible in radiographs, are temperature dependent and often
involve a non-reproducible packaging solution[82. The MOSkin dosimeter does not
experience these functional limitations and as such is the ideal interventional patient
dosimetry solution.
Throughout this thesis, MOSkin based technologies have proven to be the ideal
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solution to diagnostic dosimetry requirements and can be used either as. By design,
the MOSkin measures in real-time at a native 0.07 mm depth without being acquired
in images or producing significant perturbation of the x-ray field. This thesis has
comprehensively characterised the device for the kilovoltage range in Chapter 2, has
been clinically implemented as an aid for developing dose minimisation strategies in
Chapter 3 and has been used to effectively compare c-arm systems in Chapter 4.
During the Chapter 5 operator dose study it was observed that the sensitivity of
the MOSkin dosimeter was too low to effectively measure operator dose in real-time,
however, the requirements of an operator specific dosimetry solution were identified
and these requirements can be used during future development of prospective opera-
tor dosimetry solutions such as the FG-MOSFET technology that was prospectively
assessed in Chapter 6.
The true value of the MOSkin dosimeter in the catheterisation laboratory was
realised through the clinical applications of the dosimeter firstly as a tool to produce
dose minimisation strategies and secondly to compare imaging equipment between
catheterisation laboratories. In the context of dose minimisation, the MOSkin was used
to identify the impact of adjusting imaging and irradiation configurations in Chapter
3. It was observed that these factors significantly affect ESD and DAP delivery,
that the distinction between these parameters is not always clear or understood both
clinically and within the literature and that the estimated air Kerma and DAP values
may not even accurately represent the exposure the patient experiences. Future work
could easily result in an array type MOSkin dosimetry system that simultaneously
measures instantaneous entrance skin doses and dose area product delivery during
clinical cases or further phantom studies. Furthermore, such a system could be used
complementarily with dose contouring software packages to improve the accuracy of
these systems. Alternatively, in Chapter 4, the MOSkin was used in conjunction with
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existing protocols to assess c-arm system performance. The methodology requires
further refinement to be deployed on a larger scale, however, the potential for this
method to aid commercial decisions and spur research into improving the irradiation
apparatus could revolutionise the industry.
In conclusion, this research thesis has provided a foundation for using the MOSkin
dosimeter as a diagnostic dosimetry tool. This technology has great potential within
clinical catheterisation laboratories. Future research will broaden that potential with







A.0.1 Overview of the Clarity Upgrade: Acquisition Mode
The Philips c-arm system assessment results for acquisition mode have been presented
in both graphical and tabular formats. All acquisition mode results have been collated
into the graphic seen in Figure A.1. In this graph, the ESD delivery to the phantom
has been normalised to the ‘Cardiac Low’ ESD delivery value. In subsequent sections,
comparable pre-upgrade and post-upgrade protocols have been paired and compared
directly. Figure A.2 to Figure A.4 and Table A.1 to Table A.3 present these
individual pairings using the ‘Score Ratio’ method described in Equation 4.2. Tables
are labelled in the format ‘Protocol B’ : ‘Protocol A’.
Figure A.1: ESD delivery and image quality scores produced by the Philips Allura
Xper and Philips Allura Clarity c-arm systems in acquisition mode using
the a) 30 cm EPT, 15 cm FOV DFS configuration, b) 30 cm EPT, 20
cm DFS configuration c) 20 cm EPT, 15 cm DFS configuration and the
d) 20 cm EPT, 20 cm DFS configuration
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A.0.2 Comparison of the high detail acquisition mode
protocols: ‘Clarity Boost’ and ‘Cardiac 4’
The ratio of ESD delivery and image quality scores recorded for the ‘Clarity Boost’
and ‘Cardiac 4’ acquisition mode protocols have been presented graphically in Figure
A.2 and tabularly in Table A.1. The following comparative statements can be drawn
regarding these two protocols:
 ESD delivery was lower when using the ‘Clarity Boost’ protocol by an average
of 19.3%.
 ICR scores were higher when using the ‘Clarity Boost’ protocol by an average of
10.3% when imaging the 20 cm EPT configurations and higher when using the
‘Clarity Boost’ protocol by an average of 57.4% when imaging the 30 cm EPT
configurations.
 Spatial resolution scores were higher when using the ‘Clarity Boost’ protocol by
an average of 25.9%.
 Total WTR scores were lower when using the ‘Clarity Boost’ protocol by an
average 24.3% with exception to the 30 cm EPT, 20 cm DFS configuration in
which the ‘Clarity Boost’ scored higher than the ‘Cardiac 4’ protocol by 4.2%.
 Static MTR scores were lower when using the ‘Clarity Boost’ protocol by an
average 3.4% with exception to the 20 cm EPT, 15 cm DFS configuration where
both protocols scored comparably.
 Dynamic MTR scores were lower when using the ‘Clarity Boost’ protocol by an
average 4.1% with exception to the 20 cm EPT, 20 cm DFS configuration where
both protocols scored comparably.
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Figure A.2: Ratios of the dose delivery and image quality scores recorded when using
the ‘Cardiac 4’ and ‘Clarity Boost’ acquisition mode protocols for all
phantom and imaging configurations
Acquisition Mode












0.880 1.045 1.174 0.690 1 0.959
EPT: 20 cm
DFS: 20 cm
0.905 1.161 1.362 0.596 0.979 1
EPT: 30 cm
DFS: 15 cm
0.908 1.536 1.272 0.986 0.974 0.973
EPT: 30 cm
DFS: 15 cm
0.536 1.612 1.228 1.042 0.946 0.946
Table A.1: Ratios of the dose delivery and image quality scores recorded when using
the ‘Cardiac 4’ and ‘Clarity Boost’ acquisition mode protocols for all
phantom and imaging configurations
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A.0.3 Comparison of the high detail acquisition mode
protocols: ‘Clarity Normal’ and ‘Cardiac 4’
The ratio of ESD delivery and image quality scores recorded for the ‘Clarity Normal’
and ‘Cardiac 4’ acquisition mode protocols have been presented graphically in Figure
A.3 and tabularly in Table A.2. The following comparative statements can be drawn
regarding these two protocols:
 ESD delivery was lower when using the ‘Clarity Normal’ protocol by an average
of 54.3%.
 ICR scores were higher when using the ‘Clarity Normal’ protocol by an average
of 22.3% with exception to the 15 cm EPT, 15 cm DFS configuration in which
the ‘Clarity Normal’ protocol scored lower than the ‘Cardiac 4’ protocol score
by 1.7%.
 Spatial resolution scores were higher when using the ‘Clarity Normal’ protocol
by an average of 23.7%.
 Total WTR scores were lower when using the ‘Clarity Normal’ protocol to image
the 20 cm EPT configurations by an average of 40.9% and were lower when
using the ‘Clarity Normal’ protocol to image the 30 cm EPT configurations by
an average of 3.5%.
 Static MTR scores were comparable between protocols with exception to the
30 cm EPT, 15 cm DFS configurations in which the ‘Clarity Normal’ protocol
scored lower than the ‘Clarity Normal’ protocol by 2.6%.
 Dynamic MTR scores were lower when using the ‘Clarity Normal’ protocol by
an average of 5.3%.
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Figure A.3: Ratios of the dose delivery and image quality scores recorded when using
the ‘Clarity Normal’ and ‘Cardiac 4’ acquisition mode protocols for all
phantom and imaging configurations
Acquisition Mode












0.373 0.983 1.153 0.638 1 0.918
EPT: 20 cm
DFS: 20 cm
0.516 1.095 1.373 0.544 1 0.979
EPT: 30 cm
DFS: 15 cm
0.456 1.268 1.233 0.986 0.974 0.946
EPT: 30 cm
DFS: 15 cm
0.485 1.306 1.187 0.944 1 0.946
Table A.2: Ratios of the dose delivery and image quality scores recorded when using
the ‘Clarity Normal’ and ‘Cardiac 4’ acquisition mode protocols for all
phantom and imaging configurations
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A.0.4 Comparison of low dose acquisition mode protocols:
‘Cardiac Low’ and ‘Clarity Low’
The ratio of ESD delivery and image quality scores recorded for the ‘Clarity Low’ and
‘Cardiac Low’ acquisition mode protocols have been presented graphically in Figure
A.4 and tabularly in Table A.3. The following comparative statements can be drawn
regarding these two protocols:
 ESD delivery was lower when using the ‘Clarity Low’ protocol to image the 20
cm EPT configurations by an average of 3.7% and higher when using the ‘Clarity
Low’ protocol to image the 30 cm EPT configurations by an average of 5.7%.
 ICR scores were higher when using the ‘Clarity Low’ protocol by an average of
27.5%.
 Spatial resolution scores were higher when using the ‘Clarity Low’ protocol by
an average of 19.8%.
 Total WTR scores were lower when using the ‘Clarity Low’ protocol by an aver-
age 6.8% with exception to the 30 cm EPT, 15 cm DFS configuration in which
the ‘Cardiac Low’ protocol scored higher than the ‘Cardiac Low’ protocol scores
by 3.8%.
 Static MTR scores were lower when using the ‘Clarity Low’ protocol by an
average of 6.4% with exception to the 30 cm EPT, 15 cm DFS configuration in
which the ‘Clarity Low’ protocol scored higher than the ‘Cardiac Low’ protocol
scores by 10%.
 Dynamic MTR scores were lower when using the ‘Clarity Low’ protocol to image
the 20 cm EPT configurations by an average of 3.2% and was comparable between
protocols when imaging the 30 cm EPT configurations.
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Figure A.4: Ratios of the dose delivery and image quality scores recorded when using
the ‘Clarity Normal’ and ‘Cardiac 4’ acquisition mode protocols for all
phantom and imaging configurations
Acquisition Mode












0.971 1.030 1.13 0.923 0.979 0.958
EPT: 20 cm
DFS: 20 cm
1.028 1.587 1.379 0.884 0.959 0.978
EPT: 30 cm
DFS: 15 cm
0.956 1.231 1.139 1.038 1.1 1
EPT: 30 cm
DFS: 15 cm
1.085 1.25 1.145 0.988 0.871 1
Table A.3: Ratios of the dose delivery and image quality scores recorded when using
the ‘Clarity Low’ and ‘Cardiac Low’ acquisition mode protocols for all
phantom and imaging configurations
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A.0.5 Overview of the Clarity Upgrade: Fluoroscopy mode
protocols
The fluoroscopy mode results of the ‘Clarity’ upgrade assessment have been presented
graphically and in tabular form. An overview of the acquisition mode results has
been provided in Figure A.5. In this graph the ESD values recorded by the MOSkin
were normalised to the ‘Cardiac Low’ fluoroscopy mode dose level 1 values for each
respective EPT/FOV configuration. Figure A.6 to Figure A.9 and Table A.4 to
Table A.7 represent each individual pairing of low dose and high detail protocols in
further detail using the ‘Score Ratio’ method described in Equation 4.2. Tables are
labelled in the format ‘Protocol B’ : ‘Protocol A’.
Figure A.5: Dose delivery and image quality scores produced by the Philips Allura
Xper and Philips Allura Clarity c-arm systems in fluoroscopy modes
1 and 2 using the a) 30 cm phantom configuration and 15 cm DFS
setting, b) 30 cm phantom configuration and 20 cm DFS setting c) 20
cm phantom configuration and 15 cm DFS setting and the d) 20 cm
phantom configuration and 20 cm DFS setting
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A.0.6 Comparison of the fluoroscopy mode dose level 1
protocols: ‘Clarity’ and ‘Cardiac 4’
The ratio of ESD delivery and image quality scores recorded for the ‘Clarity’ and
‘Cardiac 4’ fluoroscopy mode dose level 1 protocols have been presented graphically in
Figure A.6 and tabularly in Table A.4. The following comparative statements can
be drawn regarding these two protocols:
 ESD delivery was lower when using the ‘Clarity’ protocol by an average of 36%.
 ICR scores were lower when using the ‘Clarity’ protocol by an average of 82.8%
with exception to the 30 cm EPT, 20 cm DFS configuration where both protocols
scored comparably.
 Spatial resolution scores were lower when using the ‘Clarity’ protocol by an
average of 17.5% with exception to the 20 cm EPT, 20 cm DFS configuration in
which the ‘Clarity’ protocol scored higher than the ‘Cardiac 4’ protocol by 0.4%.
 Total WTR scores were lower when using the ‘Clarity’ protocol by an average of
9.1%.
 Static MTR scores were higher when using the ‘Clarity’ protocol by an average
of 25.1%
 Dynamic MTR scores were higher when using the ‘Clarity’ protocol by an average
of 23.8%.
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Figure A.6: Ratios of the dose delivery and image quality scores recorded when using
the ‘Clarity’ and ‘Cardiac 4’ fluoroscopy mode protocols in the dose level














0.725 0.132 0.993 0.953 0.829 0.800
EPT: 20 cm
DFS: 20 cm
0.655 0.163 1.004 0.867 0.733 0.705
EPT: 30 cm
DFS: 15 cm
0.553 0.222 0.667 0.909 0.857 0.600
EPT: 30 cm
DFS: 15 cm
0.627 1 0.814 0.907 0.579 0.944
Table A.4: Ratios of the dose delivery and image quality scores recorded when using
the ‘Clarity’ and ‘Cardiac 4’ fluoroscopy mode protocols in the dose level
1 setting for all phantom and imaging configurations
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A.0.7 Comparison of the fluoroscopy mode dose level 2
protocols: The ‘Clarity’ and ‘Cardiac 4’ protocols
The ratio of ESD delivery and image quality scores recorded for the ‘Clarity’ and
‘Cardiac 4’ fluoroscopy mode dose level 2 protocols have been presented graphically in
Figure A.7 and tabularly in Table A.5. The following comparative statements can
be drawn regarding these two protocols:
 ESD delivery was higher when using the ‘Clarity’ protocol to image the 20 cm
EPT configurations by an average of 55.4% and lower when using the ‘Clarity’
protocol to image the 30 cm EPT configurations by an average of 48.3%.
 ICR scores were lower when using the ‘Clarity’ protocol by an average of 45%
with exception to the 20 cm EPT, 20 cm DFS configuration in which the ‘Clarity’
protocol scored higher than the ‘Cardiac 4’ protocol by 350%.
 Spatial resolution scores were higher when using the ‘Clarity’ protocol to image
the 20 cm EPT configurations by an average of 9.5% and were lower when using
the ‘Clarity Low’ protocol to image the 30 cm EPT configurations by an average
of 14.7%.
221
 Total WTR scores were higher when using the ‘Clarity’ protocol by an average
of 5.5% with exception to the 20 cm EPT, 15 cm DFS configuration in which
the ‘Clarity’ protocol scored lower than the ‘Cardiac 4’ protocol by 6.9%.
 Static MTR scores were lower when using the ‘Clarity’ protocol by an average
of 28.2% with exception to the 20 cm EPT, 20 cm DFS configuration in which
the ‘Clarity’ protocol scored higher than the ‘Cardiac 4’ protocol by 9.1%.
 Dynamic MTR scores were lower when using the ‘Clarity’ protocol by an average
of 29.3% with exception to the 20 cm EPT, 20 cm DFS configuration in which
the ‘Clarity’ protocol scored higher than the ‘Cardiac 4’ protocol by 6.5%.
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Figure A.7: Ratios of the dose delivery and image quality scores recorded when using
the ‘Clarity’ and ‘Cardiac 4’ fluoroscopy mode protocols in the dose level
2 setting for all phantom and imaging configurations
Fluoroscopy Mode 2











1.271 0.583 1.073 0.931 0.787 0.773
EPT: 20 cm
DFS: 20 cm
1.837 4.500 1.117 1.026 1.091 1.065
EPT: 30 cm
DFS: 15 cm
0.496 0.400 0.830 1.094 0.640 0.667
EPT: 30 cm
DFS: 20 cm
0.539 0.667 0.877 1.046 0.727 0.680
Table A.5: Ratios of the dose delivery and image quality scores recorded when using
the ‘Clarity’ and ‘Cardiac 4’ fluoroscopy mode protocols in the dose level
2 setting for all phantom and imaging configurations
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A.0.8 Comparison of the fluoroscopy mode dose level 1
protocols: The ‘Clarity’ and ‘Cardiac Low’ protocols
The ratio of ESD delivery and image quality scores recorded for the ‘Clarity’ and
‘Cardiac Low’ fluoroscopy mode dose level 1 protocols have been presented graphically
in Figure A.8 and tabularly in Table A.6. The following comparative statements
can be drawn regarding these two protocols:
 ESD delivery was higher when using the ‘Clarity’ protocol to image the 20 cm
EPT configurations by an average of 309.4%, was lower when using the ‘Clarity’
protocol to image the 30 cm EPT, 15 cm DFS configuration by 10.2% and was
higher when using the ‘Clarity’ protocol to image the 30 cm EPT, 20 cm DFS
configuration by 30.3%.
 ICR scores were lower when using the ‘Clarity’ protocol to image the 20 cm EPT,
15 cm DFS and 30 cm EPT, 20 cm DFS configurations by an average of 68.4%,
and were higher when using the ‘Clarity’ protocol to image the 20 cm EPT, 20
cm DFS and 30 cm EPT, 15 cm DFS configurations by an average of 116.7%.
 Spatial resolution scores were higher when using the ‘Clarity’ protocol to image
the 20 cm EPT configurations by an average of 15.9% and lower when using
the ‘Clarity’ protocol to image the 30 cm EPT configurations by an average of
18.9%.
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 Total WTR scores were lower when using the ‘Clarity’ protocol by an average of
3.9% with exception to the 30 cm EPT, 20 cm DFS configuration in which the
‘Clarity’ protocol scored higher than the ‘Cardiac 4’ protocol by 16.6%.
 Static MTR scores were higher when using the ‘Clarity’ protocol to image the
20 cm EPT configurations by an average 22.1% and were lower when using the
‘Clarity’ protocol to image the 30 cm EPT configurations by an average of 17.7%.
 Dynamic MTR scores were higher when using the ‘Clarity’ protocol by an average
of 18.6% with exception to the 30 cm EPT, 15 cm DFS configuration in which
the ‘Clarity’ protocol scored higher than the ‘Cardiac 4’ protocol by 35.7%.
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Figure A.8: Ratios of the dose delivery and image quality scores recorded when using
the ‘Clarity’ and ‘Cardiac 4’ fluoroscopy mode protocols in the dose level
1 setting for all phantom and imaging configurations
Fluoroscopy Mode 1











3.403 0.333 1.141 0.962 1.172 1.143
EPT: 20 cm
DFS: 20 cm
4.784 2.333 1.177 0.990 1.269 1.107
EPT: 30 cm
DFS: 15 cm
0.898 2 0.749 0.930 0.800 0.643
EPT: 30 cm
DFS: 20 cm
1.303 0.300 0.874 1.166 0.846 1.308
Table A.6: Ratios of the dose delivery and image quality scores recorded when using
the ‘Clarity’ and ‘Cardiac Low’ fluoroscopy mode protocols in the dose
level 1 setting for all phantom and imaging configurations
226
A.0.9 Comparison of the low fluoroscopy mode dose level 2
protocols: The ‘Clarity’ and ‘Cardiac Low’ protocols
The ratio of ESD delivery and image quality scores recorded for the ‘Clarity’ and
‘Cardiac Low’ fluoroscopy mode dose level 2 protocols have been presented graphically
in Figure A.9 and tabularly in Table A.7. The following comparative statements
can be drawn regarding these two protocols:
 ESD delivery was higher when using the ‘Clarity’ protocol to image the 20 cm
EPT configurations by an average of 92%, was lower when using the ‘Clarity’
protocol to image the 30 cm EPT, 15 cm DFS configuration by 18.3% and was
higher when using the ‘Clarity’ protocol to image the 30 cm EPT, 20 cm DFS
configuration by 12.7%
 ICR scores were lower when using the ‘Clarity’ protocol by an average of 23.4%
with exception to the 30 cm EPT, 15 cm DFS configuration in which the ‘Clarity’
protocol scored higher than the ‘Cardiac Low’ protocol by 300%.
 Spatial resolution scores were higher when using the ‘Clarity’ protocol to image
the 20 cm EPT configurations by an average of 16.7% and lower when using the
‘Clarity’ protocol to image the 30 cm EPT configurations by an average of 7%.
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 Total WTR scores were higher when using the ‘Clarity’ protocol by an average
of 26.2%.
 Static MTR scores were lower when using the ‘Clarity’ protocol to image the 20
cm EPT, 15 cm DFS configuration by 14%, were higher when using the ‘Clarity’
protocol to image the 20 cm EPT, 20 cm DFS configuration by 5.9% and were
lower when using the ‘Clarity’ protocol to image the 30 cm EPT configurations
by an average of 32.9%.
 Dynamic MTR scores were lower when using the ‘Clarity’ protocol by an average
of 13.1%.
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Figure A.9: Ratios of the dose delivery and image quality scores recorded when using
the ‘Clarity’ and ‘Cardiac Low’ fluoroscopy mode protocols in the dose
level 2 setting for all phantom and imaging configurations
Fluoroscopy Mode 2












1.826 0.767 1.155 1.234 0.86 0.895
EPT: 20 cm
DFS: 20 cm
2.013 0.863 1.178 1.361 1.059 0.971
EPT: 30 cm
DFS: 15 cm
0.817 4 0.9 1.094 0.696 0.762
EPT: 30 cm
DFS: 15 cm
1.127 0.667 0.96 1.358 0.667 0.85
Table A.7: Ratios of the dose delivery and image quality scores recorded when using
the ‘Clarity’ and ‘Cardiac Low’ fluoroscopy mode protocols in the dose
level 2 setting for all phantom and imaging configurations
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B.0.1 Overview of the GE Upgrade Evaluation
The results of the GE c-arm systems have been presented in this appendix in a tabular
format only. The acquisition mode dose level 1 results have been presented in Table
B.1 to Table B.6 while the acquisition mode dose level 2 results have been presented
in Table B.7 and Table B.12. These tables compare the dose and image quality score
results of protocols used on the pre-upgrade Innova 2100IQ c-arm system, the post-
upgrade Innova 21000IQ c-arm system and the post-upgrade IGS 520 c-arm system
commissioned at Eastern Heart Clinic. The fluoroscopy mode dose level 1 results have
been presented in Table B.13 and Table B.17 while the fluoroscopy mode dose level
2 results have been presented in Table B.18 and Table B.20. The fluoroscopy mode
tables compare the dose and image quality score results of protocols used on the pre-
upgrade Innova 2100IQ c-arm system, the post-upgrade Innova 21000IQ c-arm system.





 General imaging modality
 Imaging Dose level
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B.0.2 Comparison of the high detail acquisition mode dose
level 1 protocols: ‘Standard’ and ‘CoroPlus’
The ratio of ESD delivery and image quality scores recorded for the ‘Standard’ and
‘CoroPlus’ acquisition mode dose level 1 protocols have been presented tabularly in
Table B.1. The following comparative statements can be drawn regarding these two
protocols:
 ESD delivery was lower when using the ‘Standard’ protocol by an average of
21.0%.
 ICR scores were higher when using the ‘Standard’ protocol by an average of
11% with exception to the 20 cm EPT, 12 cm OFS configuration in which the
‘Standard’ protocol scored lower than the ‘CoroPlus’ protocol by 10%.
 Spatial resolution scores were lower when using the ‘Standard’ protocol by an
average of 13.3%.
 Total WTR scores were comparable between protocols.
 Static MTR scores were comparable between protocols.
 Dynamic MTR scores were comparable between protocols.
 Image noise was lower when using the ‘Standard’ protocol by an average of
34% when imaging the 20 cm EPT configurations and lower when using the

























































































































































































































































































































































































































































































































































































































B.0.3 Comparison of the low dose rate acquisition mode dose
level 1 protocols: ‘Low’ and ‘RDLS’
The ratio of ESD delivery and image quality scores recorded for the ‘Low’ and ‘RDLS’
acquisition mode dose level 1 protocols have been presented tabularly in Table B.2.
The following comparative statements can be drawn regarding these two protocols:
 ESD delivery was lower when using the ‘Low’ protocol by an average of 6%
with exception to the 30 cm EPT, 12 cm OFS configuration in which the ‘Low’
protocol delivered higher doses than the ‘RDLS’ protocol by 4.5%.
 ICR scores were higher when using the ‘Low’ protocol by an average of 32% when
imaging the 12 cm OFS configurations, were higher when using the ‘Low’ protocol
to image the 20 cm EPT, 15 cm OFS configuration by 7.1% and were comparable
between protocols when imaging the 30 cm EPT, 15 cm OFS configuration.
 Spatial resolution scores were lower when using the ‘Low’ protocol by an average
of 10.6% with exception to the 30 cm EPT, 12 cm OFS configuration where both
protocols scored comparably.
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 Total WTR scores were comparable between protocols with exception to the 20
cm EPT, 12 cm OFS configuration in which the ‘Low’ protocol acquired twice
as many high density WTR targets as the ‘RDLS’ protocol.
 Static MTR scores were comparable between protocols.
 Dynamic MTR scores were higher when using the ‘Low’ protocol to image the
20 cm ETP, 12 cm OFS configuration by 33.3%, were comparable between pro-
tocols when imaging the 20 cm EPT, 15 cm OFS and 30 cm EPT, 12 cm OFS
configurations and were lower when using the ‘Low’ protocol to image the 30 cm
EPT, 15 cm OFS configuration by 33.3%.
 Image noise was lower when using the ‘Low’ protocol by an average of 39.4%
when imaging the 20 cm EPT configurations and lower by an average of 65.4%













































































































































































































































































































































































































































































































































































































































B.0.4 Comparison of the post-upgrade acquisition mode dose
level 1 protocols: ‘Low’ and ‘Standard’
The ratio of ESD delivery and image quality scores recorded for the ‘Low’ and ‘Stan-
dard’ acquisition mode dose level 1 protocols have been presented tabularly in Table
B.3. The following comparative statements can be drawn regarding these two proto-
cols:
 ESD delivery was lower when using the ‘Low’ protocol to image the 20 cm EPT
configurations by an average of 40.6%, was lower when using the ‘Low’ protocol
to image the 30 cm EPT, 12 cm OFS configuration by 4% and was higher when
using the ‘Low’ protocol to image the 30 cm EPT, 15 cm OFS configuration by
2.1%.
 ICR scores were lower when using the ‘Low’ protocol to image the 12 cm OFS
configurations by an average of 8.4% and were lower when using the ‘Low’ pro-
tocol to image the 15 cm OFS configurations by an average of 18.4%.
 Spatial resolution scores were comparable between protocols.
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 Total WTR scores were comparable between protocols with exception to the 20
cm EPT, 12 cm OFS configuration in which the ‘Low’ protocol acquired twice
as many high density WTR targets as the ‘RDLS’ protocol.
 Static MTR scores were comparable between protocols.
 Dynamic MTR scores were comparable between protocols with exception to the
30 cm EPT, 15 cm OFS configuration in which the ‘Standard’ protocol scored
higher than the ‘Low’ protocol by 50%.
 Image noise was lower when using the ‘Low’ protocol by an average of 3.4%
with exception to the 30 cm EPT, 15 cm OFS configuration in which the ‘Low’



























































































































































































































































































































































































































































































































































































































B.0.5 Comparison of the post-upgrade acquisition mode dose
level 1 protocols: ‘Very Low’ and ‘Low’
The ratio of ESD delivery and image quality scores recorded for the ‘Very Low’ and
‘Low’ acquisition mode dose level 1 protocols have been presented tabularly in Table
B.4. The following comparative statements can be drawn regarding these two proto-
cols:
 ESD delivery was lower when using the ‘Very Low’ protocol to image the 20 cm
EPT configurations by an average of 36.2% and lower when using the ‘Very Low’
protocol to image the 30 cm EPT configurations by an average of 7.8%.
 ICR scores were lower when using the ‘Very Low’ protocol by an average of
20.9% with exception to the 30 cm EPT, 15 cm OFS configuration where both
protocols scored comparably.
 Spatial resolution scores were comparable between protocols.
 Total WTR scores were higher when using the ‘Very Low’ protocol to image the
20 cm EPT configurations where the ‘Very Low’ protocol acquired 17.5% more
high density WTR targets than the ‘Low’ protocol and were when using the
‘Very Low’ protocol to image the 30 cm EPT configurations where the ‘Very Low’
protocol acquired 30% high low density WTR targets than the ‘Low’ protocol.
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 Static MTR scores were comparable between protocols.
 Dynamic MTR scores were comparable between protocols when imaging the 20
cm EPT, 12 cm OFS and 30 cm EPT, 15 cm OFS configurations, and lower
when using the ‘Very Low’ protocol to image the 20 cm EPT, 15 cm OFS and
30 cm EPT, 12 cm OFS configurations by an average of 29.2%.
 Image noise was lower when using the ‘Low’ protocol by an average of 3.4% with
exception to the 30 cm EPT, 15 cm OFS configuration in which the ‘Very Low’























































































































































































































































































































































































































































































































































































































































B.0.6 Comparison of the SHC and EHC high detail
acquisition mode dose level 1 protocols: ‘Standard’
and ‘EHC-IQ+’
The ratio of ESD delivery and image quality scores recorded for the ‘Standard’ and
‘EHC-IQ+’ acquisition mode dose level 1 protocols have been presented tabularly in
Table B.5. The following comparative statements can be drawn regarding these two
protocols:
 ESD delivery was higher when using the ‘Standard’ protocol to image the 20 cm
EPT configurations by an average of 22.3% and lower when using the ‘Standard’
protocol to image the 30 cm EPT configurations by an average of 12.4%.
 ICR scores were higher when using the ‘Standard’ protocol by an average of 19%.
 Spatial resolution scores were comparable between protocols.
 Total WTR scores comparable between protocols with exception to the 20 cm
EPT, 12 cm OFS configuration in which the ‘Standard’ protocol acquired half
as many high density WTR targets as the ‘EHC-IQ+’ protocol.
 Static MTR scores were comparable between protocols.
 Dynamic MTR scores were comparable between protocols.
 Image noise was lower when using the ‘Standard’ protocol by an average of 28.5%
when imaging the 20 cm EPT configurations and lower by an average of 40.3%






















































































































































































































































































































































































































































































































































































































B.0.7 Comparison of the SHC and EHC low dose rate
acquisition mode dose level 1 protocols:‘Low’ and
‘EHC-RDLS’
The ratio of ESD delivery and image quality scores recorded for the ‘Low’ and ‘EHC-
RDLS’ acquisition mode dose level 1 protocols have been presented tabularly in Table
B.6. The following comparative statements can be drawn regarding these two proto-
cols:
 ESD delivery was higher when using the ‘Low’ protocol to image the 20 cm EPT
configurations by an average of 41.8% and lower when using the ‘Low’ protocol
to image the 30 cm EPT configurations by an average of 4.7% .
 ICR scores were higher when using the ‘Standard’ protocol by an average of
23.3% with exception to the 30 cm EPT, 15 cm OFS configuration in which the
‘Low’ protocol scored higher than the ‘EHC-RDLS’ protocol by 14.3% .
 Spatial resolution scores were comparable between protocols with exception to
the 30 cm EPT, 15 cm OFS configuration in which the ‘Low’ protocol scored
higher than the ‘EHC-RDLS’ protocol by 14.3% .
245
 Total WTR scores were comparable between protocols with exception to the 20
cm EPT, 12 cm OFS configuration in which the ‘Low’ protocol acquired twice
as many high density WTR targets as the ‘EHC-RDLS’ protocol.
 Static MTR scores were comparable between protocols.
 Dynamic MTR scores were comparable between protocols with exception to the
30 cm EPT, 15 cm OFS configuration in which the ‘Low’ protocol scored lower
than the ‘EHC-RDLS’ protocol by 33.3% .







































































































































































































































































































































































































































































































































































































































B.0.8 Comparison of the post-upgrade acquisition mode dose
level 2 protocols: ‘Standard’ and ‘CoroPlus’
The ratio of ESD delivery and image quality scores recorded for the ‘Standard’ and
‘CoroPlus’ acquisition mode dose level 2 protocols have been presented tabularly in
Table B.7. The following comparative statements can be drawn regarding these two
protocols:
 ESD delivery was lower when using the ‘Standard’ protocol by an average of
31.0% .
 ICR scores were higher when using the ‘Standard’ protocol by an average of
27.7% with exception to the 30 cm EPT, 15 cm OFS configuration where both
protocols scored comparably.
 Spatial resolution scores were lower when using the ‘Standard’ protocol by an
average of 13.3%
 Total WTR scores were comparable between protocols with exception to the 20
cm EPT, 12 cm OFS configuration in which the ‘Standard’ protocol acquired
half as many high density WTR targets as the ‘CoroPlus’ protocol.
 Static MTR scores were lower when using the ‘Standard’ protocol by an average
of 22.5% when imaging the 12 cm OFS configurations and comparable when
imaging using the 15 cm OFS configuration.
 Dynamic MTR scores were comparable between protocols.
























































































































































































































































































































































































































































































































































































































































B.0.9 Comparison of the post-upgrade acquisition mode dose
level 2 protocols: ‘Low’ and ‘RDLS’
The ratio of ESD delivery and image quality scores recorded for the ‘Low’ and ‘RDLS’
acquisition mode dose level 2 protocols have been presented tabularly in Table B.8.
The following comparative statements can be drawn regarding these two protocols:
 ESD delivery was higher when using the ‘Low’ protocol by an average of 6.5%
with exception to the 30 cm EPT, 12 cm OFS configuration where ESD delivery
was lower when using the ‘Low’ protocol by 6.4% .
 ICR scores were higher when using the ‘Low’ protocol by an average of 18.3% .
 Spatial resolution scores were comparable between protocols.
 Total WTR scores were comparable between protocols.
 Static MTR scores were comparable between protocols.
 Dynamic MTR scores were comparable between protocols.
 Image noise was lower when using the ‘Low’ protocol by an average of 46% with
the exception of the 20 cm EPT, 12 cm OFS configuration where image noise















































































































































































































































































































































































































































































































































































































B.0.10 Comparison of the post-upgrade acquisition mode dose
level 2 protocols: ‘Low’ and ‘Standard’
The ratio of ESD delivery and image quality scores recorded for the ‘Low’ and ‘Stan-
dard’ acquisition mode dose level 2 protocols have been presented tabularly in Table
B.9. The following comparative statements can be drawn regarding these two proto-
cols:
 ESD delivery was lower when using the ‘Low’ protocol to image the 20 cm EPT
configurations by an average of 36% , was lower when using the ‘Low’ protocol to
image the 30 cm EPT, 12 cm OFS configuration by 3.4% and was higher when
using the ‘Low’ protocol to image the 30 cm EPT, 15 cm OFS configuration by
6.1% .
 ICR scores were lower when using the ‘Low’ protocol by an average of 9.6% .
 Spatial resolution scores were comparable between protocols.
 Total WTR scores were comparable between protocols.
 Static MTR scores were comparable between protocols.
 Dynamic MTR scores were comparable between protocols.
 Image noise was lower when using the ‘Low’ protocol to image the 12 cm OFS
configurations by an average of 2.7% and higher when using the ‘Low’ protocol



























































































































































































































































































































































































































































































































































































B.0.11 Comparison of the post-upgrade acquisition mode dose
level 2 protocols: ‘Very Low’ and ‘Low’
The ratio of ESD delivery and image quality scores recorded for the ‘Very Low’ and
‘Low’ acquisition mode dose level 2 protocols have been presented tabularly in Table
B.10. The following comparative statements can be drawn regarding these two pro-
tocols:
 ESD delivery was lower when using the ‘Very Low’ protocol to image the 20 cm
EPT configurations by an average of 31.9% and lower when using the ‘Very Low’
protocol to image the 30 cm EPT configuration by an average of 8.4% .
 ICR scores were comparable between protocols when imaging the 20 cm EPT,
12 cm OFS and 30 cm EPT, 15 cm OFS configurations, and lower when using
the ‘Very Low’ protocol to image the 20 cm EPT, 15 cm OFS and 30 cm EPT,
12 cm OFS configurations by an average of 24% .
 Spatial resolution scores were comparable between protocols.
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 Total WTR scores were higher when using the ‘Very Low’ protocol to image
the 20 cm EPT configurations in which the ‘Very Low’ protocol acquired 17.5%
more high density WTR targets than the ‘Low’ protocol and lower when using
the ‘Very Low’ protocol to image the 30 cm EPT configurations in which the
‘Very Low’ protocol acquired 30% less high density WTR targets than the ‘Low’
protocol.
 Static MTR scores were comparable between protocols.
 Dynamic MTR scores were comparable between protocols with exception to the
30 cm EPT, 15 cm OFS configuration in which the ‘Very Low’ protocol scored
lower than the ‘Low’ protocol by 33.3% .
 Image noise was higher when using the ‘Very Low’ protocol to image the 20 cm
EPT, 12 cm OFS and 30 cm EPT, 15 cm OFS configurations, and lower when
using the ‘Very Low’ protocol to image the 20 cm EPT, 15 cm OFS and 30 cm















































































































































































































































































































































































































































































































































































































































B.0.12 Comparison of the SHC and EHC high detail acqui-
sition mode dose level 2 protocols: ‘Standard’ and
‘EHC-IQ+’
The ratio of ESD delivery and image quality scores recorded for the ‘Standard’ and
‘EHC-IQ+’ acquisition mode dose level 2 protocols have been presented tabularly in
Table B.11. The following comparative statements can be drawn regarding these two
protocols:
 ESD delivery was lower when using the ‘Standard’ protocol by an average of
16.8% .
 ICR scores were higher when using the ‘Standard’ protocol by an average of
33.3% with exception to the 30 cm EPT, 15 cm OFS configuration where ICR
scores were comparable between protocols.
 Spatial resolution scores were comparable between protocols.
 Total WTR scores comparable between protocols.
 Static MTR scores were lower when using the ‘Standard’ protocol by an average
of 23.3% with exception to the 20 cm EPT, 15 cm OFS configuration where
static MTR scores were comparable between protocols.
 Dynamic MTR scores were comparable between protocols with exception to the
30 cm EPT, 12 cm OFS configuration where dynamic WTR scores were lower
when using the ‘Standard’ protocol by an average of 25% .






























































































































































































































































































































































































































































































































































































































B.0.13 Comparison of the SHC and EHC low dose rate
acquisition mode dose level 2 protocols: ‘Low’ and
‘EHC-RDLS’
The ratio of ESD delivery and image quality scores recorded for the ‘Low’ and ‘EHC-
RDLS’ acquisition mode dose level 2 protocols have been presented tabularly in Table
B.12. The following comparative statements can be drawn regarding these two pro-
tocols:
 ESD delivery was higher when using the ‘Low’ protocol by an average of 37.3%
with exception to the 30 cm EPT, 12 cm configuration where ESD delivery was
lower when using the ‘Low’ protocol by 9% .
 ICR scores were higher when using the ‘Low’ protocol by an average of 26.3%
with exception to the 30 cm EPT, 15 cm OFS configuration in which the ‘Low’
protocol scored lower than the ‘EHC-RDLS’ protocol by 18% .
 Spatial resolution scores were comparable between protocols with exception to
the 20 cm EPT, 12 cm OFS configuration in which the ‘Low’ protocol scored
higher than the ‘EHC-RDLS’ protocol by 14.3% .
259
 Total WTR scores were comparable between protocols with exception to the 20
cm EPT, 12 cm OFS configuration in which the ‘Low’ protocol acquired twice
as many low density WTR targets as the ‘EHC-RDLS’ protocol.
 Static MTR scores were comparable between protocols with exception to the 30
cm EPT, 12 cm OFS configuration in which the ‘Low’ protocol scored lower than
the ‘EHC-RDLS’ protocol by 25.0% .
 Dynamic MTR scores were comparable between protocols.







































































































































































































































































































































































































































































































































































































































B.0.14 Comparison of the post-upgrade fluoroscopy mode
dose level 1 protocols: ‘Standard’ and ‘CoroPlus’
The ratio of ESD delivery and image quality scores recorded for the ‘Standard’ and
‘CoroPlus’ fluoroscopy mode dose level 1 protocols have been presented tabularly in
Table B.13. The following comparative statements can be drawn regarding these two
protocols:
 ESD delivery was lower when using the ‘Standard’ protocol by an average of
61.6% .
 ICR scores were lower when using the ‘Standard’ protocol by an average of 52.4%
with exception to the 30 cm EPT, 15 cm OFS configuration where both protocols
scored comparably.
 Spatial resolution was lower when using the ‘Standard’ protocol by an average
of 17.4%.
 Total WTR scores were comparable between protocols with exception to the 30
cm EPT, 15 cm OFS configuration in which the ‘Standard’ protocol acquired
33.3% more high density WTR targets than the ‘CoroPlus’ protocol.
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 Static MTR scores were comparable between protocols with exception to the 20
cm EPT, 15 cm OFS configuration in which the ‘Standard’ protocol scored lower
than the ‘CoroPlus’ protocol by 25.0% .
 Dynamic MTR scores were comparable between protocols with exception to the
30 cm EPT, 12 cm OFS configuration in which the ‘Standard’ protocol scored
higher than the ‘CoroPlus’ protocol by 100.0% .
 Image noise was higher when using the ‘Standard’ protocol by an average of
24.0% with exception to the 30 cm EPT, 12 cm OFS configuration where image


































































































































































































































































































































































































































































































































































































































































B.0.15 Comparison of the post-upgrade fluoroscopy mode dose
level 1 protocols: ‘Low’ and ‘RDLS’
The ratio of ESD delivery and image quality scores recorded for the ‘Low’ and ‘RDLS’
fluoroscopy mode dose level 1 protocols have been presented tabularly in Table B.14.
The following comparative statements can be drawn regarding these two protocols:
 ESD delivery was higher when using the ‘Low’ protocol to image the 20 cm EPT
configurations by an average of 249.4% and higher when using the ‘Low’ protocol
to image the 30 cm EPT configurations by an average of 4.4% .
 ICR scores were lower when using the ‘Low’ protocol to image the 20 cm EPT
configurations by an average of 26.8% and higher when using the ‘Low’ protocol
to image the 30 cm EPT configurations by an average of 100.0% .
 Spatial resolution scores were lower when using the ‘Low’ protocol to image the
20 cm EPT configurations by an average of 20.4% , were higher when using the
‘Low’ protocol to image the 30 cm EPT, 12 cm OFS configuration by 11.1% and
were comparable between protocols when imaging the 30 cm EPT, 15 cm OFS
configuration.
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 Total WTR scores were comparable between protocols.
 Static MTR scores were comparable between protocols with exception to the 30
cm EPT, 12 cm OFS configuration in which the ‘Low’ protocol scored higher
than the ‘RDLS’ protocol by 100.0% .
 Dynamic MTR scores were higher when using the ‘Low’ protocol to image the
12 cm OFS configurations by an average of 75.0% and were comparable when
imaging the 15 cm OFS configurations.
 Image noise was lower when using the ‘Low’ protocol to image the 12 cm OFS
configurations by an average of 8.9% and higher when using the ‘Low’ protocol


























































































































































































































































































































































































































































































































































































































B.0.16 Comparison of the post-upgrade fluoroscopy mode dose
level 1 protocols: ‘Low’ and ‘Standard’
The ratio of ESD delivery and image quality scores recorded for the ‘Low’ and ‘Stan-
dard’ fluoroscopy mode dose level 1 protocols have been presented tabularly in Table
B.15. The following comparative statements can be drawn regarding these two pro-
tocols:
 ESD delivery was higher when using the ‘Low’ protocol by an average of 52.1%
.
 ICR scores were comparable with exception to the 20 cm EPT, 15 cm OFS
configuration where ICR scores were lower when using the ‘Low’ protocol by
16.7%.
 Spatial resolution scores were comparable with exception to the 30 cm EPT, 12
cm OFS configuration where spatial resolution was lower when using the ‘Low’
protocol by 9.1% .
 Total WTR scores were comparable between protocols with exception to the 30
cm EPT, 15 cm OFS configuration where the ‘Low’ protocol acquired 25.0% less
high density WTR targets than the ‘Low’ protocol acquired.
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 Static MTR scores were comparable between protocols when using the 20 cm
EPT, 12 cm OFS configuration, were lower when using the ‘Low’ protocol to
image the 15 cm OFS configurations by an average of 41.7% and were higher
when using the ‘Low’ protocol to image the 30 cm EPT, 12 cm OFS configuration
by 100.0% .
 Dynamic MTR scores were comparable between protocols with the exception
of the 20 cm EPT, 15 cm OFS configuration where dynamic MTR scores were
lower when using the ‘Low’ protocol by 33.3% .









































































































































































































































































































































































































































































































































































































































B.0.17 Comparison of the post-upgrade fluoroscopy mode dose
level 1 protocols: ‘Low (15 FPS)’ and ‘Low’
The ratio of ESD delivery and image quality scores recorded for the ‘Low (15 FPS)’
and ‘Low’ fluoroscopy mode dose level 1 protocols have been presented tabularly in
Table B.16. The following comparative statements can be drawn regarding these two
protocols:
 ESD delivery was higher when using the ‘Low’ protocol operated in the 15 FPS
setting to image the 12 cm OFS configurations by an average of 112.1% and
higher when using the ‘Low’ protocol operated in the 15 FPS setting to image
the 15 cm OFS configurations by an average of 97.0%.
 ICR scores were higher when using the ‘Low’ protocol operated in the 15 FPS
setting by an average of 82.2% with exception to the 20 cm EPT, 12 cm OFS
configuration where both protocols scored comparably.
 Spatial resolution scores were comparable when imaging the 20 cm EPT configu-
rations and higher when using the ‘Low’ protocol operated in the 15 FPS setting
when imaging the 30 cm EPT configurations by an average of 10.0% .
271
 Total WTR scores were comparable between protocols with exception to the 20
cm EPT, 15 cm OFS configuration where the ‘Low’ protocol operated in the 15
FPS setting acquired 25.0% less low density WTR targets.
 Static MTR scores were comparable between protocols with exception to the 30
cm EPT, 15 cm OFS configuration in which the ‘Low’ protocol operated in the
15 FPS setting acquired twice as many MTR targets.
 Dynamic MTR scores were comparable between protocols when imaging the 12
cm OFS configurations and higher when using the ‘Low’ protocol operated in
the 15 FPS setting by an average of 75.0% .
 Image noise was higher when using the ‘Low’ protocol operated in the 15 FPS
















































































































































































































































































































































































































































































































































































































































B.0.18 Comparison of the post-upgrade fluoroscopy mode dose
level 1 protocols: ‘Very Low’ and ‘Low’
The ratio of ESD delivery and image quality scores recorded for the ‘Very Low’ and
‘Low’ fluoroscopy mode dose level 1 protocols have been presented tabularly in Table
B.17. The following comparative statements can be drawn regarding these two pro-
tocols:
 ESD delivery was lower when using the ‘Very Low’ protocol by an average of
53.0% .
 ICR was lower when using the ‘Very Low’ protocol to image the 20 cm EPT
configurations by an average of 28.4% and lower when using the ‘Very Low’
protocol to image the 30 cm EPT configurations where no iodine dots were
resolved in the acquired ‘Very Low’ protocol images.
 Spatial resolution scores were comparable between protocols when imaging the
12 cm OFS configurations and lower when using the ‘Very Low’ protocol to image
the 15 cm OFS configurations by an average of 9.6% .
 Total WTR scores were comparable between protocols.
 Static MTR scores were comparable between protocols with exception to the 30
cm EPT, 12 cm OFS configuration where the ‘Very Low’ protocol acquired half
as many motion targets as the ‘Low’ protocol.
 Dynamic MTR scores were lower when using the ‘Very Low’ protocol to image
the 12 cm OFS configurations by an average of 58.4% and were comparable
between protocols when imaging the 15 cm OFS configurations.



























































































































































































































































































































































































































































































































































































































B.0.19 Comparison of the post-upgrade acquisition mode dose
level 2 protocols: ‘Low’ and ‘Standard’
The ratio of ESD delivery and image quality scores recorded for the ‘Low’ and ‘Stan-
dard’ fluoroscopy mode dose level 2 protocols have been presented tabularly in Table
B.18. The following comparative statements can be drawn regarding these two pro-
tocols:
 ESD delivery was lower when using the ‘Low’ protocol by an average of 3.8%
with exception to the 30 cm EPT, 12 cm OFS configuration where ESD delivery
was higher when using the ‘Low’ protocol by 0.7% .
 ICR scores were higher when using the ‘Low’ protocol by an average of 114.4%
with exception to the 20 cm EPT, 15 cm OFS configuration where ICR scores
were 40% lower when using the ‘Low’ protocol.
 Spatial resolution scores were comparable between protocols with exception to
the 20 cm EPT, 12 cm OFS configuration where spatial resolution scores were
10.7% lower when using the ‘Low’ protocol.
 Total WTR scores were comparable between protocols with exception to the 30
cm EPT, 20 cm OFS configuration where 25.0% less high density WTR targets
were acquired by the ‘Low’ protocol.
 Static MTR scores were comparable between protocols.
 Dynamic MTR scores were comparable between protocols with exception to the
20 cm EPT, 12 cm OFS configuration where the ‘Low’ protocol acquired 25%
less motion targets than the ‘Low’ protocol.


































































































































































































































































































































































































































































































































































































































B.0.20 Comparison of the post-upgrade acquisition mode dose
level 2 protocols: ‘Low (15 FPS)’ and ‘Low’
The ratio of ESD delivery and image quality scores recorded for the ‘Low (15 FPS)’
and ‘Low’ fluoroscopy mode dose level 2 protocols have been presented tabularly in
Table B.19. The following comparative statements can be drawn regarding these two
protocols:
 ESD delivery was higher when using the ‘Low’ protocol operated in the 15 FPS
setting to image the 12 cm OFS configurations by an average of 109.9% and
higher when using the ‘Low’ protocol operated in the 15 FPS setting to image
the 15 cm OFS configurations by an average of 101.1% .
 ICR scores were higher when using the ‘Low’ protocol operated in the 15 FPS
setting to image the 20 cm EPT, 12 cm OFS phantom configuration by 18.2%,
were higher when using the ‘Low’ protocol operated in the 15 FPS setting to
image the 15 cm OFS phantom configurations by an average of 58.4% and were
lower when using the ‘Low’ protocol operated in the 15 FPS setting to image
the 30 cm EPT, 12 cm OFS phantom configuration by 25%.
 Spatial resolution scores were higher when using the ‘Low’ protocol operated
in the 15 FPS setting by an average of 11.9% with exception to the 20 cm
EPT, 15 cm OFS configuration where spatial resolution was comparable between
protocols.
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 Total WTR scores were comparable between protocols.
 Static MTR scores were comparable between protocols.
 Dynamic MTR scores were comparable between protocols.
 Image noise was higher when using the ‘Low’ protocol operated in the 15 FPS
setting to image the 20 cm EPT configurations by an average of 5.25% and was
higher when using the ‘Low’ protocol operated in the 15 FPS setting to image





















































































































































































































































































































































































































































































































































































































B.0.21 Comparison of the post-upgrade acquisition mode dose
level 2 protocols: ‘Very Low’ and ‘Low’
The ratio of ESD delivery and image quality scores recorded for the ‘Very Low’ and
‘Low’ fluoroscopy mode dose level 2 protocols have been presented tabularly in Table
B.20. The following comparative statements can be drawn regarding these two pro-
tocols:
 ESD delivery was higher when using the ‘Very Low’ protocol by an average of
9.7% .
 ICR scores were lower when using the ‘Very Low’ protocol to image the 12 cm
OFS configurations by an average of 51.2% , comparable when imaging the 20
cm EPT, 15 cm OFS configuration and lower when using the ‘Very Low’ protocol
to image the 30 cm EPT 15 cm OFS configuration where no iodine dots were
resolved in the acquired ‘Very Low’ protocol images.
 Spatial resolution was comparable between protocols with the exception of the
30 cm EPT, 12 cm OFS configuration where spatial resolution was lower when
using the ‘Very Low’ protocol by 9.1% .
 Total WTR was comparable between protocols.
 Static MTR was comparable between protocols with exception to the 20 cm
EPT, 12 cm OFS configuration where the ‘Very Low’ protocol acquired 25% less
motion targets than the ‘Low’ protocol.
 Dynamic MTR was comparable between protocols.
 Image noise was lower when using the ‘Very Low’ protocol by an average of 6.7%
with exception to the 30 cm EPT, 12 cm OFS configuration where image noise
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J.F., Chao, C.P., Cohen, A.M., Dixon, R.G. and Gross, K., 2009. Guidelines
for patient radiation dose management. Journal of Vascular and Interventional
Radiology, 20(7), pp.S263-S273.
131) E. Chambers, C., A. Fetterly, K., Holzer, R., Paul Lin, P.J., C. Blankenship, J.,
Balter, S. and K. Laskey, W., 2011. Radiation safety program for the cardiac
catheterization laboratory. Catheterization and Cardiovascular Interventions,
77(4), pp.546-556.
132) Haqqani, O.P., Agarwal, P.K., Halin, N.M. and Iafrati, M.D., 2012. Minimizing
radiation exposure to the vascular surgeon. Journal of vascular surgery, 55(3),
pp.799-805.
133) Kuon, E., Dahm, J.B., Empen, K., Robinson, D.M., Reuter, G. and Wucherer,
M., 2004. Identification of less-irradiating tube angulations in invasive cardiol-
ogy. Journal of the American College of Cardiology, 44(7), pp.1420-1428.
134) Pasciak, A.S. and Jones, A.K., 2011. Does “spreading” skin dose by rotating
the C-arm during an intervention work?. Journal of Vascular and Interventional
Radiology, 22(4), pp.443-452.
135) Wilson, S.M., Prasan, A.M., Virdi, A., Lassere, M., Ison, G., Ramsay, D.R.
and Weaver, J.C., 2016. Real-time colour pictorial radiation monitoring during
coronary angiography: effect on patient peak skin and total dose during coronary
angiography. Eurointervention, 12, pp.e939-e947.
136) National Electrical Manufacturers Association, 2000. NEMA Standards Pub-
lication XR 21-2000. Characteristics of and test procedures for a phantom to
benchmark cardiac fluoroscopic and fluorographic performance. Washington,
301
     
        
         
              
      
  
           
           
    
             
              
         
        
  
              
            
          
      
             
           
         
     
DC: National Electrical Manufacturers Association, pp.1-26.
137) Computerized Imaging Reference Systems, Incorporated, 2013, NEMA SCA&I
Cardiovascular Fluoroscopic Benchmark Phantom Model 901, Last accessed:
October 17 2018, 
http://www.cirsinc.com/file/Products/901/901%20DS%20102113(1).pdf
138) Balter, S., Heupler, F.A., Lin, P.J.P. and Wondrow, M.H., 2001. A new tool for
benchmarking cardiovascular fluoroscopes. Catheterization and cardiovascular 
interventions, 52(1), pp.67-72.
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